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Summary 
 
Campylobacter jejuni is the most common cause of human bacterial gastroenteritis, 
and infections can lead to more serious complications such as Guillian-Barre 
syndrome. Campylobacter infects many species, but importantly occurs as a 
commensal in chickens, where it can colonise to a very high level. Chicken meat is 
often contaminated during processing. Improper handling of raw poultry and intake 
of undercooked poultry are the major risk factors for campylobacteriosis in humans. 
The poultry industry wants to reduce contamination of its product, and determining 
the factors that allow the bacterium to colonise to such a high level is one promising 
approach. 
 
There are many strategies to reduce Campylobacters in poultry. Among these 
vaccination is the acceptable and the easiest method for reducing the colonization in 
poultry. The choice of antigen for delivery to the host immune system and induction 
of immune responses through optimal expression of foreign antigens are two aspects 
of creating a successful vaccine. STM-1 is an attenuated strain of S. enterica serovar 
Typhimurium mutant and these attenuated strains have the potential to deliver 
heterologous antigens and induce protection against various diseases. In this study, 
several Campylobacter antigens were selected and delivered to chickens as vaccine 
constructs. Antigens were chosen on the basis of pre-existing knowledge in the 
literature. Antigens were cloned initially into plasmid vectors for expression in 
STM1. All vaccinated groups had a reduced level of colonisation compared to the 
control groups; however the reduction was not sufficient to be a commercial vaccine. 
xix 
 
Various Bioinformatics analyses have been used for the further selection of potential 
antigens.  
 
Elucidating the Campylobacter proteins (particularly orphan proteins) that interact 
with host cells and therefore the chicken humoral immune system (i.e. secreted 
proteins) may lead to new approaches for reducing or eliminating Campylobacter 
jejuni from chickens and hence reduce the incidence of human infection. 
Bioinformatics tools were used to identify the predicted secreted proteins that are 
non-classically secreted and where the function of the proteins is still unknown. It is 
conceivable that a protein of unknown function that is predicted to be secreted may 
be a virulence protein. Of the approximately 1623 proteins encoded by the genome, 
up to 407 are predicted to be secreted or inserted into the cell membrane, as 
identified by using Bioinformatics. The detailed Bioinformatics analyses were 
performed using SignalP 3.0, SecretomeP 2.0, Gneg-PLoc, Gneg-mPLoc, TMHMM 
and MemType-2L. These analyses reduced the number of C. jejuni proteins to 41 
which are predicted to undergo extracellular secretion. Proteins selected for further 
analyses were non-classically secreted proteins with a Sec score above 0.5. Cj0391c, 
Cj0428, Cj1656c Cj0243c and Cj1450 were selected for knock-out analysis. No 
studies have been previously reported on these selected hypothetical. 
 
This study identified such proteins, and developed gene knock-out strains that will 
no longer express the protein. The knock-outs were created in order to assess the role 
in cellular adhesion of the proteins. The gene inserts were first cloned into the 
pBluescript vector. Inverse PCR was used to delete part of the gene and to introduce 
a BamH1 site. The purified PCR product and the empty PMW2 vector were digested 
xx 
 
with BamH1. Then the products were ligated with the 1.4 Kb Kanamycin cassette of 
the PMW2 vector. The resulting suicide plasmid was transformed into 
Campylobacter. In vitro analysis of the resulting knock-outs was been performed to 
analyse the phenotype using INT 407 cells. Significant differences in phenotype 
were observed with one of the knock-out’s showing no adherence to epithelial cells.  
 
Although the Bioinformatics analyses reduced the choice of possible antigens as 
vaccine candidates, another analysis was carried out to strengthen the choice of 
antigens for future work. This study concentrated on the differences in the proteomes 
of C. jejuni, which is a commensal organism in chickens, and C. concisus, which is a 
non-coloniser in chickens. Both however cause gastroenteritis in humans. If 
differences/similiarities in the secretomes is found, it may be possible to find out the 
actual proteins responsible for the high level of colonization by C. jejuni in chickens. 
Similarity between the two proteomes was investigated using BlastP. This 
comparative analysis has identified C. jejuni specific proteins with no homologue 
encoded by the C. concisus genome. Out of the 407 C. jejuni proteins analysed 109 
were found to be with no C. concisus homologue. Bioinformatics tools were used to 
further explore the secretome of C.concisus. One hundred and seventy proteins were 
predicted to be at the top of the list of proteins that may be considered future vaccine 
candidates against this organism.  
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1.1 Introduction 
 
Campylobacteraceae and “Helicobacteraceae” are the two major  families  of 
“Epsilonproteobacteria” [1]. Campylobacter are thermophilic, Gram-negative 
bacteria that require microaerophilic growth conditions (3-15% O2, 3-5% CO2), with 
carbon dioxide as an important growth factor [2]. It grows optimally at 420 C, which 
reflects an adaptation to its natural habitat, the intestine of warm-blooded animals 
and birds [3]. The Gram-negative rods are tapered at either end (1.5- 6.0 m x 0.2-
0.5 m) [3], and are motile due to a polar flagellum extending from one or both ends 
of the cell [2, 4]. Campylobacter jejuni is the leading cause of bacterial-mediated 
diarrhoeal disease worldwide [5]. Both in the developing and developed countries, 
children under the age of five and young adults remain most frequently affected [6].  
C. jejuni can cause a spectrum of diseases ranging from mild and self-limiting 
gastroenteritis, to post-infection complications such as Gullain-Barré syndrome and 
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Miller Fisher syndrome [6-8]. The most important post-infectious complication of 
campylobacteriosis is Gullain-Barré syndrome [9].  
 
The human pathogen is not transmitted from person to person, but often associated 
with the consumption of raw or undercooked poultry meat or other foods that have 
been cross- contaminated with raw poultry [5]. It is the major contributor to 
campylobacteriosis in humans causing many outbreaks and sporadic cases 
worldwide [10-13]. Although a number of candidate virulence factors have been 
identified, the mechanism involved in the pathogenesis are still poorly understood [7, 
9, 14]. 
 
Campylobacter was first described in 1886 by Theodor Escherich. He isolated spiral 
bacteria from the colons of children who had died of ‘cholera infantum’ [15].  
Although he observed spiral-shaped organisms in stool samples under the 
microscope, he was unsuccessful in culturing the organism on solid media. In 1909, 
McFadyean and Stockman reported an unknown bacterium that was frequently 
isolated from aborted foetuses, called Vibrio at that time [15, 16]. The first well-
documented instance of human Campylobacter infection was reported in 1938. It 
was isolated from the blood of 13 victims of a milk-borne diarrhoeal outbreak at two 
adjacent state institutions [17]. In 1950, Elizabeth King named the spiral bacteria as 
“related to vibrios” before they were subsequently classified as Campylobacter 
species by M. Sebald and M. Veron [17]. The term Campylobacter (Greek, curved 
rod) was proposed by Sebald and Veron in 1963 as a generic name for the 
microaerophilic vibrios [18]. The concept that bacteria are present in undercooked 
meat, and that chickens may be the primary source of human infection by 
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Campylobacter species was suggested by King [18]. Although Campylobacter 
species were not recognised as a causative agent for diarrhoea in humans until 1970, 
they had been considered a possible cause of gastric illness in man for centuries [17]. 
Campylobacter species are now considered one of the most frequently isolated 
enteric pathogens from human diarrhoea [19]. Although many species exist, C. jejuni 
is the most frequently isolated pathogen, and to a lesser extent, C. coli [20].  
 
1.2 Campylobacter biology 
 
Campylobacter jejuni is a Gram-negative, microaerophilic bacterium, which requires 
oxygen at lower levels (up to 5%) than what is present in the atmosphere (~20% 
oxygen) [21]. They are curved rods in fresh cultures but can change to a coccoid 
form after repeated subculturing, exposure to atmospheric oxygen or other stresses 
[22]. The coccoid forms are non–culturable, though viable and are difficult to detect 
efficiently by standard culture methods [23]. Under favourable conditions, these 
VBNC (viable but non culturable) forms become potentially pathogenic [23]. They 
are proposed to be in a dormant stage, though their existence and infectivity is 
controversial. Therefore the coccids’ transmission and colonisation potential needs to 
be investigated [23, 24]. 
 
The spiral-shaped  bacteria belong to the delta epsilon class of proteobacteria, in the 
order Campylobacteriales [3, 7], along with Heliobacter and Wolinella, and all three 
genera have small genomes of 1.6-2.0 million base pairs (bp). H. pylori is pathogenic 
to humans causing gastric ulcers, but can also be carried asymptomatically. 
Wolinella includes the species W. succinogenes which is a commensal in the 
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intestine of cattle. These organisms appear to be host-adapted and maintain their 
existence without generating an immune response sufficient for clearance. They 
exhibit long-term commensal relationships with their hosts without any strong 
inflammatory immune response [7]. Although Campylobacter species can grow in a 
temperature range of 32° C - 45° C, the optimum growth temperature is 42o C, which 
is the natural avian body temperature [25, 26]. Preferably, cultures are incubated at 
42° C to minimize the growth of contaminants and to provide optimal growth 
conditions for C. jejuni [20]. 
 
1.3 Bioinformatics analyses of the genome sequence of C. jejuni NCTC 11168  
 
According to the taxonomy and nomenclature, the genus Campylobacter comprises 
sixteen species and six subspsecies [20]. The genome sizes of C. jejuni and C. coli 
were estimated to be 1.7 Mbp with a map of C. jejuni’s genome constructed using 
DNA probes [27-29]. In the year 2000, C. jejuni NCTC11168 was the first food-
borne pathogen to have its entire genome sequenced [30]. The C. jejuni NCTC11168 
genome is a circular chromosome of 1.64 million bp, consisting of 1654 predicted 
coding sequences (CDS).  94.3% of the genome encodes proteins making it the most 
gene dense bacterium to be sequenced so far. It has a low G+C content (30.6%) and 
contains many hypervariable sequences that may be involved in phase variation (i.e. 
act as regulator switches for the expression of genes or operons), and the 
modification of the structures involved in survival strategies such as capsules, lipo-
oligosaccharides and flagella. Hypervariable regions are short homopolymeric tracts 
of DNA that contain multiple repetitions of a single nucleotide and may encode 
structures involved in the bacterium’s ability to evade the immune system and 
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colonise the host [7, 30].  In 2007, advanced Bioinformatics techniques were used to 
re-annotate and re-analyse the C. jejuni NCTC11168 genome sequence. This 
analysis reduced the number of predicted protein coding sequences from 1654 to 
1643, and led to the identification of genetic loci regions that code for important 
surface structures [31]. Of the 1643 predicted protein coding sequences in the C. 
jejuni genome, 77.8% have a known function, 13.5% have an unknown function and 
8.7% have no matches in the protein database. 
 
Major structural differences between Campylobacter strains were described as being 
a result of the variation in the number of homopolymeric tracts between species [32, 
33].  The genome analyses also revealed new genetic loci which may be involved in 
the specific metabolic and pathogenic properties of individual strains [32, 34] . 
 
Previous studies have shown that the genetic variability of C. jejuni is always 
exhibited through genomic reorganization and phase variation [35]. Mobile genetic 
elements, the uptake of DNA via natural transformation, and changes in 
hypervariable sequences were described as the factors responsible for the 
evolutionary changes of the genome sequence of C. jejuni. A variation in the number 
of hypervariable G tracts has been observed in different strains, such as NCTC11168 
(29), RM1221 (25), and 81-176 (19), while 81116 (NCTC11828) contains 17 
homopolymeric G tracts. Of all the C. jejuni strains that have had their genomes 
sequenced, 81116 has the fewest hypervariable G tracts. This strain is therefore 
considered to be more stable, reliable and suitable for experimentation [33-35]. 
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Major structural changes result from the hypervariable regions, including gene 
inactivation by deletion or addition of single bases resulting in altered immuno- 
reactivity [5, 8, 36, 37]. Phase variation is heritable and reversible [38]. C. jejuni is a 
naturally competent bacterial species. It is able to uptake DNA from the environment 
and incorporate it into its genome by genetic exchange and recombination [9]. 
Natural transformation is a mechanism for generating genetic diversity where 
exogenous DNA is taken up and integrated into the genome without treatment of the 
recipient cells [10, 39]. Bacteria can attain antibiotic resistance by mutations and 
horizontal gene transfer. Although natural transformations play a major role in 
genetic exchange and antibiotic resistance, its role in mediating the transfer of 
genetic material encoding antibiotic resistance is still poorly understood [11, 12, 40]. 
Natural transformation of C. jejuni is regulated by type II secretion systems, some 
components of a type IV secretion system and also by the competence of the strains 
[9, 13]. 
 
1.4 Epidemiology- Distribution and frequency of Campylobacter species in host 
organisms 
 
Although many Campylobacter strains can cause gastric infections, C. jejuni is one 
of the most common agents for gastric illness including traveller’s diarrhea [41]. In 
humans, 80-90% of enteric Campylobacter infections are associated with C. jejuni 
[13] , and C. coli accounts for most of the remainder [3, 15].  
 
The studies conducted by Tompkins et al  [16]  and Noone et al [19]  to identify the 
infectious agent in diarrhoea, reported that Campylobacter species were the most 
commonly isolated bacteria from the gastric illness cases reported in England and 
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Scotland. Children between 1–4 years old were found to be the most susceptible to 
the infection (40.8%), followed by infants (16.9%) and then the 5–9 year old age 
group (11.3%) [20]. Other Campylobacter species such as C. curva, C. rectus, C. 
gracilis, and C. concisus have a potential role in gingivitis and periodontitis in 
humans [21] . 
 
C. jejuni exists as a commensal organism in the gastrointestinal tract of chickens 
where it can colonize to a higher level than in domesticated animals such as cattle, 
swine, sheep and wild birds [13, 42, 43]. The primary reservoir for Campylobacter is 
poultry [42], and contaminated poultry meat is considered an important source of 
campylobacteriosis. Although all poultry species can carry the organism, the major 
risk is associated with those chickens bred for their meat because of the high levels 
of chicken consumption [44, 45]. 
 
Although various sources such as unpasteurized or badly pasteurized milk, cross-
contamination from raw meats to ready to eat foods, migratory birds and barbecue 
use can cause Campylobacter infections in humans, contaminated poultry meat 
remains the major risk factor for campylobacteriosis world wide [22, 46, 47].  
 
1.5 Campylobacteriosis in developed and developing countries 
 
The rate of infections caused by Campylobacter is higher than the infections caused 
by Salmonella and Shigella world wide [13, 42]. Differences in the clinical and 
epidemiological aspects of campylobacteriosis have been observed between 
developed and developing countries [13]. In developed countries, the disease is self 
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limiting and characterized by bloody diarrhoea with mucus. In the developing world, 
infection is more frequent among children and is characterised by watery diarrhoea. 
The reason for this disparity of outcomes is poorly understood. Most of the research 
and control measures occur in the developed countries because of the high incidence 
rate reported.  The number of cases in developing countries is still unknown due to 
the lack of national surveillance programs. C. jejuni enteritis has seasonal preference 
in developed countries, possibly due to the extreme temperature variation and 
adequate surveillance for epidemics [23, 48, 49]. Table 1.1 shows a comparison of 
features of C. jejuni infection in developed and in developing countries. The major 
reason for clinical and epidemiological features of C. jejuni infections in developing 
countries is the development of protective immunity due to the high level exposure 
to the organism earlier in life. The control strategies (farm biosecurity and cross 
contamination at slaughter) and monitoring programs (sampling and testing 
schemes) for reducing Campylobacter in poultry varies between countries. The 
control strategies adopted in the developed and developing countries varies due to 
their production system, cost involved and government regulations. For instance, in 
countries such as Norway, Denmark and Iceland the positive flocks should be frozen 
to reduce the Campylobacter prevalence [50]. 
 
 
 
 
 
 
9 
 
Table 1.1 Comparison of the features of C. jejuni infections between developed and 
developing countries [51]. 
Feature Developed countries Developing 
countries 
Average number of infections 
/lifetime 
0–1 >5 
Principal age group affected Young adults Children <2 years old 
Principal manifestation of illness Inflammatory 
diarrhoea 
Simple diarrhoea 
Widespread immunity among adults Absent Present 
 
 
1.6 Clinical features of infection 
 
The incubation period is usually 24–72 hours, although longer incubation periods of 
up to one week can occur when a lower rate of inoculum is ingested [52]. Disease is 
characterized by abdominal cramping, fever and acute diarrhoeal illness. Initially 
diarrhoea may be watery and then becomes bloody. Due to the presence of PMNLS 
(Polymorphonuclear leucocytes) and microscopic blood in the stool, it is evident that 
there is some kind of inflammatory response associated with the disease [53]. Tissue 
invasion has also been reported in previous studies using animal models [54]. 
Campylobacteriosis can lead to extraintestinal and nonsuppurative extraintestinal 
infections (including reactive arthritis and GBS), and may cause infections in other 
organs such as cholecystitis, pancreatitis, cystitis or septic abortion [13, 55]. 
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1.7 Diagnosis of C. jejuni infection  
 
Diagnosis is usually performed by culturing faecal samples on selective media and 
by visualising the organism in a Gram stain under the microscope, or by dark field or 
phase contrast microscopy. C. jejuni infections often lead to increased levels of 
serum antibodies, therefore serological methods may be preferred for diagnosis of C. 
jejuni infection [13]. 
 
1.8 Isolation, culture, and storage of Campylobacter species. 
 
Campylobacter species are small, highly motile, cork-screw shaped bacteria that 
have the ability to penetrate through the membrane filters with pore sizes of 0.45 
µm, 0.65µm and 0.8 µm. A filtration technique has been described by Butzler and 
Dekeyser in their previous studies as a method for Campylobacter isolation. The 
filtrate is inoculated onto selective medium and incubated under microaerophilic 
conditions for 2- 3 days at 420 C. Other methods include direct plating onto selective 
medium, previously described by Skirrow in 1977 [28], and the use of enrichment 
broth with different supplements. The inoculated selective medium and broth with 
supplements are also incubated at 420 C under microaerophilic conditions for 2-3 
days [56]. Buffered peptone water (BPW) supplemented with blood and antibiotics 
can be used as an enrichment medium for the isolation of C. jejuni and C. coli [33]. 
It was found that the isolation rate from retail broiler samples using buffered peptone 
broth was similar to the isolation rate when Bolton’s broth was used as the 
enrichment medium. Even though different types of media can be used to cultivate 
Campylobacter, Mueller Hinton broth and agar give the best isolation rate at an 
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optimum atmosphere of 85% N2, 10% CO2, and 5% O2. Ten percent glycerol or 
DMSO can be mixed with the culture for long term storage at -80º C [34].  Multiple 
preservation techniques can be used for long-term storage of C. jejuni, FBP medium 
is the most successful with 100 and 80% recovery after 1 year at -850 C and -200 C 
respectively [57]. 
 
1.9 Identification of Campylobacter  
 
Conventional culture, PCR, and DNA microarray techniques have been developed 
recently for detection of Campylobacter species directly from chicken faeces [58]. 
PCR assays using probes derived from genes were used for the concurrent detection 
of Campylobacter species, and C. coli or C. jejuni and the specificity of this assay 
was 97% [59, 60]. Studies have demonstrated that molecular tools such as PCRs, 
DNA sequencing and Multilocus Sequence Typing (MLST), have the potential to 
enhance the diagnosis of bacterial infections caused by C. jejuni [35].  
 
1.9.1 Characterisation of Campylobacter jejuni isolates 
 
The identification of Campylobacter species is an important step toward a better 
understanding of the infections linked with this organism [14, 61-63]. Significant 
factors that influence Campylobacter epidemiology and pathogenesis are the 
plasticity of the genome, and horizontal gene transfer or lateral gene transfer (LGT) 
[64, 65]. Phenotypic plasticity is the ability of an organism to modify its phenotype 
in response to variation in the environment, and LGT is any process in which an 
organism incorporates genetic material from another organism into its genome. If 
12 
 
plasticity is low, the phenotype of an organism can be reliably predicted from 
knowledge of the genotype, despite any environmental irregularity during 
development. Various typing schemes have been developed to characterize 
Campylobacter isolates in the past two decades [66, 67]. The various typing systems 
can be classified into phenotypic methods and genotypic methods. Phenotypic 
methods are based on expressed features such as somatic antigens or enzymatic 
activity i.e. an organism's actual observed properties, such as morphology, 
development, behaviour or metabolic activity. The most common phenotypic 
methods are serotyping, Colicin typing, antibiotic resistance pattern, biotyping, 
protein or fatty acid profile analysis, Multilocus enzyme electrophoresis (MLEE) and 
phage typing. Genotypic methods are based on specific molecular features of 
chromosomal or plasmid DNA i.e. an organism's full hereditary information, even if 
not expressed.  The genotypic methods can be grouped into gel based methods, 
micro arrays, sequence based typing schemes, real-time PCR analysis (polymerase 
chain reaction) and high resolution melt analysis. Some of the commonly used 
typing schemes are described in the following subsections.  
 
1.9.1.1 Phenotypic Methods 
 
Some of the commonly used phenotypic methods are Serotyping, Phage typing, 
Biotyping and Multilocus enzyme electrophoresis (MLEE). 
 
1.9.1.1.1 Serotyping 
 
Serotyping techniques regularly have a crucial role in determining species and 
subspecies. The serotyping methods identify organisms to the sub-species level 
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based on a variety of factors, allowing differentiation between two members of the 
same species [68, 69]. Two serotyping schemes known as Penner serotyping [70] 
and Lior serotyping [71] have been used exclusively for typing Campylobacter 
isolates. Penner serotyping is a widely accepted and well evaluated phenotypic 
method which detects the passive agglutination of soluble heat-stable (HS) antigens, 
while Lior serotyping detects the slide agglutination of heat-labile antigens from live 
cells. Even though both outbreak and sporadic isolates can be identified via 
serotyping, some isolates cannot be indentified by these methods.  The complexity 
and expenses involved in preparing antisera, the high number of unidentifiable 
strains, and inconsistent and irreproducible results are some of the limitations of 
these serotyping methods. However these methods are very useful when used in 
combination with other typing techniques [72]. 
 
1.9.1.1.2 Phage typing 
 
Phage typing helps to identify the source of outbreaks by detecting single strains of 
bacteria. Frost et al. describes the use of phage typing of C. jejuni as an adjunct to 
serotyping [73]. The specificity of Campylobacter phages for host cell surface 
receptors is utilized in Phage typing techniques.  The Campylobacter phage typing 
schemes are detailed by Grajewski and colleagues [74], Salama and colleagues [75] 
and Khakhria and Lior [76]. The primary scheme developed by Grajewski and 
colleagues in 1985 used 14 virulent bacteriophages isolated from poultry faeces. The 
scheme developed by Salama and colleagues in 1990 combined six phages from the 
Grajewski and colleagues’ scheme with 10 virulent phages isolated from various 
sources, including pig and poultry manure, and sewage effluent. Khakhria and Lior 
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extended the Grajewski and colleagues’ scheme of 14 phages, with an additional five 
phages isolated from chicken litter. Phage typing also has cost and complexity 
limitations similar to serotyping, but the combinatorial analysis with other typing 
schemes is recommended [77].   
 
1.9.1.1.3 Biotyping 
 
Several biotyping schemes are illustrated in the literature [78-81] that can distinguish 
strains of thermophilic Campylobacter such as C. jejuni, C. coli, and C. lari. This 
technique is based on biochemical properties of isolates such as hydrogen sulphide 
production, hippurate hydrolysis and resistance to various chemicals. The advantages 
of biotyping are the use of less chemicals and simplicity compared to procedures 
such as the preparation of anitsera. Biotyping is extensively used in Campylobacter 
epidemiological studies and speciation because of its ability to type all isolates with 
robust and reliable results. However, biotyping is used in conjunction with 
genotyping methods because biotyping alone cannot detect epidemiological links 
between isolates [66].  
 
1.9.1.1.4 Multilocus enzyme electrophoresis (MLEE) 
 
Multilocus enzyme electrophoresis (MLEE) is adopted in studies of eukaryotic cell 
genetics to detect allelic variation in a structural gene by assessing the net 
electrostatic charge of the encoded polypeptide [82]. In this method, organisms are 
characterised by the relative mobilities of multiple core metabolic enzymes through 
the electrophoresis gel. Differences in amino acid sequences among enzymes results 
in different mobilities and thus the alleles at each locus classify the EM 
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(electrophoretic mobility) of their products. Enzymatic phenotype diversity is a 
substitute for DNA sequence diversity, however this method’s resolution is lower 
than that obtained by Multilocus sequence typing (MLST) [83].  
 
1.9.1.2 Genotypic Methods 
 
Genotyping determines the genes (genotype) of an organism by examining the 
organisms DNA sequences with molecular tools. Molecular subtyping methods have 
been developed to reduce the limitations of phenotypic methods. The major 
advantage of genotyping techniques is the potential for universal availability [84]. 
The currently available technologies for genotypic subtyping of Campylobacter 
species, and their merits and demerits are described in several journal articles [66, 
85-87].  The genotyping methods can be generally classified as Gel based methods, 
Sequence based typing schemes, Micro arrays, genotyping and real-time PCR 
analysis and High resolution melt analysis. 
 
Gel based methods – flaA typing, pulsed field gel electrophoresis (PFGE), random 
amplification of polymorphic DNA (RAPD), amplified fragment length 
polymorphism detection (AFLPD). 
Sequence based typing schemes- multilocus sequence typing (MLST), flaA SVR 
sequencing, Whole genome sequencing, clustered regularly interspaced short 
palindromic repeats (CRISPR). 
Micro arrays – comparative genome hybridisation (CGH).  
Genotyping using real-time PCR analysis – MLST-SNP interrogation, binary gene 
based typing. 
High resolution melts analysis (HRM) – CRISPR HRM. 
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1.10 The pathogenesis of Campylobacter jejuni 
 
The pathogenic mechanisms of C. jejuni need to be well-understood in order to 
develop control measures for preventing its transmission to humans. The severity 
and duration of Campylobacter infections may vary greatly and thus can cause a 
range of different medical symptoms. An infective dose can be as low as 500-800 
organisms [88]. The infection occurs when the bacteria penetrates the 
gastrointestinal mucus using its high motility and spiral shape, and then adheres to 
the gut enterocytes. The toxins released from the adhered bacteria causes diarrhoea. 
The panel of different toxins (mostly enterotoxins and cytotoxins) released by C. 
jejuni varies from strain to strain and so does the severity of the enteritis. The levels 
of all immunoglobulin classes rise during infection. The infection is usually 
considered to be mild due to its self limiting nature but extra intestinal 
manifestations and post infection complications can be severe and sometimes fatal. 
The consequences of the infection depend on the host immune status and the 
virulence potential of the infecting strain [89]. Even though being recognized as the 
major trigger of bacterial gastroenteritis, the virulence determinants and pathogenic 
mechanisms of C. jejuni remain obscure [62, 90, 91]. 
 
1.11 The virulence determinants of Campylobacter jejuni  
 
For a better understanding of Campylobacter colonization of hosts and the cause of 
enteric disease, the pathogen-commensal relationships in the gastrointestinal tract 
needed to be well identified. The virulence determinants of C. jejuni are chemotaxis, 
motility, flagella, bacterial adherence to intestinal mucosa, occurrence of strain 
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recombination events, the presence of plasmids, invasive capabilities, iron 
acquisition and the ability to produce toxins [6, 24, 92]. Information about the 
biological activities related to the bacterial virulence such as bacterial attachment, 
colonization and cell invasion, are crucial in acquiring more details about the 
bacterium-host interactions. Several putative virulence factors are expressed when 
Campylobacter colonizes in the intestines. Figure 1.1 shows the colonization phases 
and the virulence factors expected to be expressed at each phase.  
 
 
 
Figure 1.1: The different phases of Campylobacter colonization of the intestines [24].  
 
 
Significant virulence factors that are proposed to be involved in pathogenesis of 
Campylobacter are discussed briefly. 
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1.11.1 Role of flagella, chemotaxis, and motility in colonization 
 
Campylobacter motility is achieved by the flagellar apparatus. The bi-polar flagella 
of Campylobacter have rapid and darting motility. Systematic analyses of genomes, 
has predicted many additional motility genes based on their location in flagellar 
operons.  
 
However, their actual roles in motility often remain unknown. New motility proteins 
in the context of the T. pallidum flagellar apparatus are shown in Figure.1.2. 

Figure 1.2:  Model of the bacterial flagellar apparatus showing newly discovered motility 
proteins [93].  
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Structurally similar to other bacterial flagella, the C. jejuni flagellum consists of at 
least three parts namely a basal body, which connects the flagellum to the cell and 
interacts with the flagellar motor, a hook that links the basal body to the flagellar 
filament, which is composed of thousands of copies of two proteins, FlaA and FlaB, 
and an outer filament which functions as a propeller [94]. The energy from the 
proton or sodium ion drives the flagellar motor to rotate in a clockwise or counter-
clockwise direction and to force the microbe across the host cell membrane.  To 
colonize the intestine, the bacterium must first penetrate the mucus layer covering in 
the intestinal cells. The combination of the flagellum and the spiral cell shape 
confers Campylobacter high motility in viscous environments, and the ‘corkscrew’ 
motion allows Campylobacter species to efficiently penetrate though this mucus 
barrier. The phase variation of C. jejuni and antigen variation in the carbohydrate 
moieties present in surface structures such as flagella by slipped strand mis-pairing, 
produces a high frequency of on and off changes [38]. Since no non-flagellar type III 
secretion apparatus genes were identified in the C. jejuni NCTC11168 genome [91], 
Song et al [95] suggests that Campylobacter utilize the flagellar export apparatus to 
secrete flagellar and non-flagellar proteins. 
 
Chemotaxis is required for Campylobacter invasion of host tissues which is only 
possible if the organism is adequately motile to travel along the gradient. 
Campylobacter colonization of a host mainly depends on the microbe’s ability to 
detect, and then move up and down chemical gradients. Both motility and 
chemotaxis have great roles to play in virulence and colonization. Chemical-in-plug 
chemotaxis assay studies were conducted to  detect chemotactic responses and found 
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that C. jejuni exhibits chemotactic behaviour towards fucose, several amino acids 
and organic acids, and mucin [96]. Recently Kanungpean et al [97] and Li et al [98] 
conducted studies to show the possibility of false positive responses of C. jejuni 
when using the Chemical-In-Plug Chemotaxis Assay. In the Kanungpean et al 
studies, a nonchemotactic mutant (cheY mutant) and a nonmotile mutant (flhA 
mutant) were constructed for use as negative controls in the assay.  Both studies 
showed that both nonmotile and nonchemotactic mutants of C. jejuni appeared to 
exhibit chemotaxis in the chemical-in-plug assay. They advised that non-motile or 
non-chemotactic mutants should be used as controls, and results should be confirmed 
with other types of assays. 
 
1.11.2 Bacterial adherence to intestinal mucosa and invasion 
 
The bipolar flagella of C. jejuni are used for adhesion and invasion of host cells, and 
are considered the primary contributor to pathogenesis [92]. C. jejuni’s adhesion to 
epithelial cells is promoted by the multiple adhesive proteins (adhesions) possessed 
by the isolates. The molecules proposed to act as adhesins are synthesized 
constitutively by C. jejuni, and metabolically inactive C. jejuni (heat-killed and 
sodium-azide killed)  were found to bind to cultured cells at levels comparable with 
metabolically active organisms [99]. Several authors have illustrated that outer 
membrane proteins such as PEB1 (periplasmic/membrane-associated protein, 28 
kDa) [100],  CadF (Campylobacter adhesion to fibronectin Fn, 37 kDa) [101],  JlpA 
(jejuni lipoprotein A, 42.3 kDa) [102], FlpA (fibronectin-like protein A) [103], 
flagella and lipopolysaccharides (major surface antigens) are involved in adhesion of 
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C. jejuni to HeLa cells and to Hep-2 cells. Invasion by C. jejuni depends on the 
proteins it expresses and the host cell signal transduction [104].  
 
1.11.3 Occurrence of strain recombination events 
 
Gene transfer between C. jejuni and its sister species Campylobacter coli is 
facilitated by strain recombination. Genetic exchange (transfer of DNA) has a crucial 
role in the development of many bacteria. Due to recombination events, diversity is 
generated at double the rate of de novo mutation [105]. The great similarity between 
the two genes encoding the subunits of C. jejuni’s flagellar filament (flaA and flab) 
results in recombination [106].  Suerbaum et al [107] analysed the allelic diversity 
and population structure of C. jejuni using multilocus nucleotide sequence analysis. 
Out of the inter-strain and intra-strain recombination events occurring amongst C. 
jejuni, intra- specific recombination occurs frequently and has generated a wide 
variety of allelic profiles from a small number of polymorphic nucleotides. Recently 
Didelot et al [108] analysed nucleotide sequence data, looking at genetic exchange 
involving homologous recombination and calculated the frequency of recombination, 
its impact on different parts of the genome, and the patterns of gene flow within 
bacterial populations. 
 
1.11.4 Invasiveness, iron acquisition and toxin production 
 
A number of virulence factors such as invasiveness of C. jejuni strains, iron 
acquisition, toxin production, motility, chemotaxis and translocation, are postulated 
to be involved in the pathogenesis of infection. Bacterial invasive capabilities are 
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measured by the invasion efficiency and the number of internalized bacteria per host 
cell. The percentage of the starting inoculum internalized by the end of the assay 
represents Invasion Efficiency (IE). Al-shaikh et al 2007 [109] reported that the 
experiments conducted using positive (S. typhimurium) and negative (E. coli) 
controls had shown remarkable differences in IE levels of Campylobacter. Iron acts 
as a catalyst for the formation of hydroxyl radicals and catalyses a wide range of 
biochemical reactions necessary for most living organisms. Iron is a micronutrient 
for bacterial growth, and iron acquisition along with its metabolism promotes 
successful microbial proliferation [110]. Bacterial cytotoxin and Cytolethal 
distending toxin (Cdt) production do not play a role in the adherence to either human 
or avian cells though may play a role in the invasion, and/or survival, of C. jejuni in 
human cells [111].  
 
1.12 Immune responses  
 
1.12.1 Infection in Humans 
 
Campylobacter jejuni is the most common cause of inflammatory enteritis in 
humans. The incubation period ranges from two to five days with a low infective 
dose of 500-800 bacteria [112]. Campylobacteriosis is typically a self limiting 
disease resolved in one week but symptoms may extend up to two weeks.  
Socioeconomic status has a major impact on the difference in the manifestation of 
the disease [53, 113]. 
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The intestinal mucus layer is a substantial structure, often 30 to 50 µm thick, and is 
continuous with the glycocalyx along the intestine (26). This viscous glycoprotein 
gel covering the epithelial cells of the intestinal tract is likely to be the initial point of 
contact between the host and C. jejuni. C. jejuni penetrate through the mechanical 
barriers of the gastrointestinal tract such as mucus layer of the GI epithelium to 
establish an infection. The intestinal mucus layer serves as the first line of defence, 
and once C. jejuni passes it, adhesion to mucosal surfaces is mediated by several 
largely unknown factors. 
 
Previous studies have shown that C. jejuni induces IL-8 secretion from intestinal 
epithelial cells by two independent mechanisms. One of the mechanisms requires 
adherence and/or invasion and the second requires CDT [114, 115]. C. jejuni’s 
ability to stimulate the production of proinflammatory cytokines plays a central role 
in the pathogenesis processes, though this ability is not well understood.  ERK 
activation (Extra cellular signal regulated kinase) is the central mechanism for the 
stimulation of the proinflammatory cytokine IL-8 [116]. 
 
1.12.2 Human immune response to C. jejuni infection 
 
Previous studies have shown that humoral immune responses are induced in humans 
and several animal models following C. jejuni infection [117-120].  C. jejuni 
infection is characterized by a more severe form of inflammatory diarrhoea, often 
with faecal leukocytes, blood, and mucus [121]. The studies conducted by Black et al 
[88] showed that specific serum IgG, IgM, and IgA responses were seen in 
individuals who had diarrhoea after ingestion of C. jejuni and indicated that 
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protective immunity was elicited after a primary infection. Systemic and local 
humoral immune responses against Campylobacter infection have also been reported 
in humans and animals [120, 122-124].  Circulating Campylobacter-specific 
antibodies and complement-dependent bactericidal activity of normal serum against 
C. jejuni have been reported during the acute and convalescent phases of C. jejuni 
infection [119, 125].  
 
It is widely accepted that the TLR’s acts as a critical sensor of infection followed by 
the production of cytokines, chemokines, and antimicrobial peptides [126, 127]. 
Although the exact role of interleukin 8 (IL-8) remains unclear, increased production 
by epithelial cells during C. jejuni infection has been demonstrated in previous in 
vitro studies [114, 115]. hBD-1, hBD-2 and hBD-3 are members of the human- 
defensin (hBD) family and are induced  during gastro intestinal (GI) infection and 
inflammation [128].  The expression of these peptides may play a role in immune 
surveillance in a healthy host though no studies have been conducted to date [129].  
Studies conducted by Zilbauer et al [129] showed that the overall net effect of the 
greater killing capacity of the inducible defensins contributes to the self-limiting 
nature of C. jejuni infection in a healthy individual. In short, the induction of these 
beta-defensins may have an important role in maintaining a healthy GI tract [129]. 
Bacterial capsular polysaccharide (CPS) has been reported as an important factor in 
modulating host immune responses as well as providing resistance against host 
antimicrobial factors [130]. 
 
Different mucosal cell type(s) including Natural Killer (NK) cells, CD8 and CD4 T 
cells have the capacity to secrete IFN and may contribute to innate cytokine 
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production during GI infection(s) in humans [131]. A previous study described that 
production of an innate cytokine, such as IFNc/IL-22/IL-17, and an adaptive Th-
17/Th-1 dual response, may provide an adequate ‘antimicrobial shield’ against C. 
jejuni and promote bacterial clearance along with generation of protective immunity. 
In conclusion, the IFNc, IL-22 and IL-17 family gives protection both in the acute 
and effector phases of C. jejuni infection [132]. The cytokines in this family are 
considered critical mediators of host immune responses and therefore they modulate 
subsequent T-cell mediated immunity in the host. 
 
A recent study showed that C. jejuni has evolved specific immune evasion strategies 
and can survive within IEC (intestinal epithelial cells), avoiding contact with the 
lysosome in the cells [116].  
 
Campylobacter infection occurs in humans through different routes such as ingestion 
of contaminated water or food products, most commonly contaminated poultry meat, 
bacterial colonisation of the colonic mucosal layer, adherence to the underlying 
epithelial cells and production of interleukins (IL-8) and survival of C. jejuni within 
the epithelial cells [7, 133].  IL-8 is an important chemokine for the recruitment of 
professional phagocytes (dendritic cells, macrophages, monocytes, and neutrophils), 
which encounter and rapidly internalise C. jejuni. IL-8 production may also be 
induced by other stimuli [115] and has been reported in the stools of patients with 
campylobacteriosis [134]. It may be important signalling molecule in C. jejuni 
infection and generates a massive innate pro-inflammatory response through the 
activation of natural killer cells, cytokines and TNF factors [7, 135]. The responses 
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produced by the host, such as inflammation, diarrhoea and clearance, contribute 
heavily to disease pathogenesis [7, 136].   
 
Differences in the immune status of human hosts may result in different clinical 
outcomes of C. jejuni infection, including asymptomatic infection, watery diarrhoea, 
or inflammatory diarrhoea [3]. Antibodies against flagella, major outer membrane 
proteins (MOMPs), outer membrane proteins (OMPs), LOS, and CDT can be 
detected in human sera during C. jejuni infection [36, 137, 138]. The studies 
conducted by Kaldor et al.[139], showed that anti-Campylobacter specific serum 
immunoglobulins IgA, IgG and IgM, are also present during C. jejuni infection. 
 
The role of the cytokine IL-6 in the primary host response to C. jejuni infection has 
been demonstrated in previous studies [140]. It was shown that C. jejuni surface 
polysaccharides induce IL-6 secretion from intestinal epithelial cells via TLR-2 in a 
MyD88-independent manner.  The proinflammatory cytokine interleukin-6 (IL-6) 
plays a critical role in the maintenance of the intestinal epithelium and in governing 
the transition from innate to acquired immunity [141]. IL-6 is secreted from immune 
and non-immune cells and is believed to be important for maintaining the 
homeostatic balance within tissues. C. jejuni-stimulated secretion of IL-6 has been 
reported for monocytic and dendritic cell lines, though little is known about the 
signalling route to the epithelial cells [135, 142]. Two families of pattern recognition 
receptors (PRRs), including the 11 members of the  Toll-like receptor (TLR) family 
and two nucleotide-binding oligomerization domain (Nod) family members, have 
been identified for microbial recognition [143-145]. Intestinal epithelial nucleotide 
oligomerization domain 1 (NOD1) serves a critical role in eliciting host bactericidal 
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immune responses against C. jejuni [129]. Bacterial lipopolysaccharide stimulates 
cytokine and chemokine secretion via interactions with TLR-2 and TLR-4 [144]. The 
activation of TLRs leads to signalling through MyD88 to induce nuclear factor 	B 
(NF-	B) transcriptional regulation of inflammatory cytokines [146]. 
 
Cell-mediated immunity (or Th1) involving dendritic cells (DCs) and macrophages 
play an active role in clearing C. jejuni from the site of infection [147]. Dendritic 
cells, macrophages and neutrophils are the antigen-presenting cells (APCs), widely 
distributed in tissues, and play an important role in immune responses. Dendritic 
cells start the adaptive immune response by presenting to T cells. Dendritic cells are 
also a source of proinflammatory cytokines for inducing the primary immune 
response. They regulate the type of T-cell-mediated immune response to an 
infectious agent. There is evidence that Campylobacter can come into contact with 
numerous leukocytes at the time of infection, and macrophage infection by C. jejuni 
has also been investigated [121, 148]. 
 
Induction of apoptosis in macrophages has emerged as a common virulence 
mechanism among bacterial pathogens. Studies have revealed that the inoculation of 
macrophages with C. jejuni results in the processing of IL-1 and apoptosis through 
different regulatory pathways. This data indicates that C. jejuni may use a 
mechanism distinct from Salmonella typhimurium and Shigella flexneri to initiate 
macrophage apoptosis and release of IL-1 [149]. 
 
The interaction between human monocyte-derived dendritic cells and C. jejuni was 
studied and found that C. jejuni was internalized by DCs over a 2 hours period and 
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only a few viable bacteria remained intracellularly after a prolonged infection period 
(24 or 48 hours) [135]. The data available from these studies indicates that 
Campylobacter-infected DCs triggers an innate inflammatory response through 
activation of NF-	B. Activated  NF-	B stimulates production of interleukin-1(IL-
1), IL-6, IL-8, IL-10, IL-12, gamma interferon, and tumor necrosis factor alpha 
(TNF-) [135]. 
 
C. jejuni can survive within human monocytic cell vacuoles and remain viable for 
long periods, inducing apoptotic death via cytolethal distending toxin release [149-
151]. Catalase is essential for C. jejuni intramacrophage persistence, and growth was 
suggested by Day et al [152]. The production of isotype-specific human antibodies 
against C. jejuni Flagellin Protein and against a Synthetic N-Terminal Flagellin 
Peptide was demonstrated by Nachamkin et al [153] using a microdilution enzyme-
linked immunosorbent assay (ELISA). Figure 1.3 illustrates the model of C. jejuni 
Infection in humans.  
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Figure 1.3:  Schematic illustration of the model of C. jejuni Infection in humans.  C. jejuni 
(grey) invades the intestinal epithelial cells. CDT (star) is released from the cell and causes 
activation of NF-
B-dependent genes which leads to apoptosis (black stars) of the host cell. 
Immune cells are released to the area infected which leads to the destruction of C. jejuni [7]. 
 
1.12.3 Colonisation in chickens 
 
Colonisation by C. jejuni is an early key step in its pathogenesis. Avian mucus or 
avian luminal factor(s) appear to contribute to the inhibition of Campylobacter 
interaction with epithelial cell surfaces. Although Campylobacter induced diarrhoea 
has been observed with experimental infection of chickens with C. jejuni, there is no 
evidence of typical naturally acquired C. jejuni diarrhoeal infection in chickens [154, 
155]. 
 
Genetic screening studies have been employed where candidate genes are mutated 
and assessed to understand how the bacterium promotes commensalism. Mutants 
with defined deletions of flagellar genes have demonstrated reduced colonization 
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capacities compared with wild-type strains [156]. Other genes associated with 
flagellar motility were also shown through mutation studies to be important for 
efficient chicken colonization [133].  
 
Campylobacter jejuni can grow at a temperature range of 30° C to 47° C, with an 
optimal temperature of 42° C.  Differential gene expression at these two 
temperatures may account for why Campylobacter only colonizes chickens, while it 
results in disease in humans.  Studies have shown that temperature shift can lead to 
up/down regulation of the expression of different proteins in different hosts [157]. A 
differential surface structure pattern of proteins between human and chicken residing 
C. jejuni may be explained by the downregulation and upregulation of proteins of the 
same functional group [158]. Growth arrest can be observed upon temperature stress, 
and this allows the bacterium to rearrange itself to maintain existence at the new 
temperature. Glycoproteins and the protein glycosylation pathway play an important 
role in the pathogenesis of C. jejuni and its attachment to human and chicken host 
cells [37, 159]. Studies conducted on mutated genes such as cadF, dnaJ, pldA, and 
ciaB have shown that the proteins encoded by these genes are required for efficient 
cell invasion and GI colonization of newly hatched chickens [160, 161]. Chick 
colonization is also influenced by other factors including antimicrobial resistance 
mechanisms, metabolism of iron and different amino acids, and aerobic/anaerobic 
conditions [162, 163]. 
 
Studies have shown that Campylobacter species can stimulate the avian host in a 
proinflammatory manner, inducing proinflammatory cytokines and chemokines in 
the avian primary chick kidney cells, and the avian macrophage cell line HD11 
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[164]. Toll-like receptors (TLRs) are activated upon entry of pathogenic bacteria into 
the host cell and they induce inflammatory responses. Systematic comparisons of the 
human and chicken TLR responses to Campylobacter have been investigated. The 
major differences between human and chicken TLR responses is a lack of production 
of IFN- after LOS stimulation in chickens, and activation of chicken TLR21 by 
Campylobacter chromosomal DNA. The study conducted by Zotoe et al has revealed 
that differences in bacterial cell wall integrity and in TLR responses to 
Campylobacter LOS and/or DNA may contribute to the distinct clinical 
manifestation between the species[165].  
 
Studies conducted by Sahin et al indicated that anti-Campylobacter maternal 
antibodies (mAbs) provide possible protection from Campylobacter colonization in 
young broiler chickens in natural environments [166]. The newly hatched chick is 
also protected by a functionally sufficient innate immune system which includes pro-
inflammatory cytokines, chemokines and antibacterial -defensins, in addition to the 
protection conferred by the mAbs. -defensin and presenilin 1 gene expression has 
been demonstrated to be a result of a gut-specific extramedullary granulopoietic 
process which involves the recruitment of bone marrow-derived heterophils in the 
newly hatched chick [24]. 
 
C. jejuni and its close relative C. coli colonize the intestinal mucosa of most warm-
blooded animals, including all food-producing animals and humans [155]. The 
favoured environment appears to be the intestines of all avians including wild birds 
and chickens [167-170]. Although contact with faecal material could result in egg 
contamination, the bacteria are restricted to the inner shell or membranes rather than 
32 
 
the egg contents [171, 172]. Therefore if the natural infection of the egg contents 
occurs, it would primarily be due to faecal contamination and penetration through 
cracks in the shell [171]. C. jejuni colonizes the mucus overlying the epithelial cells 
of chicken caeca and small intestine, but may also be recovered from the gut spleen 
and liver.  It colonises in the intestinal tract of many birds to very high numbers 
without eliciting any pathological symptoms in this natural host because of its 
commensal nature [154, 156]. The mucous lining of the deep crypts of the ceacum is 
the primary site of Campylobacter colonization in chickens [173]. The pathology and 
environment for survival of the organism are similar in both humans and chickens. 
The only difference is in the body temperatures with 42º C in chickens, and 37º C in 
humans [7]. 
 
Studies have shown that C. jejuni is capable of infecting fertile chicken eggs and can 
survive until the chicken has hatched [174].  Diarrhoea and weight loss with 
moderate infiltration of mononuclear cells was observed in chickens after a small 
oral inoculum. No evidence of disrupted intestinal mucosa was observed during the 
C. jejuni infection [175]. Studies indicated that strains of C. jejuni isolated from 
enteritis patients can produce diarrhoea in 36 to 72 hours old chickens after an oral 
dose of 102 to 106 live cells. Systemic invasion was common whereas local invasion 
was only observed occasionally [176].  Although studies have shown that 
experimental infection of chickens with C. jejuni can lead to diarrhoea and invasion 
of the chicken intestinal mucosa [177], this is not typical. 
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1.12.4 Chicken immune responses to C. jejuni infection 
 
Experimental infection of chickens with C. jejuni can lead to diarrhoea [4, 5], though 
the response is less symptomatic than the human response to C. jejuni infection.  H. 
pylori are pathogenic to humans causing gastric ulcers, but can be carried 
asymptomatically. Wolinella species includes W. succinogenes which occurs as a 
commensal in the intestine of cattle. These organisms appear to be host-adapted and 
maintain their existence without generating a response sufficient for clearance. The 
cells involved in the immune mechanisms of humans and chickens are different.  
Neutrophils are the primary responders to invading pathogens in humans whereas the 
avian innate immune system contains similar, but different cells, termed heterophils. 
Neutrophils are highly phagocytic, short-lived cells with internal granules. They 
release granules at the time of invasion to kill bacteria extracellularly or 
intracellularly. Heterophils also attack invading pathogens by releasing granules, 
though are less phagocytic [178, 179]. Figure 1.4 shows the innate immune 
responses to C.  jejuni in humans and chickens. 
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Figure 1.4.  Innate immune responses to Campylobacter jejuni in humans and 
chickens.  Reproduced from Young et al. 2007 [7] 
 
Campylobacter has the potential to initiate a range of immune responses in cultured 
human cells. Previous studies have shown that IL-8 and TNF- are produced from 
Intestinal INT407 and T84 cells during C. jejuni infection, and infected THP-1  
monocytes and DCs respond to C. jejuni by producing cytokines [114, 135, 141, 
142, 180-182]. Similarly, an increase in cytokine expression [43] and circulating 
monocytes/macrophages [183] was observed in isolated chicken tissues upon 
infection. Up regulation of cytokines was also observed during in vitro infection 
[184-186]. 
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1.13 Control strategies to reduce incidence of campylobacteriosis in humans 
 
Poultry is the leading reservoir for Campylobacter species, and poultry meat 
products are the leading source of human infections world wide. Consumption of 
poultry meat products is higher than that of ruminants due to the lower fat content 
and lower cost. The main source of campylobacteriosis in humans is the 
consumption of undercooked poultry. Campylobacter first colonize in the GI tract of 
poultry and horizontal transmission occurs throughout the flock. In order to reduce 
the colonization in poultry, proper preventive measures to avoid colonization, 
transmission and cross contamination should be adopted. Different possibilities for 
preventive measures have been investigated in numerous studies, such as 
administration of bacteriophages [187], certain nitrocompounds [188-191], 
supplemented feed with selected organic acids [192], and cetyl pyridinium chloride 
as an antimicrobial treatment [193] to name a few.  Rapid development in the field of 
molecular vaccinology and immunology opens the possibility of developing an 
effective vaccine against Campylobacter colonization of poultry, for which there is 
no vaccine to date [165]. As chickens are a natural host for Campylobacter species, 
they appear to be a good model for studying both the colonisation of C. jejuni, and 
anti-Campylobacter strategies aimed at protecting human populations from 
campylobacteriosis [7]. A reduction in the bacterial count in chickens by lowering 
the count to < 104 CFU/g faeces would greatly reduce the incidence of enteric 
disease in humans. 
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The implementation of high levels of biosecurity on the farm, stopping multispecies 
farming, thinning (the process of partially depopulating broiler houses) and 
competitive exclusion have had limited success in preventing the introduction of 
Campylobacter into poultry flocks [187]. Use of bacteriocin in feed appears to be 
effective in preventing colonisation, though is not yet commercially available [194]. 
Therefore vaccination seems the best option for reducing the colonization level in 
chickens. The antigenic variety among strains, the lack of knowledge of antigens 
which induce a protective immune response, the vague knowledge of protective 
epitopes and the requirement of immune cells that provide protection in the very 
early stages of the bird’s life are the main factors hampering vaccine development 
[187]. The control strategies aimed at reducing Campylobacter infection rates have 
generally not been successful due to the genetic diversity. 
 
1.14 Development of Campylobacter vaccines 
 
Vaccination of chickens seems to be the most effective method to limit C. jejuni 
infection in humans. The potential of CjaA- and Peb1A-based vaccines for control of 
C. jejuni in poultry has been demonstrated by vaccinating with recombinant CjaA 
subcutaneously, there was a reduction in the caecal load of C. jejuni at three and four 
weeks post-challenge [195]. Serum IgG and mucosal IgA antibody responses have 
been shown after oral immunization of chickens with Salmonella expressing the 
Campylobacter cjaA gene [196]. The data showed that chicken immunisation with 
avirulent Salmonella carrying the Campylobacter CjaA gene reduced the 
colonisation level of wild strain [196]. 
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Although studies are still underway, vaccines have not yet been developed against 
campylobacteriosis [165]. For the development of a successful vaccine, the main 
challenges need to be considered, which include (1) identifying novel cross- 
protection inducing antigens, (2) the vaccine needs to induce a rapid and potent 
immune response, and (3) the development of a novel adjuvant to further stimulate 
immunity against Campylobacter. When young chicks come into contact with 
Campylobacter during early life, the vaccine should be able to elicit a protective 
response. The immunity developed should be cross-protective for both C. jejuni and 
C. coli including a variety of serotypes. The developed vaccine should be cost-
effective and easy to deliver to massive numbers of chickens. Finally, there should 
be a 5 log reduction (preferably higher) of bacterial numbers in colonized animals. If 
a vaccine meets all of the described criteria it can be considered an effective vaccine 
[165]. An overview of the vaccination studies against Campylobacter in chickens is 
shown in Table 1.2. 
 
In vitro studies have shown that virulence determinants such as Peb1, JplA, CadF 
and FlaC have influence on bacterial adhesion or invasion [95, 197, 198]. Toxins 
produced by different strains of Campylobacter have been considered important 
virulence factors in the pathogenesis of Campylobacter diarrhoea in humans. 
Numerous antigens such as flagellin, major outer membrane proteins (MOMPs), 
lipopolysaccharides (LPS) and their corresponding Campylobacter specific 
antibodies (serum IgG and Serum IgM ) can be detected in the serum [120, 199]. 
Studies have indicated that C. jejuni membrane proteins are recognized by the 
maternal IgG in 1-day-old chicks [166]. Bacterial proteins (flagellin, CadF and 
CiaB), protein N-glycosylation machinery and two components signal transduction 
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systems such as RacR/RacS, FlgS/FlgR and DccR/DccS, appear to be major factors 
in effective colonisation in the gut and may be potential vaccine targets [37, 161].  
 
Table 1.2: An overview of the vaccination studies against Campylobacter in 
chickens [200]  
 
Type of vaccine Administration Effect 
Experimental colonization with 
wildtype C. jejuni  
Orally  
 
 
1 log reduction upon 
homologous 
challenge [201] 
Experimental colonization with 
non-colonizing mutant 
of C. jejuni 
 
Orally  No effect upon 
homologous challenge  
[161] 
Formalin-inactivated C. jejuni +/− 
LT  
Orally with 
boosters  
1.5 log reduction upon 
homologous 
challenge no additional 
effect of LT [202] 
 
Formalin-inactivated C. jejuni +/− 
LT or CT  
 
Orally with 
boosters  
No effect upon 
homologous challenge 
[201] 
Formalin-inactivated C. jejuni 
complete Freund’s 
adjuvant 
 
SC with booster  Some reduced shedding 
during first 2 weeks 
upon homologous 
challenge only [203] 
 
Heat-killed C. jejuni  In ovo with oral 
booster  
Generation of flagellin-
specific serum IgG, 
IgM and IgA, and IgA in 
bile and intestine [204] 
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Native flagellin +/− heat-killed C. 
jejuni  
IP with IP or oral 
booster  
1–2 log reduction upon 
homologous 
challenge [205, 206] 
Recombinant flagellin fused to LT  Orally with 
booster  
Reduction of C. jejuni 
positive chickens 
(40/145 vs. 70/142 in 
control group) [207] 
 
Plasmid DNA containing the 
flagellin gene  
IM with booster  2 log reduction upon 
homologous challenge 
[208] 
67, 73.5 and 77.5 kDa 
immunogenic C. jejuni proteins  
IP  No effect upon 
homologous challenge 
[205] 
Attenuated Salmonella expressing 
CjaA  
Orally  >6 logs reduction upon 
homologous 
challenge [196] 
 
1.15 Construction of vaccine vector 
 
Previous studies have shown that STM-1 can synthesise proteins from other 
organisms, and when used to vaccinate animals, an immune response is made against 
these proteins [209, 210]. This is termed heterologous antigen delivery, as the 
vaccine is delivering proteins from a different (heterologous) organism. The basic 
method is shown schematically in Figure 1.5. 
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Figure 1.5 Schematic illustration of the vaccine construct [210] 
 
Several C. jejuni antigens have been selected and cloned such that they can be 
delivered by STM-1. Antigens were cloned into plasmid vectors for expression in 
STM1. By evaluating any reduction in colonization, it is possible to identify 
potential antigens that can be developed as a vaccine.  
 
A variety of Campylobcter strains has been created due to various factors such as 
frequent DNA rearrangements, DNA transfer among strains and the presence of 
phase variable genes. This also resulted in genotypic and phenotypic instability of 
many Campylobacters. Identification of protective antigens present in all serotypes 
of C. jejuni and C. coli would be ideal for the development of a vaccine against 
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Campylobacter. Studies conducted by Zoete et al have reported that, surface exposed 
antigens generally have the highest potential as vaccine candidates, although factors 
that Campylobacter secretes into the environment may also provide protection [200]. 
They also reported that a thorough understanding of the Campylobacter (surface) 
proteins or structures essential during colonization can greatly improve the quality of 
vaccines. For example, an increased C. jejuni bacterial adhesion and invasion of 
eukaryotic cells in the presence of bile salts has been reported by Zoete et al [200], 
and Pace [211]. Protective proteins identified by proteomics studies could be 
excellent candidates for the development of an effective C. jejuni subunit vaccine as 
they are present in a wide variety of C. jejuni strains [212].  
 
1.16 Virulent secretory proteins of C. jejuni 
 
The secretory mechanisms of C. jejuni are poorly understood compared to other 
bacterial pathogens. Studies have shown that mutants of C. jejuni ciaB were deficient 
in the secretion of proteins indicating that CiaB is required for the secretion process. 
In vitro studies conducted on cultured epithelial cells have shown that CiaB is 
required for invasion of the epithelial cells [157]. CiaB mutants were also shown to 
have reduced chick colonization levels, indicating that secretory proteins play a 
major role in invasion and colonization characteristics of the bacterial pathogen 
[161]. Injection of CiaB and Type III secretion are clearly understood [7].  A 
functional flagellar export apparatus is required for the secretion of CiaB, and other 
secreted Cia proteins (CiaA–H), which is similar to the protein secretion of Yersinia 
species [213, 214]. FlaC is secreted through the flagellar apparatus and binds to the 
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epithelial cells enabling cell invasion [95]. Cia protein synthesis is induced by bile 
salts and various eukaryotic host cell components, which indicates that antigens 
secreted by Campylobacter during invasion are stimulated by host signalling [215]. 
In the presence of chicken serum and mucous, C. jejuni secretes Cia proteins and 
promotes colonisation of the chicken gut indicating that Cia proteins play an 
important role in colonisation [111]. These data suggest that the proteins secreted by 
C. jejuni could be good targets as vaccine. 
 
1.17 “Hypothetical” non-classically secreted proteins of C. jejuni with unknown 
function   
 
Proteins secreted from the bacteria may be important virulence factors, given their 
potential role in pathogenesis [216]. Several class III non-flagellar genes with 
unknown function, including cdtC, katA and pseA, are important for virulence and 
host evasion [216].  Therefore, it is possible that orphan genes, including genes with 
unknown function, are expressed (i.e. are co-regulated) with late flagellar genes.  
Folded proteins are transported across the biological membranes using a bacterial 
protein export pathway called the Tat (twin-arginine translocation) system, which 
recognizes a specific sequence tag or motif (N-terminal signal peptide) in the protein 
to be secreted [217]. In bacteria various secretion pathways such as Sec-dependent 
secretion and a Sec-independent secretory pathway have been discovered. N-
terminal signal peptides play a central role in the Sec- and Tat-dependent secretion 
pathways, whereas some bacterial proteins have been found to be secreted without 
any apparent signal peptide via non-classical secretion. These non-classically 
secreted proteins can be distinguished from cellular proteins by amino acid 
43 
 
composition, secondary structure and disordered regions [218]. The complete 
annotated genome sequence of C. jejuni NCTC11168 reveals C. jejuni has 1,641,481 
base pairs, with 1,654 predicted coding sequences [30]. Some non-classically 
secreted “hypothetical” proteins in C. jejuni are encoded by orphan genes with 
species-specific functions, and may be involved in immune avoidance and/or 
actively suppressing components of the chicken immune system. Therefore, it is 
important to create mutations in unknown genes and analyse the characteristics of 
any non-classically secreted “hypothetical” proteins in the C. jejuni genome, and 
study their immunomodulatory effects in a suitable in vitro cell model. These 
secretory proteins could then be tested as suitable virulence candidates for anti-
Campylobacter strategies (e.g. gene knock-out experiments in chicken models or 
antigenic determinants in vaccine production) aimed at reducing the colonisation of 
chickens, and protecting human populations from Campylobacter-induced enteric 
and associated neurological diseases. If the selected “hypothetical” non-classically 
secreted proteins are shown to down-regulate the immune response in chickens, they 
could be deliberately removed (or made dysfunctional) from vaccine preparations to 
enable chickens to induce stronger immune responses against the vaccine strains, and 
therefore be able to subsequently clear wild-type strains.   
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The aims of this project are: 
 
1. Investigation of the efficacy of outer-membrane vaccine constructs in a chicken 
vaccine trial 
2. Elucidation of Campylobacter proteins that may interact with host cells and the 
chicken humoral immune system using Bioinformatics Tools 
3. Knock-out Mutagenesis of the selected hypothetical genes and study of the 
phenotypes by in vitro analysis 
4. Investigation of the differences in the proteomes of Campylobacter that can or 
cannot colonize chickens 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
45 
 
 
Chapter 2 
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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


The materials and methods detailed here relate to general laboratory procedures. The 
methods for Bioinformatics analyses and specific procedures can be found in the 
relevant chapter, and are not detailed here. 
 
 
2.1  General Procedures used prior to Experiments 
 
All glassware were placed in a warm concentrated aqueous solution of Pyroneg 
detergent (Diverey Pty Ltd, Melbourne, Australia), and soaked for several minutes. 
Glassware was washed thoroughly with tap water and given a final rinse with 
deionized water before use. The chemicals and reagents used in the experiments 
were of analytical laboratory grade. All solutions were prepared using deionised 
water and were obtained by filtration through a Millipore Milli-Q-water System 
(Liquipure, Melbourne, Australia). Sterilisation of media, reagents, glasswares, and 
pipette tips was performed by autoclaving at standard conditions (1210 C for 15 
mins) unless specified. Micro pipettes were used to accurately measure and dispense 
small volumes of liquid. All solutions were dispensed using Finnpipette (Pathtech, 
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Australia) for all volumes ranging from less than 0.5 µl to 1000µl and these were 
calibrated regularly as per manufactures recommendations. 
 
2.2 General Chemicals and Equipments 
 
ABI sequencing Kit     Micromon Sequencing Clayton, 
Australia 
Acetic acid, glacial    Merck Chemicals, Australia 
Acetone    Merck Chemicals, Australia 
Agar (Bacteriological)  
  
Oxoid Ltd, England 
Agarose (DNA grade)    Bioline, Australia 
Ammonium chloride                                        Merck Chemicals, Australia 
Ammonium acetate                                           Merck Chemicals, Australia 
Ammonium hydroxide                                 BDH Chemicals, UK 
Ammonium persulfate                                        Merck Chemicals, Australia 
5 bromo -4 chloro-3indoyl-b-D-
galactopyranoside  
Bioline, Australia 
Countess TM Automated Cell Counter  Invitrogen 
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Centrifuge 
 
Eppendorf centrifuge      Eppendorf Geratebau, Germany 
High speed centrifuge    Beckman, USA 
Thermo-Multifuge centrifuge      Centaur 2, MSE 
 
Centrifuge tubes 
 
 
1.5 ml micro Centrifuge tubes  Interpath, Australia 
10 ml Centrifuge tubes   Interpath, Australia 
50 ml Centrifuge tubes   Interpath, Australia 
 
Choloroform    Merck Chemicals, Australia 
Cryovials    Interpath, Australia 
DNA Ligase (T4)    Promega 
DNase 1(bovine pancreas, grade 1 )  Sigma-Aldrich Pty , Ltd, USA 
DNA polymerase    Bioline, Australia 
dNTPs (deoxynucleotide 
triphosphates)10 mM  
Bioline, Australia 
Dulbecco`s Modified Eagle`s Medium 
(DMEM)  
Invitrogen, Australia 
DMSO      Merck Chemicals, Australia 
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Electrophoresis Power Supply 
 
EPS600     Pharmacia Biotech 
POWER PAC 300   Bio-Rad 
PP Basic     Bio-Rad 
 
Electrophoresis unit 
 
DNA mini gel    Bio-Rad 
DNA mini gel    Bio-Rad 
DNA midi gel    Plaztek scientific 
 
Ethanol     Merck Chemicals, Australia 
Ethidium Bromide (EtBr)   Sigma-Aldrich Pty, Ltd, USA 
Ethylenediamine tetra acetic acid, 
disodium salt (EDTA) 
Merck Chemicals, Australia 
Gentamycin sulphate    Sigma-Aldrich Pty, Ltd, USA 
 
Gel Doc Image System  Bio-Rad 
 
Glucose      Science Supply, Australia 
Glycerol     Science Supply, Australia 
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Campygen 2.5 L   Invitrogen 
Hexadecyltrimethyl ammonium 
bromide (CTAB)  
Sigma-Aldrich Pty, Ltd, USA 
High Purity Plasmid MaxiPrep System       Marligen, Australia 
Hydrochloric acid    Merck Chemicals, Australia 
Hydroxide (pellets)                                   Merck Chemicals, Australia 
Incubator for tissue culture (5% CO2)
  
Forma scientific, US 
Kanamycin disulfate salt   Sigma-Aldrich Pty, Ltd, USA 
Isoamyl alcohol                                              Astral  scientific, Australia 
Isopropanol  Astral  scientific, Australia  
Isopropyl thiogalactoside (IPTG)  Astral  scientific, Australia 
Lambda DNA                                                 Pharmacia LKB, Sweden 
Ligase and Ligase Buffer   Promega 
Lysozyme                Boehringer Mannheim, Germany 
Magnesium chloride                                       BDH Chemicals, UK 
Magnesium sulphate                                        BDH  Chemicals, UK 
Methanol     Science supply 
Microtitre plates (96 wells)                             Interpath, Australia 
Microscopes 
Light microscope (CH2)                        Olympus Optical Co., Japan 
Phase contrast microscope                     Nikon Kogaku KK, Japan 
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Microscope slides                                            LOMP scientific Co., Australia 
 
Needle (19 g, 21 g, 26 g)                                   Therumo Pty Ltd, Australia 
Newborn Calf Serum (NCS)                          Cytosystems Pty Ltd, Australia 
PCR Master Mix    Roche 
Phenol saturated    Astral  scientific, Australia 
Phenol/chloroform                                           BDH Chemicals, Australia 
Petri Dish     Interpath, Australia 
PH meter     Metrohm Swissmade, Australia 
Phosphate buffered saline (PBS)  Oxoid Ltd, England 
Potassium acetate    Rowe scientific, Australia 
Potassium chloride                                         Rowe scientific, Australia 
Primers              Geneworks 
Proteinase K              Sigma Chemicals Co., USA 
Restriction enzymes               Promega, USA 
RNase               Boehringer Mannheim, Germany 
Skim milk                                                     Bonlac Foods Ltd., Australia 
Sodium acetate              Merck Chemicals, Australia 
Sodium choloride              Astral  scientific, Australia 
Sodium dodecyl sulphate (SDS)  Crown scientific, Australia 
Sodium phosphate    Oxoid Ltd, England 
Sucrose     Merck Chemicals, Australia 
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Skirrows Suppliment for Campylobacter Oxoid Ltd, England 
Syringe (1 ml, 5 ml, 10 ml, 20 ml, 50 ml) Interpath, Australia 
Spreader-disposable    Mirella, Australia 
Syringe filters     Sartorious, Australia 
Thermometer     Crown Scientific, Australia 
Tris HCL  Merck Chemicals, Australia 
Tissue culture flasks (25 cm2, 75 cm2) Sarstedt, Australia 
Tissue culture plates (24 wells) Sarstedt, Australia 
Transilluminator (UV) BioRad, USA 
Triton X-114 Sigma-Aldrich Pty, Ltd, USA 
Trypsin-EDTA Trace Biosciences, Australia 
Tryptone Oxoid Ltd, England 
Tween 20 Sigma-Aldrich Pty, Ltd, USA 
TOPO TA cloning Kit Invitrogen 
Yeast Extract   Oxoid Ltd, England 
QIA quick R PCR purification Kit QIAGEN 
QIA quick R Gel Extraction Kit QIAGEN 
QIA quick R Spin Mini prep Kit QIAGEN 
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2.3 Materials 
 
Solutions, antibiotic stock solutions and enzyme stock solutions used are detailed 
here. 
 
2.3 .1 Solutions  
 
Agarose  
1.0-1.5% (w/v) multipurpose agarose (Bioline) 
Alkaline lysis solution I 
50 mM glucose (BDH), 10 mM EDTA (Merck), 25 mM trisbase (Roche), pH to 8.0 
with HCL; stored at 40 C 
Alkaline lysis solution II 
0.2 M NaOH (BDH), 1% (w/v) SDS (Merck); prepared by fresh on day 
Alkaline lysis solution III 
5 M potassium acetate (Sigma), 2 M glacial acetic acid (BDH); stored at 40 C 
Cetyltrimethylammonium bromide (CTAB)/NaCl 
10 % (w/v) CTAB (Sigma), 0.7 M NaCl (Chem Supply); heated to 650 C 
Chloroform/isoamylalcohol (C: I) 
24 volumes chloroform: 1 volume isoamylalcohol (Research Organics), pH 8.0; 
stored at 40 C 
Deoxynucleotide triphosphates (dNTPs) 
25 mM of each datp, dttp, dgtp, and dctp (Bioline); stored at -200 C 
EDTA  
0.5 M EDTA, pH 8.0 
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Ethanol  
70 % (v/v) ethanol prepared from absolute ethanol (96%) commercial grade (Merck) 
Ethidium Bromide  
0.5 µg /ml ethidium Bromide (Fluka) = 1 mg per 2 L MQ water bath 
10x Gel loading dye 
10% (w/v) Ficoll 400, 50% (v/v) glycerol (Ajax), 0.5% (w/v) Orange G (BDH), 1% 
SDS, 10 mM EDTA, 50 mM Tris-base, pH to 8.0 with HCl; stored at 40 C 
Glycerol 
10-80% (v/v) glycerol, autoclaved 
KOAC: 60 ml 5 M KOAC, 11.5 ml acetic acid, 28.5 ml water 
Lambda ( ) PstI DNA ladder 
100 µg  DNA (500 µg/ml, Promega), 100 U PstI (10 U/µl, Promega), 90 µl 10x 
restriction enzyme Buffer H (Promega), MQ water to 900 µl; incubated overnight at 
370 C, then added 100 µl 10x gel loading dye; stored at -200 C 
MQ water 
Sterile MQ water (Millipore) or deionised water was used to prepare reagents 
Molecular grade water 
Distilled water, DNAse-free and RNAse-free (Invitrogen) for PCR reactions and 
genomic DNA 
NaCl 
5 M NaCl 
 (P: C: I)  
25 volumes phenol: 24 volumes chloroform: 1 volume isoamylalcohol (Research 
Organics), pH 7.8; stored at 4°C 
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IPTG: 2g IPTG (DCL) in 10 ml water, filter sterilized, dispensed into 1 ml aliquots 
and stored at -200 C used at concentration of 100 mM 
Propan-2-ol (Isopropanol) 
100% (v/v) Isopropanol (BDH) 
Phenol: Phenol  
Sodium acetate (NaOAc) 
3 M NaOAc (BDH), pH 4.6 with HCl, autoclaved 
Sodium dodecyl sulphate (SDS) 
10% (w/v) SDS 
TAE buffer 
40 mM Tris-base, 20 mM glacial acetic acid, 2 mM EDTA  
TE buffer, pH 8.0 
10 mM Tris-base, 1 mM EDTA, pH to 8.0 with HCl; for alkaline lysis method, add 
20 µg/mL RNAse - fresh on day; stored at 4° C 
PBS 
5-bromo-4-chloro-3-indolyl--D-galactoside (X-gal)  
40 mg/ml X-gal (Progen) in dimethylformamide (BDH); stored at -20o C protected 
from light 
 
2.3.2 Antibiotic Stock Solutions 
 
Antibiotic solutions were prepared by dissolving the antibiotics in appropriate 
solvents to the desired concentration. These stock solutions were stored at -200 C 
after being filter sterilised. Antibiotic stock concentrations were as follows: 
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Ampicillin 
100 mg/ml ampicillin (CSL) in sterile Milli-Q water; filter sterilized by passing 
through 0.2 µm filter (Whatmann syringe filter); stored at -200 C 
Gentamycin 
Gentamycin (Sigma Chemicals) was prepared as a stock of 10 mg/ml and filter 
sterilized by passing through 0.2 µm filter; stored in 1 ml aliquots at -200 C 
Kanamycin 
100 mg/ml Kanamycin (Sigma Chemicals) in sterile Milli-Q water; sterilized by 0.2 
µm filter 
Penicillin 
5 mg/ml Penicillin (Thermo Trace) in DMEM medium used for tissue culture cell 
line maintenance 
Skirrows antibiotic supplement  
Skirrows supplement was supplied by Oxoid and stored at 40 C. Two mls sterile 
Milli-Q water was added into one 500 mg vial and mixed the supplement with the 
media before dispensing. 
 
2.3.3 Enzyme stocks  
DNase 1 
10 mg /ml stock solution prepared in molecular grade water and stored at -200 C 
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T4 DNA ligase 
3 U/µl T4 DNA ligase (Promega); stored at -20° C 
Proteinase K 
20 mg/ml Proteinase K (Sigma) stored at -20° C 
Ribonuclease A (RNAse) 
10 mg/ml RNAse (Sigma); stored at -20° C 
10x Multi-Core buffer 
10x Multi-Core Buffer (Promega); stored at -20° C 
10x Ligation buffer 
10x Ligation Buffer (Invitrogen); stored at -20° C 
ATP 
10 mM ATP (Sigma); stored at -200 C 
DNase (RNase-free): RQ1 RNase –free DNase with 10x buffer (Promega) 
Pfu DNA polymerase: 3 U/µl (Promega) 
Taq DNA polymerase: 5 U/µl Ampli Taq (Perkin Elmer) 
Restriction enzymes: All restriction enzymes used were purchased from Promega 
(Sydney, Australia) and were used as per manufacturer’s instructions 
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2.4 Bacteriological media 
 
All media were prepared according to manufacturer’s recommendations unless 
specified in the text. Sterilization was performed at standard conditions, 1210 C for 
15 minutes. Media was poured into sterile Petri plates under aseptic conditions and 
left to set for 20 minutes in a laminar flow cabinet. Liquid media was ready to use 
after autoclaving and cooling to room temperature. 
Brucella Broth 
2 % (w/v) Brucella broth powder (Becton Dickins, Australia) in Milli-Q water 
Glycerol Cryogenic medium 
50% (v/v) glycerol (BDH), 50% v/v LB broth and autoclaved under standard 
conditions 
Heart Infusion (HI) Agar 
Dehydrated Heart Infusion broth (Oxoid) (2% w/v) and Bacteriological agar (1.2%) 
were dissolved in water and sterilised under standard conditions. 
Heart Infusion (HI) Broth 
Heart infusion powder in deionized water and autoclaved 
Horse Blood Agar (HBA) media 
3.9% (w/v) Columbia agar base (Oxoid) was autoclaved at standard conditions and 
cooled to 500 C. The media was supplemented with 5% (v/v) Horse blood (CSL) 
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Horse Blood Agar (HBA) media with Skirrows 
3.9% (w/v) Columbia agar base (Oxoid) was autoclaved at standard conditions and 
cooled to 500 C. The media was supplemented with 5% (v/v) Horse blood (CSL) and 
one vial of skirrows (Oxoid) (dissolved in 2 ml sterile Milli-Q water) supplement per 
500 ml of media.  
Horse Blood Agar (HBA) media with Skirrows and Kanamycin 
3.9% (w/v) Columbia agar base (Oxoid) was autoclaved at standard conditions and 
cooled to 500 C. The media was supplemented with 5% (v/v) Horse blood (CSL) and 
one vial of skirrows (Oxoid) (dissolved in 2 ml sterile Milli-Q water) supplement per 
500 ml of media. The media was mixed and kanamycin was added to a final 
concentration of 50 µg /ml and stirred well before poured into the Petri dishes. 
Luria Bertani (LB) broth  
1% (w/v) tryptone (Oxoid), 0.5% (w/v) yeast extract (Oxoid), 0.5% (w/v) NaCl 
autoclaved 
Luria Bertani (LB) broth with Kanamycin 
1% (w/v) tryptone (Oxoid), 0.5% (w/v) yeast extract (Oxoid), 0.5% (w/v) NaCl 
autoclaved and kanamycin was added to a final concentration of 50 µg /ml 
Luria Bertani (LB) agar 
1% (w/v) tryptone (Oxoid), 0.5% (w/v) yeast extract (Oxoid), 0.5% (w/v) NaCl and 
1.0% (w/v) bacteriological agar (Oxoid), autoclaved 
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Luria Bertani (LB) agar containing antibiotics 
1% (w/v) tryptone (Oxoid), 0.5% (w/v) yeast extract (Oxoid), 0.5% (w/v) NaCl and 
1.0% (w/v) bacteriological agar (Oxoid), autoclaved and cooled to 500 C and 
ampicillin was added to a final concentration of 100 µg /ml 
Muller Hinton Agar  
3.8% Muller Hinton Agar powder (Oxoid) was dissolved in distilled water and 
autoclaved 
Muller Hinton Broth 
2.1% Muller Hinton broth powder (Oxoid) in distilled water and autoclaved 
SOC media 
2% (w/v) tryptone, 0.5% (w/v) yeast extract, 10 mM NaCl, 2.5 mM KCl (Ajax 
Laboratory Chemicals), 10 mM MgCl2 (BDH), 10 mM MgSO4 (BDH), pH to 7.0 
with NaOH, and autoclaved. Then filter-sterilised 20 mM glucose is added prior to 
use. 
Tryptone/skim milk storage media 
10% (w/v) skim milk powder (Diploma), 1% (w/v) tryptone, 10 mM Tris-base, pH to 
7.5 with HCl; autoclaved at 1090 C for 10 minutes; stored at 40 C 
X-gal /IPTG Agar 
5–bromo-4-chloro-3-indoyl-beta-D-galactopyranoside (X-gal) [Diagnostic 
Chemicals Limited, (DCL)] and isopropyl-beta-D-thiogalactopyranoside (IPTG) 
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[DCL] were spreaded onto sterile LB agar using L-spreaders and then allowed to set 
for few minutes by protecting from light. 
 
2.5 Tissue Culture Media 
 
Dulbecco’s Modified Eagle’s medium (DMEM) 
200 ml 5x DMEM, 27 ml sodium bicarbonate, 20 ml HEPES, 9 ml L-glutamine in 
744 ml sterile Milli-Q water (Trace Biosciences) 
HEPES Buffer 
1 M HEPES buffer sterile (Trace Bioscience) 
New Calf Serum (NCS) 
Heat inactivated NCS was added to medium to a final concentration of 10 % (Trace 
Biosciences) 
Dimethyl sulfoxide  
Filtered through 0.5 micron filters (Aldrich) 
Sodium Bicarbonate  
7.5%, sterile (Trace Bioscience) 
Trypan Blue Solution  
1 % (w/v) trypan blue (Sigma) dissolved in sterile PBS 
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Trypsin EDTA 
1:250, pH 7.0, without phenol red (Trace Bioscience) 
Tryton –X- lytic solution 
Triton X-110 non-ionic detergent (BioRad)  
 
2.5.1. Tissue culture cell lines 
 
Human embryonic intestinal cell lines (INT 407) were used for in vitro analysis, 
obtained from RMIT central stock stored in liquid nitrogen. Cell lines were 
confirmed as Mycoplasma free by performing dark field microscopy and samples 
were prepared by the instructions provided in the RMIT tissue culture manual. 
 
2.6 Microbiological Methods 
 
2.6.1. Bacterial Growth Conditions 
 
C. jejuni strains were routinely grown on HBA or HBA/skirrow plates, and 
incubated at 420 C for 48-72 hours under microaerophilic conditions (10% CO2, 5% 
O2 and 85% N2). Selected colonies were sub-cultured onto fresh plates to form pure 
lawn cultures and incubated under the same conditions.  E. coli strains were grown in 
LB broth or on LB Agar at 370 C overnight, shaking at 180 rpm on an orbital shaker. 
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Appropriate antibiotics were added to the agar plates as per the requirements of 
various concentrations such as ampicillin 100 µg /ml, and kanamycin 50 µg /ml. 
 
2.6.2. Storage of bacterial strains  
 
All Campylobacter strains were stored at -800 C in tryptone/skim milk freezing 
medium. 700-800 µl of sterilised tryptone /skim milk storage media was added to 
one lawn subculture of each strain within 48 hours of incubation. The colonies were 
mixed with the storage media using a sterile L-shaped spreader and the bacterial 
culture was collected into a sterile cryogenic vial for long term storage. For short 
term storage of these bacterial strains, strains were stored at 40 C on appropriate 
media, supplemented with appropriate antibiotics. E. coli DH5 alpha strains were 
stored at -800 C in glycerol freezing medium. 
 
2.7  DNA Molecular Techniques 
 
2.7.1. Genomic DNA extraction 
 
Genomic DNA extraction was performed using the CTAB extraction method [219]. 
Lawn culture of C. jejuni strains were grown under microaerophilic conditions for 48 
hours at 420 C. Bacterial cells were harvested in 9.4 ml TE buffer and 0.1 ml 0.5 M 
EDTA and lysed with 0.5 ml 10% (w/v) SDS.  Proteinase K (final concentration of 
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0.1 mg/ml) was added to the mixture and incubated at 370 C for 2 hours. Five M 
NaCl (1.8 ml) and 1.5 ml of 10 % ( w/v) CTAB in 0.7 M NaCl were added and the 
mixture was incubated for 30 minutes at 650 C. Five ml of 
chloroform/isoamylalcohol was added to the mixture and centrifuged at 4700 g for 
10 minutes at 40 C. The top aqueous layer was transferred into a new falcon tube and 
5 ml of 25:24:1 phenol/chloroform/isoamylalcohol was added. This step was 
repeated twice to obtain pure DNA and precipitated by adding 0.6 volumes of 100% 
isopropanol. At the end of this procedure, the extracted DNA was dissolved in 50 µl 
of molecular grade water in a 1.5 ml Eppendorf tube, and stored at -200 C. 
 
2.7.2. Quantification of DNA concentration 
 
Concentration of the extracted DNA (chromosomal DNA and plasmid DNA) was 
measured by appropriate methods. DNA concentrations of plasmid DNA were 
estimated by comparison of sample DNA against the lambda Pst1 digested 
molecular weight marker (50 µg/ml). For chromosomal DNA, concentration was 
estimated by measuring the optical density at wavelengths 260 nm and 280 nm. 1:50 
diluted genomic DNA was used to measure the concentrations using an Eppendorf 
Biophotometer. The purity of the sample was determined by the ratio of ODs 
obtained at 260 nm and 280 nm (>1.8 for clean DNA) respectively. 
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2.7.3 Plasmid DNA extraction (Mini Prep) 
 
The alkaline lysis method was used to isolate plasmid DNA from the host bacteria 
[220] and used for further analysis. A single isolated colony  was inoculated on to a 
5 ml Mueller Hinton broth (MH broth) with appropriate antibiotics  and was grown 
overnight on a shaker  at 37o C. One and a half mls of culture was taken in a sterile 
microfuge tube and the cells were collected by centrifugation at 22,000 x g for 1 
minute. The supernatant was removed and the pellet was resuspended in 100 µ  of 
ice cold solution I (50 mM glucose, 10 mM EDTA, 25 mM TrisCl pH 8, 4 mg/ml 
lysozyme) and left at room temperature for 5 minutes. Two hundred µls of freshly 
prepared Solution II (0.2 N NaOH/1% SDS) was added to lyse the bacterial cell wall 
completely and left the tube on ice for 5 minutes. Chilled potassium acetate solution 
(Solution III, prepared by adding 5M acetate and 3 M potassium) was added to 
precipitate protein and chromosomal DNA and left the tube on ice for another 5 
minutes. This was then mixed thoroughly by inverting the tubes several times and 
separating out the impurities by centrifugation. The supernatant was transferred into 
a new centrifuge tube and an equal volume of phenol/chloroform/isoamylalcohol 
(PCI) was added. The contents were mixed vigorously and centrifuged at 22,000 g.  
The aqueous phase was transferred to a new tube and the residual phenol was 
removed by the addition of chloroform/isoamyl alcohol (CI). An equal volume of 
isopropanol was added to precipitate the DNA and spun down the sample for 10 
minutes. The pelletted DNA was washed with 70% ethanol and ethanol residues 
were removed completely by keeping the tube upside down on tissue paper. Finally, 
the DNA pellet was resuspended in 20 microlitres of TE buffer and stored at -200 C. 
65 
 
2.7.4.   Polymerase Chain Reaction (PCR) 
 
PCR was performed by a PCR express Thermal cycler Machine in sterile PCR tubes. 
Bacterial cells and the isolated DNA samples were used to perform PCR reaction. 
Colony PCR was conducted by using fresh isolated colonies. Fresh colonies were 
taken up by toothpicks. The colonies were immersed in 50 microlitres PCR reaction 
mix and grounded on the wall of the PCR tube for 2 seconds. The remaining 
bacterial cells on the toothpick were subcultured on an agar plate with an appropriate 
antibiotic. PCR Master Kit supplied by Roche was used to set up the reaction. PCR 
was performed using the general protocol described in the instruction manual. The 
details of the PCR cycling conditions are stated in each section.  
 
2.7.5. Primer Design 
 
Primers were designed using the Clone Manager suite of analysis tools (Sci Ed 
Central website). Clone Manager performed experiments to confirm that the genes 
and corresponding designed primers were correctly cloned into the vector, both in-
frames with the start codon of the vector and in the correct orientation for proper 
expression of the selected gene. All primer sequences were selected from the 
genome sequence of C. jejuni strain NCTC11168.  Restriction enzyme (RE) sites 
were also included in the primer design to facilitate the cloning of amplicons into the 
vectors and 45- 50% of GC content was considered to be acceptable for C. jejuni. 
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2.7.6. Agarose Gel Electrophoresis 
 
Agarose gel electrophoresis was used to separate DNA fragments by length and to 
estimate the size of DNA. Gel slabs were prepared using 1.0-2.0% of agarose 
powder in 1 x TAE buffer and dissolved by boiling in a microwave. An electric field 
was created by applying a current of 40 – 100 V for 1 – 3 hours and the DNA 
fragments were separated according to size. The size of the DNA was estimated by 
running each sample against a lambda DNA marker prepared by digestion with Pst I 
restriction enzyme.  The gel tanks used were either mini or midi with 1 x TAE buffer 
as the wells needed. The gels were stained in an EtBr bath for 10 minutes and 
destained under running tap water for 30 minutes. The Gel Doc Imaging system 
(Bio-Rad) was used to visualize DNA fragments under UV illumination. 
 
2.7.7 Purification of PCR products for sequencing  
 
50 µl of 95% analytical ethanol and 2 µl of sodium acetate were added to 20 µl of 
sequencing reaction and mixed by vigorous shaking on a rotary shaker. The reaction 
mixture was placed on ice for 10 minutes and centrifuged for 30 minutes at 22,500 g. 
The supernatant was removed by pipetting carefully and the pellet was resuspended 
in 250 µl of 70% ethanol. The solution was then mixed by pipetting up and down 
and then centrifuged again for 10 minutes at 22,500 g. The air dried pellet was sent 
to Monash University (Clayton, Victoria) for sequencing. The ABI Prism 377 DNA 
sequencer was used to perform the reaction and was performed by staff at Monash 
University. 
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2.7.8.   Restriction Enzyme Digestion 
 
All digestion reactions were carried out with the following reagents: 
DNA     X µl 
RE      0.5 µl (10 µl) 
10x buffer    2 µl  
Water     X µl 
Total volume             20 µl 
All digestion reactions were carried out at 370 C for 2 - 16 hours and then stored at –
200 C. 
2.7.9. DNA Ligation 
Ligation reactions were performed either at room temperature or at 40 C for 14 
hours.  
The protocol used for ligation reactions is given below: 
Plasmid DNA    X µl 
Insert DNA    X µl 
Ligase (T4)    1 µl (1U/ µl) 
10x Ligation buffer   2 µl  
Water     X µl  
Total volume   20 µl 
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 The amount of plasmid DNA and insert DNA added to the ligation reaction was 
determined by the following equation: 
 vectorinsert to of ratiomolar  (kb) vector of size
(kb)insert  of size vector of ng
 insert DNA  of ng ××=  
 
2.7.10. Cycle parameters for DNA sequencing 
 
The PCR conditions used for sequencing are given below. 
 
Stage 1: Initial denaturation at 960 C for 1 min 
Stage 2: Denaturation at 960 C for 10 s 
   Annealing at 500 C for 5 s 
   Extension at 600 C for 4 s 
   Number of cycles = 25 
Stage 3: Hold samples at 40 C indefinitely    
 
2.7.11 Purification of DNA fragments from Agarose Gel (Gel extraction) 
 
The DNA bands of interest after restriction enzyme digestion were excised from the 
agarose gel using a sterile scalpel blade. The excised bands with the agarose was put 
into a micro centrifuge tube, weighed, and purified using the QIAquick Gel 
Extraction Kit (QIAgen) as per the manufacturer’s instructions. Three volumes of 
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QIAgen buffer were added to 1 volume of the excised DNA bands. The agarose was 
melted by keeping the tubes in the waterbath   at 500 C for 10 minutes. At every 2 
minutes the tube was inverted to keep the particles in suspension. The sample was 
then centrifuged and the pellet was washed again by the buffer supplied with the kit. 
At the completion of the gel extraction, the purified samples were eluted in 30 µl 
of elution Buffer, and stored at -200
 
C. It is understood that there is an ~30% loss in 
DNA quantity (ng) during the gel extraction procedure. DNA quantity was estimated 
by loading the samples on a 1.5% agarose gel and confirmed by calculating the 
intensity of the extracted DNA bands.  
 
2.7.12. Purification of DNA from PCR amplification 
 
Purification of DNA from PCR amplification was performed by using a Wizard PCR 
prep kit. One hundred µl of purification buffer was added to each PCR reaction and 
mixed briefly by the pipette. One ml of resin was added to the mixture and vortexed 
briefly. The entire mixture was then transferred to a column and was gently passed 
through it. Two mls of isopropanol was added and centrifuged it again for 1 minute. 
The DNA was then eluted in 20 µl of elution buffer and stored in a -200 C freezer. 
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2.8  Electroporation 
 
2.8.1. Preparation of electro competent cells (E. coli DH5α)  
 
A single colony of E. coli DH5α was inoculated into 5 ml of LB broth and grown 
overnight at 370 C on a shaker. Two ml of the overnight culture was transferred to 
200 ml of pre-warmed LB broth and the cells were grown at 370 C with vigorous 
shaking to an OD 600 of 0.6 (~2-3 hours). The cells were then chilled on ice for 30 
minutes to slow down the cell growth. The cells were harvested by centrifugation at 
4700 g for 15 minutes at 40 C and the cell pellet was resuspended in 200 ml chilled 
sterile Milli-Q water. The supernatant was completely drained off after 
centrifugation and then resuspended in 100 ml of 10% glycerol in chilled sterile 
water and centrifuged as above. The cells were pelleted and resuspended again in a 
final volume of 2 ml of ice cold 10% glycerol. Centrifugation was repeated and the 
pellet was resuspended in 250 µl of 10% glycerol and aliquoted out in 50 l volumes 
and stored immediately at -800 C. 
 
2.8.2. Electrotransformation 
 
The method employed was based on the Biorad Gene Pulser apparatus instruction 
manual. Briefly, 1-2 µg of plasmid DNA was added carefully to a 50 µl vial of 
electrocompetent E. coli DH5 cells and stored on ice for 1 minute before 
transferring to a cuvette. The Gene Pulser setting used to deliver the DNA into the 
cell was set at 200 ohms, 25 µF capacitance, and 2.0-2.5 kV, with a 4-5 ms pulse.  
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The ligated product with plasmid DNA was transferred to the bottom of an ice-cold 
sterile cuvette (with a 2 mm gap). The cuvette was placed in the apparatus using an 
ice-cold sliding device, and pulsed once. One ml of SOC medium or LB broth was 
immediately added to the cuvette resuspending the cells. The electroporated sample 
was transferred to a 1.5 ml polypropylene tube, and incubated for 1 hour at 370 C 
with shaking. Hundred mls of suspension was plated out onto a pre-warmed LB agar 
plate containing selective antibiotics. The remaining 900 µl was centrifuged at 1200 
g (RT), and the supernatant discarded. The cells were resuspended in 100 µl broth 
medium, and the entire 100 µl “concentrated transformants” was plated out onto 
another LB agar plate containing antibiotics. The plates were incubated at 370 C 
overnight, and checked for the transformants and stored at 40 C. Transformation 
efficiency was tested by adding 1 µL of undigested “empty” vector (miniprep 
sample) to a 50 µl vial of electrocompetent E. coli DH5 cells, and the cells were 
electro-transformed as described above. 
 
2.9 Chemical transformation  
 
Chemically competent E. coli DH5TM-T1R cells (Invitrogen) were used to perform 
chemical transformation.  Two µl of “ligated” product was added into one vial (50 
µl) of chemically competent cells, mixed gently and incubated for 30 minutes on ice. 
The cells were exposed to heat shock for 30 s at 42° C (waterbath) and immediately 
transferred to ice. SOC medium was added into the tubes and incubated at 370 C for 
1 hour on a shaker. The transformants were plated out on to pre-warmed agar plates 
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with selective antibiotics. Transformants were visualised by blue/white colony 
screening. 
 
2.10 Natural Transformation of C. jejuni 
 
C. jejuni cells were grown on Horse Blood Agar Plate at 42° C for 16 hours. The 
cells were resuspended in 1 ml of HIB.  Two hundred µl volumes of cells were 
overlayered into an Eppendorf tube with 1 ml of HI agar. The lid was closed and 
pierced. The Eppendorf tube with media was incubated under microaerophilic 
conditions for 3 hours at 37º C.  Ten µg of plasmid DNA was added on to the 
bacterial suspension and incubated at 370 C for another 3 hours. The entire volume 
of cells and the DNA was plated out on to HBA plates with appropriate antibiotics. 
The plate was incubated under microaerophilic conditions at 420 C for 24-48 hours or 
370 C for 4 days. Colonies were confirmed by colony PCR and restriction enzyme 
digestion. 
 
2.10.1. Preparation of C. jejuni competent cells  
 
C. jejuni competent cells were prepared by washing with ice cold filter sterilised 
sucrose glycerol solution. Sucrose-Glycerol solution was prepared by adding 9% 
sucrose and 15% glycerol in Milli-Q water and filter sterilised by passing through a 
0.2 micrometer membrane filter. Bacterial cells were collected by centrifugation at 
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3,300 g for 5 minutes at 40 C. The pelletted cells were resuspended in 0.5 ml of cold 
sucrose glycerol solution and aliquoted in 40 micrilitre volumes into microcentrifuge 
tubes. The competent cells were stored at -700 C. 
 
2.10.2. Electrotransformation of plasmid DNA into competent C. jejuni  
 
The constructed plasmid DNA (0.1-1.0 g) was mixed with C. jejuni competent cells 
and kept on ice for 1 minute. The mixture was transferred into a chilled 
electroporation cuvette of 0.2 micro meter width and electroporated at 25 F, 2.5 kV 
and 200 ohms using Gene Pulse Controller (Bio-Rad). The cuvette was immediately 
filled with 1 ml of SOC medium and transferred onto a Blood Agar plate without 
antibiotic. The plates were incubated at 370 C under microaerophilic conditions for 
overnight. The cells were harvested in Heart Infusion Broth and grown on Blood 
Agar plate supplemented with Skirrows and appropriate antibiotics. The plates were 
incubated at 420 C for 2 days under microaerophilic conditions. 
 
2.11 Tissue culture Methodology  
 
2.11.1. Media and Reagents 
 
INT 407 cells were cultured in standard DMEM media and standard PBS was used 
when working with INT 407 cells. 
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2.11.1.1. Dulbecco’s Modified Eagle’s Medium (DMEM) 
 
To 372 ml of deionised distilled water (double sterilised), 100 ml of 5 x DMEM, 
13.5 ml of 7.5% Sodium bicarbonate, 10 ml of HEPES buffer and 4.5 ml of L-
glutamine were added by direct filter sterilisation and stored at 4° C. Fresh aliquots 
of DMEM supplemented with 10% v/v newborn calf serum (NCS) were used in 
culture. 
 
2.11.1.2. Trypsin Solution 
 
Trypsin/EDTA was mixed 1:1 with PBS and used to dissociate INT 407 cells and 
stored at -200 C. 
 
2.11.1.3 Gentamycin Solution 
 
Gentamycin sulphate (400 g/ml) in DMEM  
 
2.11.1.4. Phosphate buffered saline (PBS) 
 
Phosphate buffered saline (PBS) was prepared by dissolving 1 tablet of pre-made 
PBS, obtained from Oxoid, in 100 ml distilled water and sterilized by autoclaving at 
1090 C,  for 15 min. It was otherwise prepared from 8 g of NaCl, 0.2 g of KCl, 1.44 g 
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of Na2HPO4 and 0.24 g of KH2PO4 dissolved in 1 litre of distilled water and the pH 
adjusted to 7.3. This was then sterilized by autoclaving.  
 
2.12 Tissue culture Techniques 
 
2.12.1. Tissue culture cell lines 
 
The cell line INT 407 were resuscitated from liquid nitrogen stocks of the 
Biotechnology laboratory, School of Applied Sciences and grown in DMEM 
Medium. Cultures were grown to exponential phase before they were split and 
transferred to a larger flask. The cells were passaged no more than 15 times before a 
fresh stock of cells were resuscitated. Cultures were split by removing the media and 
washing twice in PBS. Trypsin solution was added to an appropriate volume and the 
flask was incubated at 370 C for 5-10 minutes in 5% CO2. The dissociated cells were 
removed from the flask and washed twice in DMEM. An appropriate volume of cells 
were used to seed a new flask or flasks. 
 
2.12.2. Storage and Maintenance of cell lines 
 
Tissue culture cells were stored in liquid nitrogen in DMEM medium supplemented 
with 10% DMSO as a cryoprotectant. Cells were dissociated by adding trypsin 
EDTA and incubated for 5-10 minutes in the tissue culture incubator. They were 
transferred to a centrifuge tube, washed them twice and centrifuged at 1000 g for 5 
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minutes. The cells were stored at -700 C for 2-3 days before transferring them to 
liquid nitrogen. 
 
2.12.3. INT 407 cells 
 
INT 407 cells used were grown in DMEM medium supplemented with 10% NCS. 
Cells were grown to 70-80% confluency in a 75 cm2 tissue culture flask. The number 
of live cells was counted using a Neubauer cell counting chamber after 
trypsinisation.  Trypan blue exclusion method was used to determine the percentage 
of viability of cells in which cells were suspended in a 0.04% trypan blue solution 
for 2 minutes. A percentage viability of at least 95% was used to perform the assays. 
24 well tissue culture tray was used  and a seed culture of 1x105 cells in 500 
microliter  of DMEM supplemented with 10% NCS  was loaded on to each well. The 
cells were grown overnight for 18 hours till a monolayer was formed. 
 
2.12.4. Bacteria 
 
Campylobacter jejuni 11168 was grown on Horse Blood Agar plates for 48 hours 
under microaerophilic conditions.  A single colony was inoculated on to 2 ml of 
brucella broth and incubated under the same conditions, and was used as the positive 
control. All knock-out strains were grown under same conditions and media was 
supplemented with appropriate antibiotics. E coli DH5 cells were grown on MHA 
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agar at 370 C overnight. MHA broth inoculated with a single isolated colony and 
incubated overnight on shaker was used as a negative control.  
 
2.12.4.1. Preparation of Inoculum 
 
Overnight bacterial culture was added to PBS, the required concentration (~1x 107 
cells) was adjusted by checking the optical density. The cells were pelletted at 4700 
g for 5 minutes by centrifugation and resuspended in DMEM medium supplemented 
with NCS.  It was ready to load on to tissue culture plates with monolayer of 
intestinal cell lines for performing the assay. 
 
2.12.5. Adhesion assay 
 
INT 407 cells were washed twice with PBS. 100 microlitres of the inoculum 
containing 1x 107 cells was used to infect the INT 407 cells by overlaying the 
bacteria on the top of the intestinal cell lines. Four hundred microlitres of medium 
was added to the wells to make a final volume of 500 microlitres. The infected cell 
layers were incubated at 370 C in the tissue culture incubator with 95% air and 5% 
CO2 for 1 hour. The cells were washed twice with PBS to remove non adherent 
bacteria. The detergent Triton X-114 was added to release the intracellular bacteria 
and this was incubated at 370 C for 15 minutes to lyse the INT 407 cells. Eight 
hundred microlitres of PBS was added to each well and 100 microlitres of the lysate 
was taken and serial dilutions were performed before being plated on to agar plates.  
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2.13 Knock-out Mutagenesis 
 
The Gene of `interest` was selected for knock-out analysis. The gene inserts were 
first cloned into the pCRII-TOPO cloning vector, and verified by DNA sequence 
analysis. Double-digestion of pCRII-TOPO constructs and pBluescript empty vector 
was performed with Kpn1 and SacI. Digested DNA bands were excised from the gels 
using a scalpel. The empty vector (pBluescript) and the insert bands were purified 
using the QIA Quick Gel Extraction Kit and ligated together. The ligated products 
were electro-transformed into E. coli DH5 alpha cells. Selected colonies were tested 
for to confirm clones. 
 
Inverse PCR was used to delete part of the gene and to introduce a BamH1 
restriction site. The purified PCR product (purified using a Promega Wizard PCR 
purification Kit) and an empty PMW2 vector were digested with BamH1. The 
products were then ligated with the 1.4 Kb Kanamycin cassette of the PMW2 vector. 
The ligated products were electro-transformed into E. coli DH5 alpha cells and 
selected colonies were analysed and and confirmed kanamycin cassette in the gene 
of interest. The resulting suicide plasmid was transformed into Campylobacter jejuni 
by natural transformation or electrotransformation. 
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3.1 Introduction 
 
Vaccination plays an important part in preventing or reducing the adverse effects of 
specific diseases of the poultry flock. Vaccination administers a biological 
preparation which contains an agent that resembles the disease-causing micro-
organism, or at least a key component of it. The vaccine is often made from 
weakened or killed forms of the microbe or its toxins. The agent stimulates the 
body's immune system and retains immunological memory. Commercial poultry are 
exposed to a number of pathogens. The disease-causing organisms in poultry can be 
categorized as viruses, mycoplasma, bacteria, fungi, protozoa, and parasites. All 
these organisms except viruses are vulnerable to chemotherapy [221]. Viral diseases 
are prevented through strict sanitation and biosecurity and by vaccination. The 
generally used poultry vaccine delivery systems are in ovo injection, aerosol, spray, 
drinking water, eye drop, and wing web injection. Poultry respond to vaccines by 
developing humoral and cellular immune responses [222, 223]. Commonly used 
vaccines in poultry are Marek's disease vaccines, Newcastle disease vaccines, 
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infectious bronchitis vaccines, laryngotracheitis vaccines, pox virus vaccines, fowl 
cholera vaccines and avian encephalomyelitis vaccines [223-225]. Vaccines are also 
available against bacterial pathogens such as Salmonella vaccine, cholera vaccine 
etc. 
 
Campylobacter and Salmonella are the two most common bacteria commonly found 
in live poultry and raw poultry products. Recent studies show that Campylobacter is 
more prevalent and has become the largest threat to human food borne illness related 
to poultry products. 5.4 million cases of food-born gastroenteritis are reported each 
year in Australia [226]. Although Norovirus, enteropathogenic Escherichia coli and 
Salmonella spp., can cause gastroenteritis, Campylobacter spp. are the most 
frequently reported enteric pathogens in Australia [227, 228]. Poultry appears to be 
the leading reservoir for Campylobacters and thus poultry meat products are found to 
be the leading source of campylobacteriosis. Campylobacter colonises the intestinal 
tract of chickens and is transferred to carcasses and the environment during 
slaughtering and processing [87]. Cross- contamination is a key factor which 
promotes the spreading of Campylobacter throughout poultry processing. 
Contamination occurs during processing, and remains until consumption. In order to 
minimise contamination of poultry products, the industry undertakes several 
measures, including adhering to strict hygiene, biosecurity and carcass treatments. 
Identifying the virulence factors or factors promoting colonization in chickens may 
lead to strategies to reduce the level of Campylobacter in poultry. Table 3.1 
summarizes the strategies that have been employed to reduce the contamination in 
poultry [229]. 
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Table 3.1 Strategy to reduce Campylobacters in poultry [229, 230] 
Strategies References 
Antimicrobial treatments Horrocks et al [231] 
Administered of  bacteriocins Svetoch and stern [232] 
Administration of bacteriophage Wagenaar et al. [233] 
Chemical feed additives Horrocks et al [231] 
Nitrocompounds (2-nitro-1-propanol) Horrocks et al [234] 
Deaminase inhibitors (diphenyliodonium 
chloride and thymol) 
Anderson et al [235] 
Competitive exclusion Hakkinen and Schneitz [236] 
Feed supplementation using organic acid Heres et al.[237] 
Carcass treatment with 1ppm of free chlorine Blaser et al.[238] 
Addition of chlorine to drinking water Pearson et al.[239] 
Treating of carcass with lactic acid or alkaline 
chemicals 
Okolocha and Ellerbroek [240] 
Vaccination of chickens De Zoete et al. [200] 
Cetylpyridinium chloride (between 0.1 to 
0.5%) 
Waldroup et al [241] 
Freezing and thawing Frederick [242]  
Inside-outside bird washers Smith el al. [243] 
 
Although campylobacteriosis is one of the leading causes of gastroenteritis 
worldwide [8, 244-246], it is little known about the factors that are required to elicit 
a protective immune response in chickens. To date, a number of vaccine candidates 
have been tested with varying degrees of success [247-249].  However, there is still a 
lack of a suitable vaccine. Therefore the need for a vaccine against this pathogen is 
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well recognized. Lack of understanding of the pathogenicity, antigenic diversity of 
the organism, poorly defined protective epitopes and lack of understanding of the 
factors that are required to elicit a protective immune response are some of the 
problems encountered by researchers trying to develop a Campylobacter vaccine. 
 
Studies have indicated that outer-membrane proteins (OMPs) may be suitable targets 
for a protective immune response. Previous studies have shown that outer-membrane 
proteins can be useful for future studies aimed at identifying C. jejuni surface 
proteins as vaccine components [250]. Therefore for subunit vaccine research, OMPs 
play an important role, primarily because they are surface exposed [250]. A number 
of C. jejuni proteins such as MOMP [102, 157, 251-262] have been experimentally 
localized to the outer membrane.  
 
C. jejuni  contains a major outer membrane proteins (MOMP)  which belong to the 
maltoporin super-family, sharing common structural motifs and an apparent 
molecular weight of about 45 kDa  [252].  It is a putative porin and a multifunction 
surface protein of C. jejuni, and plays an important role in the adaptation of the 
organism to various host environments [253].  Most of the gram-negative bacteria 
have one or more predominant outer membrane proteins (OMPs) [253]. These 
predominant OMPs usually function as porins regulating the permeability of the 
membrane to small molecules [263]. Hence, the major outer membrane proteins play 
an important role in the communication between bacteria and the environment [253]. 
Studies have demonstrated that these proteins are resistant to detergent and protease, 
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a key property required for enteric bacteria to survive in the intestinal tract [263, 
264]. There is evidence that porin-based vaccines can induce protective immunity 
against some bacterial infections [265, 266].  Various experimental results suggest 
[253] that MOMP may have additional biological functions contributing to the 
adaptation of the pathogenic organism to various host environments. As MOMP has 
important physiological functions, it may be a potential vaccine candidate for 
inducing protective immunity against Campylobacter in chickens [267]. This is the 
rationale for the use of OMPs in the study detailed here. 
 
Cell adherence by C. jejuni is facilitated by a number of adhesins.  CadF is a 
fibronectin binding protein of C. jejuni with a molecular weight of 37 k Da [258]. It 
appears to play a role in promoting the binding of C. jejuni to Fn (Fibronectin) and 
promotes the phosphorylation of paxillin, a focal adhesion protein [257]. CadF is an 
immunoreactive protein, and exhibits a number of characteristics of a surface 
exposed OMP including heat modifiability [268]. Studies have shown that 
identification of C. jejuni binding factors such as CadF may permit the construction 
of attenuated vaccine strains or the design of subunit based preparations for oral 
immunization [157]. It has been indicated that CadF may be useful as a specific 
acellular vaccine constituent as it is present in both C. jejuni and C. coli, but not  in 
several other bacterial intestinal pathogens[157].  
 
Bacterial OMPs such as CadF and CfrA have high accessibility for the host immune 
system and play a significant role in the host-bacterium cross-talk [269]. These 
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surface- exposed proteins are highly immunogenic in chicks [269]. C. jejuni 
periplasmic PEB1 is highly immunogenic in humans, and deserves further attention 
as a possible candidate for vaccination studies in chicks although the 
immunogenicity in the chicken host is not known. There are other candidates such as 
Cj0178, the secreted CiaB and transmembrane Tlp-10 which were also shown to be 
immunogenic in humans. 
 
The distinct characteristic of C. jejuni colonization in poultry is that this organism is 
not detected in chicks less than 2 to 3 weeks of age under commercial broiler 
production conditions [270-273]. C. jejuni infection usually starts from the third 
week, increases with age, and peaks at 6 to 7 weeks [272, 274, 275]. This suggests 
that young chickens may have age-related resistance to Campylobacter colonization 
[166].   Previous studies have shown that specific anti-Campylobacter antibodies are 
induced throughout the lifetime of a chicken. Antibodies against the bacterium are 
generated by C. jejuni colonization and a decrease in the number of C. jejuni has 
been observed at 6-7 weeks of age. The Campylobacter strain-specific maternal 
antibodies developed at this stage are passed through the ovum to chicks. The level 
of these maternal antibodies remains high for 3 to 4 days after hatching and 
gradually decrease to undetectable levels at approximately 2 to 3 weeks of age [276]. 
C. jejuni colonization of chickens coincides with the decrease (absence) of the 
maternal antibodies. The hypothesis is therefore that these maternal antibodies 
inhibit colonization during the first two weeks of age. Campylobacter-specific 
maternal antibodies (MAB) may be one of the possible contributing factors for the 
resistance which are widely present in young chickens [272, 277, 278]. Therefore, 
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the targets of these antibodies are vaccine candidates. Immunoblotting studies 
conducted by Sahin and colleagues [277] revealed that maternally derived antibodies 
recognized multiple membrane proteins of C. jejuni ranging from 19 to 107 kDa and 
anti-Campylobacter maternal antibodies were active in cell mediated  killing of C. 
jejuni as assayed by in vitro serum bactericidal assays [277]. 
 
Researchers have hypothesized that these antibodies may not clear an established 
population of Campylobacter bacteria but can cause a decrease in the microbial load 
[166, 279].  Studies showed that chickens immunized with avirulent Salmonella 
carrying the Campylobacter cjaA gene greatly reduced the bacterium’s ability to 
colonise chickens [196, 280]. Shoaf-Sweeney et al [280] have reported a list of 
immunogenic membrane-associated C. jejuni proteins recognized by maternal 
antibodies. The antibodies passed from hens to chicks are fully protective against 
Campylobacter colonization of chicks which may indicate their targets are vaccine 
candidates against C. jejuni [280]. As the antibodies present in adult chickens are 
presumably involved in the observed reduction in Campylobacter colonisation in 
older birds, and the delay of colonization in chicks, the targets of these antibodies 
may be potential vaccines. Some of those identified are: 
1. CJJ81176_0164:- Outer Membrane protein OMP 85 Family  
2. CJJ81176_0128: - Hypothetical Periplasmic protein 
3. CJJ81176_1295 Fibronectin type III domain protein 
4. cadF: - Outer membrane Fibronectin Binding protein. CadF aids in the 
colonisation of chickens [281, 282]. The fibronectin binding domain of CadF 
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consists of 134-137 aminoacids which binds to epithelial cells specifically 
fibronectin located basolaterally.  C. jejuni CadF mutants were shown to have greatly 
reduced capability for chicken colonisation when compared with wild type [280, 
283].  
 
Considering the potential importance of these antigens, these were selected for 
testing in a vaccine trial. 
 
STM-1 is an attenuated strain of S. enterica serovar Typhimurium which harbors a 
mutation in the aroA gene region. It is a commercial vaccine strain used to protect 
poultry against Salmonella infection [210]. These attenuated strains have the 
potential to deliver heterologous antigens and induce protection against various 
diseases. The potential advantages of live attenuated vaccines are simple mode of 
inoculation such as oral spray or in ovo delivery and generation of strong immune 
responses that make them ideal candidates for the delivery of antigens [284-286]. 
The choice of antigen for delivering into the host immune system and induction of 
immune response through optimal expression of foreign antigens are two aspects of 
creating a successful vaccine [287]. 
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3.2 Objectives 
 
1. To investigate the efficacy of outer-membrane vaccine constructs in chicken 
2. Ascertain if STM1 is a useful vector for the delivery of antigens to the immune 
system in chickens 
3. After subsequent challenge, do these constructs reduce the levels of 
Campylobacter in chickens? 
 
3.3 Materials and Methods 
 
3.3.1 Antigens and number of animals used in the study 
 
The project was designed to test the ability of the vaccine to subsequently reduce the 
colonization by Campylobacter. The timeline for the experiments are as follows. 
1. Chickens arrive at day 1 (One day  old female chicken) 
2. Control swabs were taken at day 3 to make sure  no Campylobacter before 
the challenge 
3. Vaccinated at day 7 
4. Second vaccination at day 21 
5. Challenge at day 30 
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6. Collection of cloacal swab at day 32 
7. Termination of the experiment at day 40 
 
The antigens and the number of animals used in this study are listed in Table 3.2.  
 
Table 3.2 List of antigens and number of animals used in the study 
 
 
 
 
 
Group # Vaccine Number of chickens 
1 STM-1 5 
2 STM-1/ Empty plasmid 5 
3 cadF/sspA 5 
4 Omp85/sspA 5 
5 CJJ81176_0128/sspA 5 
6 CJJ81176_1295/sspA 5 
Total  30 
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3.3.2 Procedures performed during Animal experiments 
 
All experiments were conducted under the direction of the RMIT Animal Ethics 
Committee. 
 
Wing tagging: To identify chickens throughout the trial they were tagged with a 
metal tag, which involves clipping the tag through the wing membrane using an 
applicator tool.  
Vaccination and challenge: Two vaccination doses were given to each chicken. 
Chickens were vaccinated orally using a purpose built gavage needle with 1 X 109 
live STM-1 in 200 microlitres PBS. Nine days after the second vaccination chicks 
were orally challenged with 1 X 109 Campylobacter. The challenge was performed 
in an identical way to the oral vaccination. Chickens had their food withdrawn 20 
hours prior to the vaccinations and challenge.  Feed was restored immediately after 
vaccination and challenge. This assisted with the establishment of the bacteria.  
Monitoring during the project: During and immediately after procedures, chicks 
were monitored for abnormal behavior, feather pecking, malaise and vocalisation. 
There were no specific clinical symptoms for Campylobacter infection.   
Collection of cloacal swab: Cloacal (anal) swabs were taken periodically to confirm 
colonization. 
Termination of experiment: Chickens were killed by decapitation and organs 
immediately removed for bacterial assays.  
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3.4 Analyses of the results 
 
1. The cloacal swabs were taken and directly plated out on Horse blood agar plate 
with skirrows before they were incubated in a microaerobic atmosphere at 37°C for 
48 h. The growth of Campylobacter was confirmed by biochemical analyses 
including the hippurate hydrolysis test.  
2. At the end of the experiment, chickens were killed by decapitation. Caecal 
samples were collected in a 50 ml falcon tube. Dilutions of the intestinal contents 
were made in phosphate-buffered saline (PBS) and plated on Horse Blood Agar 
supplemented with Skirrows supplement to obtain the number of Campylobacter 
cells per gram of intestinal contents. The plates were incubated microaerobically at 
420 C for 48 hours. The number of colonies and the colonization level were 
calculated per gram of caecal samples. 
 
3.5 Results 
3.5.1 Colonisation levels after challenge  
Five chickens were used in each group, although several deaths due to congenital 
abnormalities meant that some groups ended with less than five.  Faecal samples 
were collected in 50 ml falcon tubes after decapitation. One gram of faecal sample 
was re-suspended in 1 ml of PBS (duplicates were prepared for each sample) and this 
was serially diluted such as 1/10, 1/100, 1/1000 so on to obtain further dilutions up 
to 10-7.  One hundred micro liters of the last 3 dilutions was plated to enumerate 
colonies.  
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The numbers of colonies per gram of caecal samples were enumerated after 48 hours 
incubation. These results are shown in Table 3.3, with duplicate plates for each 
chicken. The effectiveness of the vaccine constructs were analyzed based on the 
number of colonies obtained.  A reduction in the number of colonies was obtained in 
the study. This indicates that the delivery vector used in the study can deliver 
heterologous antigens which have an effect in the reduction in the colonization level. 
Although there was a reduction in the number of colonies in all vaccinated groups, 
the least number of colonies (i.e. greatest protection) was observed in the STM-
1/sspAomp85 group. 
Table 3.3 Colony count for 100 microlitres of 1/100,000 dilution 
STM-1 STM-
1/pKK 
STM-
1/sspAcadF 
STM-
1/sspAomp85 
STM-
1/sspA81176-
128 
STM-
1/sspA8117
6-1295 
1005 930 16 15 51 100 
978 1110 18 21 67 113 
967 1248 114 12 76 70 
1060 1135 126 18 85 97 
858 1187 14 9 250 80 
869 1185 17 8 245 85 
1002  180 82 108 159 
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1122  175 76 100 163 
1030  9  78 92 
1026  12  84 86 
Mean 
991.7 
 
1132.5 
 
68.1 
 
30.13 
 
114.4 
 
104.5 
SD 
80.48 
 
110.08 
 
72.12 
 
30.52 
 
71.92 
 
31.99 
 
 
3.5.2 Evaluating the level of colonization of C. jejuni after vaccination 
 
 
All vaccinated groups had a significantly reduced level of colonisation compared to 
the two control groups. The lowest level was in the STM-1/sspAomp85 group, with 
a mean count of 30 x 106 CFU/g. This equated to 0.3% colonisation compared to the 
controls. The graphical representation of the results obtained is shown in Figure 3.1. 
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Figure 3.1 Vaccinated groups show reduced colonization level compared to the 
control groups with a significant P value (P<0.001) 
 
3.6 Discussion  
 
A recent article published identified the targets in Campylobacter of maternal 
antibody [280]. As the antibodies present in adult chickens are presumably involved 
in the observed reduction in Campylobacter colonisation in older birds, and the 
absence of colonization in young chicks, the targets of these antibodies may be 
potential vaccines. A chicken colonisation trial was performed to analyse the level of 
colonization of C. jejuni after vaccination. Campylobacter antigens can be delivered 
by STM-1 to chickens and a subsequent reduction in colonisation after challenge was 
STM-1 STM-
1/pKK 
STM-
1/sspAcad
STM-
1/sspAomp85 
STM-
1/sspA81176-128 
STM-
1/sspA81176-
1295 
Vaccine construct 
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observed. These antigens were several C. jejuni OMPs that had been found to be 
immunogenic against maternal antibodies [280].   
Although there was a reduction in the colonization level, the reduction observed in 
this instance is probably not high enough to warrant further development as 
vaccines. Although the maximum reduction was to 0.3% of the control values, 
anecdotally, industry would desire a vaccine that induces at least a 5 log reduction. 
Therefore, the antigens tested here, although inducing a reduction in colonization, 
might not be optimal for delivery by STM1.  However, previous reports would 
indicate that attenuated Salmonella can induce strong protective responses when 
delivering a Campylabacter antigen. For example, a protection experiment carried 
out by Wyszy´nska et al showed that chicken immunization with avirulent 
Salmonella carrying Campylobacter cjaA gene greatly reduced the ability of 
heterologous wild type C. jejuni strain to colonize the bird cecum [196]. This study 
also detailed that chickens orally immunized with Salmonella expressing 
Campylobacter the cjaA gene developed serum IgG and mucosal IgA antibody 
responses against Campylobacter membrane proteins and Salmonella OMPs. These 
studies have indicated that immunization of chickens with a recombinant Salmonella 
vaccine strain carrying the C. jejuni cjaA gene may be an attractive and efficient 
approach for bird vaccination [196]. 
 
STM1 was developed at RMIT University, and is licensed to Bioproperties Pty Ltd 
as a Salmonella vaccine for use in chickens. Vaccination with STM1-vectored 
antigens will have the added advantage that protection will be provided against 
salmonellosis in the chicken in addition to targeting the pathogen from which the 
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vectored antigen is derived. Previous studies have shown that STM1 have used as a 
vector for the delivery of model antigens to the immune system in mice [209, 210, 
288].  The characterisation of the chromosomal architecture in STM1, and designed 
strategies to insert foreign DNA at specific sites within the chromosome and 
successful design of constructs have been described in previous studies [210]. 
Experiments delivering antigens specified by this foreign DNA has been performed 
successfully in mice, with immune responses to vectored antigen obtained [210]. In 
the present study, antigens were chosen on the basis of pre-existing knowledge in the 
literature. The article published in 2008 identified the targets in Campylobacter of 
maternal immunity [280]. As the antibodies present in adult chickens are most 
probably involved in the observed reduction in Campylobacter colonisation in older 
birds, the targets of these antibodies may be potential vaccines. 
STM-1 was used to “deliver” Campylobacter antigens to an animal’s immune system 
where they can induce an immune response and therefore the reduction of the 
colonisation of the campylobacter. Recombinant vaccines are able to reduce the 
levels of Campylobacter colonisation in the chicken gut. The reduction in 
colonisation might be the result of the induction of immune response in chickens. 
The previous immunogenicity trial performed in the lab showed that each of the 
constructs that was created were able to induce an immune response in mice, 
whereas no response was observed in the control groups. This validates the ability of 
recombinant STM-1 to deliver foreign (i.e: Campylobacter) antigen and induce an 
immune response. Further immunological studies (in chickens) in the future are 
needed to further evaluate the results obtained.  Recombinant vaccines can be 
theoretically delivering a foreign antigen from any pathogen. It can theoretically 
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deliver multiple antigens also. This might be by constructing several recombinant 
strains, and administering these together, or constructing a single strain that 
expresses several antigens. Multi antigen vaccination with several of these constructs 
might be useful to the reduction in colonisation, further studies needed to prove this.  
 
Although this experiment demonstrated that STM 1 is a useful vaccine vector to 
deliver hetrologous antigens, the next objective of the work undertaken is to identify 
further potential Campylobacter antigens that may induce a reduction in the 
colonization of Campylobacter in chickens. Bioinfomatics analyses have been used 
for the further selection of the antigens. This analysis is detailed in chapter 4. 
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Chapter 4 
 
Elucidation of Campylobacter proteins that may 
interact with chicken cells and the humoral immune 
system using Bioinformatics Tools 
 
 
4.1 Introduction 
 
The results obtained in the previous chapter indicate that while Salmonella is a 
potentially useful delivery system, it may not induce the protective responses 
required to reduce Campylobacter colonization to acceptable levels using the 
antigens selected. This may be an inherent property of the Salmonella strain that was 
used, or may indicate that the optimal antigens have not been identified. Therefore a 
study was undertaken to unearth potential new vaccine candidates. This study 
analyses the possible vaccine candidates of C. jejuni that potentially interact with the 
host humoral immune system. These proteins should therefore be secreted or located 
in the outer membrane. Potential vaccine candidates include proteins that assist C. 
jejuni to adhere and invade the host epithelial cells and contribute to inflammatory 
responses. In chicken colonization, they will include proteins that enable the 
bacterium to avoid host immune responses. Predicting vaccine candidates against C. 
jejuni was carried out by genome analyses of Campylobacter, using different 
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methods such as prediction of classically secreted and non-classically secreted 
proteins, sub-cellular localization of proteins, and predicting membrane types and 
their functions. The selected proteins were compared with other genomes using 
BlastP to determine sequence similarity and to attempt to predict function. The 
detailed Bioinformatics analyses were performed using SignalP 3.0, SecretomeP 2.0, 
Gneg-PLoc [289, 290], Gneg-mPLoc [289-291], TMHMM [292] and MemType-2L 
[293] and Basic Local Alignment Search Tool (BlastP).  
 
4.2 Bioinformatics analyses 
 
To accomplish virulence mechanisms, bacteria secrete proteins into their host 
environment, some of which may act to subvert or dampen the expanding immune 
response [294].  Secreted and cell-surface proteins play a fundamental role in 
intercellular communications [295]. Exported/ secreted bacterial proteins are also 
important in pathogenesis and modulation of the host immune system [216]. 
Extracellular secretion of proteins is classified as either classically secreted or non-
classically secreted based on the secretion mechanisms [296]. For a long time, it was 
believed that an N-terminal signal peptide was strictly required for exporting 
proteins to the extracellular space. Proteins are synthesized at the ribosome and 
transported to their site of function directed by the targeting signals. Although many 
different classes of targeting signals are present, one of the commonly occurring 
signals is formed by short, transient peptides known as signal peptides. Signal 
peptides are present in both prokaryotic and eukaryotic cells and are usually found at 
the amino terminus of proteins destined for secretion [297]. Signal peptides are 
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critical for classical protein secretion and are made up of 15-40 amino acids [298]. 
They are characterised by three distinct domains, a positively charged amino 
terminal “n” region, a central hydrophobic “h” region, and a cleavage site of a more 
polar carboxy terminal “c” region which is cleaved by signal peptidases during 
translocation across the membrane [299, 300].  
 
Interestingly, signal peptides are not present in all secreted proteins [301, 302], 
suggesting that other mechanisms for protein targeting exist. There are now 
numerous studies that show proteins can be exported without a classical N-terminal 
signal peptide [218]. Secretion of proteins without an N-terminal signal peptide is 
now identified as leaderless secretion or the non-conventional/non-classical secretory 
pathway. Studies have shown that interleukin 1 and thioredoxin were found to be 
secreted despite being devoid of any identifiable signal peptide [303, 304]. Little is 
known about the dynamic aspects of the non-classical secretion apparatus [218]. The 
non-classically secreted proteins are leaderless proteins without signal peptides and 
this characteristic makes the prediction of their secretion more difficult and 
complicated than the classical secreted proteins [305]. C. jejuni NCTC 11168 does 
not encode a typical type111 secretion system, in which secreted proteins from the 
bacterial cytoplasm are injected directly into the cytoplasm of a eukaryotic host cell 
by a needle like apparatus [7, 306]. However, class 111 flagellar proteins in C. jejuni 
include coordinately expressed nonflagellar genes with unknown function that are 
important for virulence and host invasion [216]. 
 
100 
 
The objective of the analyses undertaken is to identify secreted proteins, particularly 
non-classically secreted proteins and their further analyses using various 
Bioinformatics tools. Many of these are hypothetical proteins and the function is still 
unknown. However, it is quite conceivable that a protein of unknown function that is 
predicted to be secreted may be a virulence protein.  The initial aim of the study was 
to search for proteins that are secreted from C. jejuni using the Bioinformatics tool, 
SignalP 3.0. The SignalP 3.0 server was used to select classically secreted proteins 
from the list of 1623 proteins predicted from the proteome of C. jejuni NCTC 11168 
[30]. Once this was completed other prediction methods and search tools were 
employed to predict that the proteins that may be non-classically secreted. The 
SecretomeP 2.0 server was used as a neural network method to predict the proteins 
with an NN score above 0.5 as non-classically secreted with/without a signal peptide 
[307].  For each input query sequence, four neural network outputs were generated 
by the server, and the “Sec P score” was indicative for non-classical secretion. These 
methods give a summary of proteins that are predicted to be classically secreted or 
non-classically secreted. 
 
Sub-cellular location of proteins was performed by a different Bioinformatics tool 
named Gneg-PLoc. It indicates that the proteins are located either outside or inside 
the cell. Gneg-mPLoc, an advanced version of Gneg-PLoc was used to predict 
multiple locations of the protein.  
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The TMHMM 2.0 web-server employs an algorithm called N-best to predict the 
number, location and orientation of transmembrane helices and intervening loop 
regions in a queried protein sequence [308]. It also predicts the expected number of 
amino acids contained within transmembrane helices. The graphical output shows 
the probabilities that a protein sits inside the membrane (cytoplasm), outside the 
membrane, or within the membrane.   
 
BlastP compares a protein sequence query against a protein sequence database and 
finds regions of local similarity between sequences. BlastP is used to calculate the 
statistical significance of functional and evolutionary relationships between 
sequences and helps to identify members of gene families. The algorithm was used 
to determine if there were homologous proteins in the database, as an aid to 
predicting function. 
 
4.3 Materials and Methods 
4.3.1 Identification of potential virulence genes 
 
The complete annotated genome sequence of C. jejuni NCTC11168 reveals C. jejuni 
has 1,641,481 base pairs and 1654 predicted coding sequences, with 77.8% of 
predicted coding sequences having a known function, 13.5% an unknown function 
and 8.7% with no database match or no functional information [30] i.e. might be 
orphan proteins. The genome was re-annotated and re-analysed in 2007 and the 
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predicted CDS was reduced to 1,643 [31]. The present study included the 1623 CDS 
which are available in the Sanger Institute website. Predicted protein sequences were 
retrieved from the website in FASTA format.  
 
SignalP 3.0, SecretomeP 2.0 server, Gneg-PLoc, TMHMM, MemType-2L and The 
Basic Local Alignment Search Tool (BlastP), were used to identify potential 
virulence proteins. The methods used for analysis using the Bioinformatics tools are 
given briefly in the following section.  
 
4.3.1.1 Prediction of signal peptides using the SignalP 3.0 server: classically 
secreted proteins 
 
The SignalP 3.0 Server was used to predict the signal peptide [309]. Three output 
scores were generated by the SignalP server for each input query protein sequence, 
an S score; Y score and a C score. The S score was included in the graphical output 
for predicting the signal peptide, with high scores indicating that the amino acid in 
the query sequence is a part of an N terminal signal peptide and low scores 
indicating that the amino acid is part of a mature protein. The Signal Peptidase 
cleavage site was given by the C score, with a high score indicating the position of 
the cleavage site. The Y max score was the derivation of the C score and the S Score, 
and results in a better cleavage site prediction than C score alone. 
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4.3.1.2 Search for non-classically secreted “hypothetical” proteins using 
SecretomeP 2.0 server 
 
The SecretomeP 2.0 server [310] was employed as a neural network to predict non-
signal peptide mediated protein secretion. Of four output scores generated by the 
server, proteins that have a total score above 0.5 (Sec P score) were predicted to be 
non-classically secreted. 
 
4.3.2 Prediction of Subcellular location of proteins (Single location using Gneg-
PLoc   and Multiple Locations using Gneg-mPLoc) 
 
Bioinformatics tools Gneg-PLoc [311] and Gneg-mPLoc [311] were also used in the 
study. These two networks were employed for the prediction of subcellular location 
of proteins in Gram-negative bacteria. It covers eight subcellular protein locations 
such as cytoplasm, extracellular, fimbrium, flagellar, innermembrane, nucleoid, outer 
membrane and periplasm as shown in Figure 4.1.  
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   Figure 4.1: Schematic representation of the subcellular locations of Gram-negative 
bacteria proteins. Reproduced from http://www.csbio.sjtu.edu.cn/bioinf/Gneg/ 
 
Subcellular localisations of Gram-negative bacteria proteins were also predicted by a 
newer version termed Gneg-mPLoc (Figure 4.2). It was able to provide information 
regarding multiple potential protein locations as indicated by the character “m” in 
front of “PLoc”of its name. 
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Figure 4.2: Prediction of subcellular location of Gram-negative bacterial proteins 
using Gneg-mPLoc. Reproduced from http://www.csbio.sjtu.edu.cn/bioinf/Gneg-
multi/ 
 
4.3.3 Prediction of Membrane proteins  
 
The two methods used to predict membrane proteins were Trans-membrane helix 
prediction using TMHMM and Membrane type prediction using MemType-2L. 
Membrane proteins can be divided into several groups such as integral membrane 
proteins, peripheral membrane proteins and lipid-anchored proteins. MemType-2L is 
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a 2 layer predictor for predicting membrane protein types [312].  The first layer 
predicts whether the query sequence is a membrane protein or not. The second layer 
provides the membrane types when the output of the first layer is a “membrane 
protein”. The output gives 8 types of membrane proteins as shown in Figure 4.3. 
 
Figure 4.3 The output given by MemType-2L predicts 8 types of membrane 
proteins. (1) Type I transmembrane, (2) type II, (3) type III, (4) type IV, (5) 
multipass transmembrane, (6) lipid-chain-anchored membrane, (7) GPI-anchored 
membrane, and (8) peripheral membrane. Types I, II, III, and IV are all single-pass 
transmembrane proteins. (http://www.csbio.sjtu.edu.cn/bioinf/MemType/) 
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4.3.4 Prediction of transmembrane regions using the TMHMM Server  
 
An algorithm named N-best was employed by the TMHMM web server to predict 
the number, position and direction of transmembrane helices and intervening loop 
regions in query sequences. The expected number of amino acids contained within 
transmembrane helices was also predicted by the server. Different output formats are 
generated by the server such as long and short. The long output format gives 
statistical analysis, list of the location of the predicted transmembrane helices and the 
predicted location of the intervening loop regions.  “Plot of probabilities” is also 
given by the long output format which shows the total probability that a residue sits 
in a helix, inside, or outside.  In the short format, one line is produced for each 
protein with no graphics. Each line starts with the sequence identifier and then the 
fields such as   "len=", "ExpAA=", “First60=", "PredHel="and "Topology=".  
 
ExpAA refers to the number of amino acids in transmembrane helices. First60 is the 
predicted number of amino acids in the first 60 amino acids. Additional information 
available from the graphical output regarding transmembrane helices was “PredHel” 
and “Topology”. “PredHel” indicates the number of transmembrane helices whereas 
the “Topology” describes the position, i.e. whether the loop is on the inside (i) or the 
outside (o) of the transmembrane helices. For instance, the protein in Table 4.1 was 
predicted to have one transmembrane helix and within its 78 amino acids. The helix 
started from the outside and enters the membrane at amino acid 25 and ends at amino 
acid 42 on the inside of the membrane. 19.58 represent the number of aminoacids in 
the transmembrane helix. 19.51 is the predicted number of amino acids involved in 
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helices in the first 60 amino acids. As this number is virtually identical to “ExpAA”, it 
indicates the TM helix is wholly contained with the first 60 amino acids. 
 
Table 4.1 Output from the TMHMM server for protein Cj0988c 
Protein Length ExpAA First60 PredHel Topology 
Cj0988c 78 19.58 19.51 1 o25-42i 
 
 
4.3.5 Search for homology of the C. jejuni genes with other genomes 
 
BLAST, one of the most widely used Bioinformatics programs, was used to find 
homologues of proteins. When queried using BlastP, domains, homology to other 
organisms, and predicted functions were recorded where found. Proteins were 
grouped and classified under different groups according to the results shown by 
BLAST query. Primarily, this was used to determine if proteins were C. jejuni 
specific, Campylobacter spp. specific, or had homologues in other species.  
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4.4 Results 
 
4.4.1 Classically and non-classically secreted proteins 
 
A total of 1623 proteins were queried using the SignalP 3.0 and SecretomeP 2.0 
servers and were annotated to be secreted/non-secreted proteins. The presence and 
location of signal peptide cleavage sites of each protein was queried using the 
SignalP 3.0 server. Two hundred and ninty-five proteins were predicted to have 
signal peptides. The selected proteins are listed in Appendix IV. 
 
The SecretomeP 2.0 server was employed to predict non-classically secreted 
proteins. Out of four output scores generated by the server, proteins which have a 
total NN score above 0.5 (Sec P score) were predicted to be non-classically secreted.  
112 proteins were predicted to be non-classically secreted. Therefore, out of the 1623 
proteins analysed 1216 proteins were predicted to be non-secreted proteins and 407 
were predicted to be secreted proteins. Distributions of the proteins are shown in 
Figure 4.4. 
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Figure 4.4 295 proteins are predicted to be classically secreted whereas 112 proteins 
are predicted to be non-classically secreted from the total of 1623 Campylobacter 
jejuni NCTC11168 proteins. 
 
 
4.4.2 Predicted locations for the 407 predicted secreted proteins according to 
Gneg-PLoc.  
 
Four hundred and seven proteins which were categorized under the group “secreted 
proteins (classically secreted/non-classically secreted)” were further investigated.  
The Gneg-PLoc Server was used to predict the location of the proteins. The proteins 
were then catalogued into various groups depending on the site of location such as 
extracellular, flagellar, fimbrium, outer membrane and periplasm. Interestingly, out 
of the 407 proteins analysed only 71 proteins were predicted to be located outside the 
cell, and 18 of the 407 were predicted to be located in the periplasm. Of the 71 
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predicted proteins, thirty seven proteins were predicted to be completely 
extracellular, 22 located on the outer membrane.  Cj1464 was the only protein found 
to be located on the fimbrium. Eleven proteins were predicted to be located on the 
flagella. Surprisingly, a majority of the potentially secreted proteins are predicted to 
be intracellular- the significance of this is unclear, but it will presumably be prudent 
to concentrate on proteins that are predicted by both SignalP or SecreteomeP and 
Gneg-PLoc to be secreted or membrane localised. The proteins which are predicted 
to be located in various locations are shown in Figure 4.5.  
 
Figure: 4.5 Location of the 407 predicted secreted proteins according to Gneg-PLoc. 
 
The 407 proteins were queried using the Gneg-PLoc server and the proteins that are 
predicted to be in more than location were recorded. 83 proteins were predicted to be 
located in more than one site. This included one location (34), two locations (74), 
three locations (8), five locations (1), and too short to be predicted, < 50 amino acids 
(10). The proteins which are found in multiple locations are particularly interesting 
Predicted to be 
intracellular 
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because they may have some unique biological functions [313]. It may however, also 
indicate an uncertainty in localization. These are shown in Figure 4.6.  
 
 
Figure 4.6 Eighty three proteins are predicted to be located in more than one 
location  
 
A more advanced version of Gneg-PLoc termed “Gneg-mPLoc” was also used for 
the prediction of the subcellular localisation of Gram-negative bacterial proteins. 
Four hundred and seven predicted secreted proteins were included in the Gneg-
mPLoc analysis. Multiple location proteins were predicted which are indicated by 
the character “m” in front of “PLoc” of its name. The number and the protein 
locations have been listed in Table 4. 2. 
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Table 4.2 The number of proteins predicted to be located totally or partially 
extracellular according to Gneg-mPLoc. 
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MemType -2 L, a 2 layer predictor was employed for predicting membrane protein 
types. The first layer will predict if the query sequence is potentially a membrane 
protein. The second layer provides information about the membrane protein types 
when the output of the first layer is “membrane protein”. The 407 proteins predicted 
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to be located extracellularly were analysed by Gneg-mPLoc. Out of the 120 proteins 
localised, 29 were predicted to be in the membrane. The distribution of the 
membrane types is shown in Table 4.3.  
 
Table 4.3 The proteins predicted as membrane proteins by Memtype  
Membrane Types Number of Proteins 
Lipid anchor 6 
Multi-pass 17 
Peripheral 2 
Single-pass type I 2 
Single-pass type II 2 
Total 29 
 
 
4.4.3 Prediction of transmembrane regions using the TMHMM Server  
 
An algorithm termed N-best was employed by the TMHMM web server to predict 
the number, position and direction of transmembrane helices and intervening loop 
regions in query sequences. Out of 407 predicted secreted proteins, 162 secreted 
proteins were predicted to have a transmembrane helix (TMH) according to the 
TMHMM prediction and results are shown in Table 4.4.  
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Table 4.4 There are 162 putative proteins predicted to contain at least one 
transmembrane helix (TMH) according to the TMHMM output.  
 
Number of TMH Number of proteins  
1 75 
2 13 
3 8 
4 7 
5 3 
6 13 
7 6 
8 4 
9 5 
10 5 
11 7 
12 10 
13 4 
16 2 
Total 162 
 
4.5 Summary of Bioinformatics analyses 
Figure 4.7 demonstrates the results of each stage of the Bioinformatics analyses 
carried out in this study. This proposes 41 proteins are considered to be significant 
candidates for vaccine study. 
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Figure 4.7 The results obtained by the Bioinformatics analyses to predict the proteins that 
can be considered for further vaccine study.  
 
 
 
 
 
 
 
Classically secreted (295) Non-Classically secreted (112) 
Predicted Secreted (407) 
Gneg –PLog Gneg –mPLog 
Total/Partial 
Extracellular (120) 
Membrane 
proteins (29) 
Transmembrane 
helix (162) 
No Transmembrane 
helix (245) 
No Transmembrane 
helix & secreted 
extracellular (41) 
Transmembrane prediction 
Total Proteins 1623 (C. jejuni) 
Predicted Non-Secreted (1216) 
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4.6 Proteins at the top of the list to be studied after Genome mining of C. jejuni 
 
Out of 407 proteins analysed, 245 proteins were predicted to contain no 
transmembrane helix. Forty nine of the 245 proteins were predicted to be located 
extracellularly; out of these forty nine proteins, eight proteins were found to be less 
than 50 amino acids and were omitted from the list. This suggests that 41 proteins 
should be at the top of the list to be studied to further explore the virulence 
mechanisms of C. jejuni. The protein names and GI numbers have been listed in 
Table 4.5.  
 
Table 4.5 41 proteins of C. jejuni at the top of the list to be studied. 
 
Protein name GI 
number 
Predicted 
secretion 
Location of 
predicted 
proteins 
Homology 
flagellar hook protein 
FlgE 218563315 
Non-
classically 
secreted 
Extracellular C. jejuni, C. coli 
hypothetical protein 
Cj1656c 218563245 
Non-
classically 
secreted 
Extracellular 
C. jejuni, C. coli, C. 
upsaliensis & 
Helicobacter 
hypothetical protein 
Cj1631c 218563220 
Non-
classically 
secreted 
Flagellar C. jejuni, C. coli, C. 
upsaliensis 
flagellar hook-
associated protein FlgK 218563069 
Non-
classically 
secreted 
Extracellular Various Campylobacter spp. 
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hypothetical protein 
Cj1464 218563067 
Non-
classically 
secreted 
Fimbrium Various Campylobacter spp. 
flagellar basal body P-
ring protein 218563065 
Classically 
secreted Extracellular 
Various 
Campylobacter spp. 
putative ATP/GTP-
binding protein Cj1450 218563053 
Non-
classically 
secreted 
Extracellular Various Campylobacter spp. 
putative secreted serine 
protease 218562974 
Non-
classically 
secreted 
Extracellular Campylobacter & other bacteria 
flagellin 218562948 
Non-
classically 
secreted 
Flagellar Various Campylobacter spp 
flagellin 218562947 
Non-
classically 
secreted 
Flagellar Various Campylobacter spp 
hypothetical protein 
Cj1242 218562854 
Non-
classically 
secreted 
Extracellular Various Campylobacter spp 
serine protease 218562840 Classically 
secreted Extracellular 
Campylobacter & 
Helicobacter 
single-stranded DNA-
binding protein 218562685 
Non-
classically 
secreted 
Extracellular 
Campylobacter, 
Helicobacter & other 
bacteria 
branched-chain amino-
acid ABC transporter 
periplasmic binding 
protein 
218562634 Classically 
secreted Flagellar 
Campylobacter & other 
bacteria  
hypothetical protein 
Cj0972 218562588 
Non-
classically 
secreted 
Extracellular C. jejuni 
hypothetical protein 
Cj0971 218562587 
Non-
classically 
secreted 
Extracellular C. jejuni 
hypothetical protein 
Cj0970 218562586 Non-classically 
Extracellular C. jejuni 
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secreted 
putative periplasmic 
protein 218562585 
Classically 
secreted Extracellular C. jejuni, C. coli 
putative lipoprotein 218562569 Classically 
secreted Extracellular 
Campylobacter, 
Helicobacter & other 
bacteria 
flagellar hook-
associated protein FlgL 218562507 
Non-
classically 
secreted 
Extracellular 
Campylobacter, 
Helicobacter & other 
bacteria 
hypothetical protein 
Cj0859c 218562487 
Non-
classically 
secreted 
Extracellular C. jejuni 
hypothetical protein 
Cj0814 218562442 
Non-
classically 
secreted 
Extracellular C. jejuni, C. coli, C. 
upsaliensis 
hypothetical protein 
Cj0794 218562422 
Non-
classically 
secreted 
Flagellar Campylobacter & other bacteria 
hypothetical protein 
Cj0739 218562378 
Non-
classically 
secreted 
Extracellular C. jejuni 
flagellin 218562359 
Non-
classically 
secreted 
Flagellar Campylobacter & other bacteria 
flagellar basal body rod 
protein FlgG 218562337 
Non-
classically 
secreted 
Extracellular 
Campylobacter, 
Helicobacter & other 
bacteria 
flagellar basal body L-
ring protein 218562326 
Classically 
secreted Extracellular 
Campylobacter, 
Helicobacter & other 
bacteria 
flagellar capping 
protein 218562200 
Non-
classically 
secreted 
Flagellar 
Campylobacter, 
Helicobacter & other 
bacteria 
flagellar hook-basal 
body protein FliE 218562178 
Non-
classically 
secreted 
Flagellar 
Campylobacter, 
Helicobacter & other 
bacteria 
hypothetical protein 218562086 Non- Extra C. jejuni, C. coli 
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Cj0428 classically 
secreted 
cellular 
hypothetical protein 
Cj0418c 218562076 
Non-
classically 
secreted 
Extracellular 
Campylobacter, 
Helicobacter & other 
bacteria 
hypothetical protein 
Cj0391c 218562049 
Non-
classically 
secreted 
Extra 
cellular 
Campylobacter, 
Helicobacter & other 
bacteria 
periplasmic fusion 
protein CmeA 218562025 
Classically 
secreted Flagellar 
Campylobacter, 
Helicobacter & other 
bacteria 
putative periplasmic 
protein 218561795 
Classically 
secreted Extracellular 
Campylobacter, 
Helicobacter & other 
bacteria 
peptidoglycan 
associated lipoprotein 218561794 
Classically 
secreted Extracellular 
Campylobacter, 
Helicobacter & other 
bacteria 
putative periplasmic 
protein 218561774 
Classically 
secreted Extracellular 
Campylobacter & other 
bacteria 
putative periplasmic 
protein 218561773 
Classically 
secreted Flagellar 
Campylobacter & other 
bacteria 
cytolethal distending 
toxin B 218561761 
Classically 
secreted Extracellular 
Campylobacter 
Helicobacter & other 
bacteria 
flagellar hook protein 218561735 
Non-
classically 
secreted 
Extracellular Campylobacter & other bacteria 
flagellar basal body rod 
modification protein 218561734 
Non-
classically 
secreted 
Extracellular Campylobacter & other bacteria 
putative flagellar hook-
length control protein 218561733 
Non-
classically 
secreted 
Extracellular 
Campylobacter, 
Helicobacter & other 
bacteria 
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4.7 Discussion 
 
Although a number of virulence factors have been identified, the mechanisms 
involved in the colonisation of chickens are still poorly understood. It would be a 
far-reaching task to analyze all the proteins by in vivo and in vitro studies and so 
Bioinformatics analysis is a useful tool for investigating the complete C. jejuni 
genome, predicted to encode 1623 proteins [30]. In this study various Bioinformatics 
tools were used to identify genes encoding proteins that are fully or partially 
extracellular in the bacterium, and therefore may induce a humoral immune response 
in the host and/or be responsible for the remarkable colonizing capability of 
Campylobacter in chickens. These proteins may be targets of an anti-colonisation 
vaccine. Some of these may be orphan proteins. The orphan genes that code for 
proteins that are secreted or transmembrane are of particular interest as these are the 
macromolecules which interact within the host and may be able to induce humoral 
immune responses. If they are “orphan” proteins, that are either only identified in C. 
jejuni or only in Campylobacter species, the proteins are presumably undertaking 
species-specific tasks. 
 A total of 1623 proteins were analysed and 407 of these were predicted to be 
secreted into the extracellular environment. Out of the 407 secretory proteins 
predicted, 295 were predicted to be classically secreted and 112 were predicted to be 
non-classically secreted proteins. The first stage of the Bioinformatics analysis 
reduced the number of proteins for further investigation by tabulating the proteins 
into “secreted proteins” (407) which are classically secreted or non-classically 
secreted.  
122 
 
In the second stage of analysis, the location of proteins was investigated. Although 
the majority of these “secreted” proteins were predicted to be located intracellularly, 
71 of the 407 proteins were predicted to be located outside the cell. It is interesting 
that there is such a wide variation in the predicted locations using different 
Bioinformatics tools, and is one of the main reasons that a “consensus” approach to 
analyzing such data is taken. Proteins that also contain transmembrane helices will 
usually have part of their structure exposed to the extracellular environment; 
therefore these proteins were also categorized. This analysis reduced the number of 
proteins for further investigation. This method yielded 162 proteins with 
transmembrane helices (TMH) according to TMHMM prediction. There are 245 
proteins predicted to contain no TMH. Forty-one of the 245 proteins were predicted 
to be located extracellularly, this suggests that these 41 proteins should be at top of 
the list should be studied as vaccine candidates. Non-classically secreted proteins 
which are predicted to be secreted extracellularly were selected for further study. If 
the selected extracellular proteins are able to produce a strong immune response, 
they would be anti-colonization vaccine candidates. All these selected proteins were 
non-classically secreted proteins with a Sec score above 0.5 and among them 
Cj0391c, Cj0428, Cj1450 and Cj1656c were included from the 41 proteins presented 
in Table 4.5. These proteins were predicted to be secreted extracellularly. The 
protein Cj1656c showed similarity with C. jejuni, C. coli, C. upsaliensis and 
Helicobacter with an E value less than or equal to 0.01. Cj0428 is a hypothetical 
non-classically secreted protein and shows similarity with only Campylobacters such 
as C. jejuni and C. coli. Cj0391c shows similarity with Campylobacter, Helicobacter 
& other bacteria. Cj1450 is a putative ATP/GTP-binding protein and shows 
similarity with various Campylobacter species and other bacteria.  Freepatentsonline 
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2008  [314] “secreted Campylobacter flagella coregulated proteins as imunogens” 
detailed that Cj0243c and Cj1450 are co-regulated with flagellar genes and to be 
secreted from the bacteria. These two proteins were predicted to be non-classically 
secreted. Cj 0243 shows similarity with various bacterial species. The predicted 
locations of this protein was analysed by Gneg-PLoc and Gnegm-PLoc. According 
to Gneg-PLoc analysis, it was predicted to be located in the cytoplasm but was 
predicted to be located extracellularly by version 2 i.e. Gnegm-PLoc. Considering 
the information obtained from the patent, predicted extracellular protein and not a 
membrane protein, Cj0243c also was included in the following study. Therefore the 
genes Cj0391c, Cj0428, Cj1656c, Cj0243c and Cj1450 were selected for knock-out 
analysis. No experimental studies have been carried out using these hypothetical 
proteins to date, make these proteins important in the study detailed here. This is 
detailed in Chapter 5.The summary of the selected proteins for further study is 
shown in Table 4.6. 
Table 4.6 Proteins selected for knock-out study 
   Predicted location of proteins   Protein 
Name  
Accession 
Number  
Non-classically 
secreted protein  
Version 1 
 Gneg-PLoc 
Version 2 
 Gneg-mPLoc 
MemType  
Cj0391c  gi_218562049  yes Extra 
cellular  
Extracellular  Not  a 
membrane 
protein  
Cj0428  gi_218562086  yes Extra 
cellular  
Extracellular  Not a membrane 
protein  
Cj0243c  gi_218561906  yes Cytoplasm  Extracellular  Not  a 
membrane 
protein  
Cj1656c  >gi|218563245  yes Extracellular  Extracellular, 
Fimbrium.  
Lipid anchor 
membrane  
Cj1450  >gi|218563053  yes Extracellular  Extracellular  Not a membrane 
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protein  
The availability of different Bioinformatics tools for annotating the Campylobacter 
genome has opened the possibility to identify Campylobacter proteins that interact 
with the chicken immune system. If components that actively suppress the chicken 
immune system are identified, it may be possible to vaccinate against these. As a 
result the chicken immune system will then eliminate the bacterium, controlling 
Campylobacter levels in poultry. The analysis started with 1623 proteins and has 
reduced the number of potential candidates to 41. The function of some of these 
proteins is unknown, and they may in fact be Campylobacter-specific proteins that 
are involved with C. jejuni virulence mechanisms. From this study, it was found that 
these proteins show potential and should be further investigated.  
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5.1 Introduction 
 
In order to predict proteins that may be involved in virulence mechanisms, 
Bioinformatic tools were used as described in the previous chapter to assess a 
number of proteins. The C. jejuni genome encodes a predicted 1623 proteins and it 
would be an extensive task to perform experimental studies with all these proteins, 
and so after Bioinformatics analyses five proteins were chosen for investigation. 
These genes do not have an assigned function, and it is possible they may be 
virulence factors specific for Campylobacter. Genes which code for proteins that are 
secreted extracellulary, with no transmembrane helix and are of particular interest as 
these are the molecules which presumably interact within the host, and may also be 
able to induce humoral immune responses. The non-classically secreted hypothetical 
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proteins Cj 1656c, Cj 0428, Cj 0391c, Cj 0243c and Cj 1450 were selected for 
experimental analysis. 
 
The objectives of this study were to create knock-out mutant strains and evaluate the 
in vitro interactions with cultured mammalian cells. Knock-out mutagenesis [58] was 
used to analyze the characteristics of a protein by inactivating the gene of interest. 
Adhesion was analyzed by studies in a human intestinal cell line [109]. This is a 
well-established procedure in our laboratory [174]. 
 
The colonization (in chickens) and disease (in humans) mechanism is still poorly 
understood, but is thought to involve different factors such as motility, cellular 
adherence, invasion, and toxin production [32]. Exported /secreted proteins are 
potential virulence factors and play an important role in pathogenesis [315]. CdtC, 
pseA are class III nonflagellar proteins with unknown function and were found to be 
important in virulence and host cell invasion [315]. Therefore, non-classically 
secreted proteins with unknown function have the possibility to be involved in 
virulence mechanisms.  
The aims of work described in this chapter were to: 
1. Clone, sequence and characterise the genes of interest  
2. Create knock-out strains of Campylobacter 
3. Test the ability of these strains to adhere to a Human intestinal cell line 
(INT407 cell line) 
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5.2 Experimental procedures 
 
Details of bacteria, plasmids and primers used in the study are provided here below. 
C. jejuni 11168 was grown at 420 C under microaerophilic conditions, inoculated on 
horse blood agar plate supplemented with skirrows. Escherichia coli DH5 was used 
as a host for all recombinant plasmids.  
 
5.2.1 Materials  
 
5.2.1.1   Primers  
 
The primers used throughout the study are given in the Table 5.1. Primers were 
designed using Clone Manager software used in the laboratory. Primers were named 
according to the gene’s name with a suffix letter ‘f’ or “r”. The letter “f” indicates 
forward primer and the letter “r” indicates reverse primer. 
 
Table 5.1 The primers used in this study are listed (5’-3’) 
. 
Cj1656c f  GCGGTACCAATATCCAAACCACTAGAGC 
 
Cj1656c r  GCGAGCTCGGTTTCAGATGTTTCTATGGG 
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Cj1450 f  GCGGTACCCTATGTATGACAATCAAAGCG 
 
Cj1450 r   GCGAGCTCTAAAGATTTAAACTATCATCTG 
 
Cj0391c f  GCGGTACCCGCTAGCATGGCACGAACAC 
 
Cj0391c r  GAGCTCTTAAGCTTGAAGATCTAGAGT 
 
Cj0428 f   GCGGTACCATGCAGGTAAATTATAGAACG 
 
Cj0428 r   GCGAGCTCAACGCTAGCACTTTGAGCTC 
 
Cj0243c f  GGTACCGCATAGCAAAAGAACTCGCAAAAC 
 
Cj0243c r  GAGCTCGTGTTTTCTATGGCTTTATC 
 
Cj1656c inv f  GACGGGATCCGAATGAACTCATCGAAGGTATGG 
 
Cj1656c inv r  GACGGGATCCTGCCTCGTTTGTGTCCATAG 
 
Cj1450 inv f  GACGGGATCCGGCAAATGTTCTACCAACACC 
 
Cj1450 inv r  GACGGGATCCCTTTTGGCTTTAACTCTCCGAC 
 
Cj0391c inv f  CCGGGGATCCTTTGGAGTGGAAAATACAGC 
 
Cj0391c inv r   CGGCGGATCCCTGAACTAGGTAAATTTGTG 
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Cj0428 inv f  GACATGGATCCGCGGAGATGCTTTAAATTCTAGCAG 
 
Cj0428 inv r   GCGATGGATCCTCATCCGCCTTATTTAACATATCC 
 
Cj0243c inv f  GGATCCGAAATTGATTTGGCATTAAGC 
  
Cj0243c inv r  GCGGGATCCGTTTAAATTTTCGTCTTG 
 
5.2.1.2   Bacteria and plasmids  
 
The bacterial strain of C. jejuni, the strains created with the kanamycin marker, the 
host bacteria used for transformation and the plasmids used in the study are detailed 
here below. 
 
5.2.1.2 .1 C. jejuni strains  
 
NCTC11168 C. jejuni  
 
NCTC 11168 C. jejuni 1656c kan R 
 
NCTC 11168 C. jejuni 1450 kan R 
 
NCTC 11168 C. jejuni 0391 kan R 
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NCTC 11168 C. jejuni 0428 kan R 
 
NCTC 11168 C. jejuni Cj0243 kan R 
 
5.2.1.2 .2  E. coli strain  
 
E. coli DH5 
 
5.2.1.2.3 Plasmids  
Plasmids Description 
pB SKII                           cloning vector pBluescript SKII 
plasmid PMW2              vector with ampicillin and kanamycin resistant cassettes 
pBK 1450         A 564 bp PCR product of the Cj1450 gene from NCTC11168 
C. jejuni  in pBluescript SK 
pBK0391      A 636 bp PCR product of the Cj0391c gene from NCTC11168 
C. jejuni  in pBluescript SK 
pBK0428 A 384 bp PCR product of the Cj0428 gene from NCTC11168 
C. jejuni  in pBluescript SK 
pBK0243 A 339 bp PCR product of the Cj0243c gene from NCTC11168 
C. jejuni  in pBluescript SK 
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5.2.2 Growth, isolation and storage of C. jejuni strains 
C. jejuni 11168 was aseptically streaked onto separate HBA/skirrow plates, and 
incubated at 42º C for 48-72 hours under microaerophilic conditions (10% CO2, 5% 
O2, and 85% N2). Selected colonies were sub-cultured onto fresh plates and 
incubated under the same conditions to form lawn cultures.  Sterilised tryptone/skim 
milk storage media was added to one lawn subculture of each strain and the colonies 
were mixed with the storage media using a sterile L-shaped spreader. Finally, the 
entire culture suspension was collected into a sterile 2 ml cryogenic vial and the 
stocks were maintained at -80° C.  
 
5.2.3 Genomic DNA extraction 
 
Genomic DNA extraction from the bacterial cells was performed using the CTAB 
(refer section 2.7.1) extraction method [316]. At the end, the extracted DNA was 
dissolved in 50 µl molecular grade water in a micro-centrifuge tube (1.5 ml). The 
concentration and purity of genomic DNA was estimated using an Eppendorf 
Biophotometer by measuring the optical density (OD) at 260 nm and the ratio of OD 
obtained at 260 nm and 280 nm respectively. The extracted DNA was stored at -
20°C. 
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5.2.4 Primer design, Optimisation of PCR, Confirmation of products using 
agarose gel electrophoresis 
 
The primers for the selected genes were designed using the Clone Manager suite of 
analysis tools (Sci Ed Central).  Clone Manager was used to design the cloning 
strategy, and to determine the optimal annealing temperature for the designed 
primers. The PCR Master kit (Roche Applied Science) was used to amplify C. jejuni 
genes from genomic DNA extracted from C. jejuni NCTC11168. 
After the PCR reaction, products were loaded onto a 1.5% agarose gel, and 
electrophoresed for 1 hour at 100 V to separate the DNA into fragments of 
decreasing molecular size. The gel was stained in an ethidium bromide (0.5 µg/ml) 
bath for 10 min, and destained in a running water bath for at least 20 min. The DNA 
bands were visualised using gel doc (BioRad) and the size of the gene fragment was 
compared with the  PstI DNA (10 l = 1000 ng) molecular ladder (range 247 to 
11501 bp).  The molecular weights of the  PstI marker are shown in Appendix I. 
 
5.2.5 Cloning of PCR products into primary (pCRII-TOPO) vector  
 
The amplified product was cloned into the pCRII-TOPO vector using TOPO TA 
Cloning Kit (Invitrogen). For the cloning reaction, 1 µl fresh amplified product was 
added to 1 µl salt solution (final concentration of 200 mM NaCl and 10 mM MgCl2), 
3 µl molecular grade water, and 1 µl pCRII-TOPO vector (10 ng) in a sterile tube. 
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The tube was mixed gently and incubated for 5-10 min at room temperature, and 
placed on ice. The “ligated” product was chemically transformed into One Shot 
chemically competent E. coli DH5TM-T1R cells (supplied with kit). For the 
chemical transformation reaction, 2 µl of “ligated” product was mixed gently with 
chemically competent E. coli DH5TM-T1R cells. After incubating on ice for 30 min, 
heat shock was given at 42° C in a water bath for 30 s and immediately transferred to 
ice. SOC medium (250 µl) was added to each tube, and  incubated at 37° C by 
shaking at 200 rpm for 1 hour. 
 
The “transformants” were plated out evenly onto pre-warmed LB agar plates 
containing ampicillin (100 µg/ml) and X-gal (40 µl of 40 mg/ml solution), and the 
plates were incubated at 37° C overnight (protected from light). After overnight 
incubation, the plates were analyzed for blue/white colonies. 
 
Several white colonies were selected. Each isolated colony was inoculated into 5 ml 
LB broth containing ampicillin, followed by overnight incubation at 37° C with 
shaking. Plasmid DNA was extracted from overnight culture using the QIAgen 
plasmid extraction Kit following the manufacturer’s instructions. The isolated 
plasmid DNA was re-suspended  in 50 µl TE buffer, ph 8.0/RNAse (20 µg/ml), 
and stored at -20o
 
C. Plasmid DNA integrity was confirmed by restriction enzyme 
digestion and sequencing reaction was performed on the samples.  
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The restriction enzyme EcoRI (Promega) was used to digest the plasmid DNA 
samples. For the digestion reaction, 2 µl plasmid DNA was  mixed with 1 µl 10 x 
Digestion buffer H (Promega), 0.5 µl EcoRI (5 U), and made up to a final volume of 
10 µl by adding 6.5 µl molecular grade water in  micro-centrifuge tube. The reagents 
were mixed gently using in the micro-centrifuge tube and given a short spin and 
incubated at 37° C. The entire digested samples were loaded onto 1.5% agarose gels, 
and separated by agarose gel electrophoresis. 
 
The ABI Prism BigDye Terminator Cycle Sequencing Ready Reaction Kit (section 
2.7.7) was used to perform DNA sequencing. For each DNA sequencing reaction, 
200-400 ng  of plasmid DNA sample was added to 2 µl Big Dye, 3 µl 5  x Dilution 
buffer, 1 µl M13 primer, and made up to a final volume  of 20 µl by adding 
molecular grade water in a PCR tube and the sequencing reaction was performed  in 
the  PCR machine. Ethanol/sodium acetate precipitation was used to perform the 
clean up reaction and the “cleaned” DNA samples were sent to the Micromon DNA 
Sequencing Facility to be sequenced. The DNA sequencing results were analysed 
using various sequence analysis tools. 
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5.2.6 Cloning of “gene of interest” into the pBluescript vector  
5.2.6.1 Isolation of pBluescript vector 
 
The pBluescript vector was kindly provided by Manvendra Saxena from the RMIT 
central stock and was used for the experiments. The empty pBluescript vector in E. 
coli was inoculated into 5 ml LB broth containing ampicillin (100 g/ml), and 
incubated overnight at 37° C with vigorous shaking (225 rpm). The plasmid was 
extracted from the culture using QIAprep Spin Miniprep Kit, as per manufactures 
instructions. The plasmid map of vector pBluescript is shown in Appendix II. 
 
5.2.6.2 Double-digestion of plasmid DNA with KpnI and SacI 
 
The “empty” pBluescript vector was digested with KpnI and SacI. Each double-
digestion reaction was performed by adding 5 µl of plasmid DNA to 1 µl KpnI (10 
U), 1 µl SacI (10 U), 2 µl 10 x Multi-Core buffer and made up to a final volume of 
20 µl by adding 11 µl molecular grade water in a PCR tube. The reaction tubes were 
gently mixed and incubated at 37
 
C waterbath for 3-4 hrs. The entire digests were 
loaded onto 1.5% gel, and separated by gel electrophoresis for 2 hours at 40 V. 
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5.2.6.3 Excision and gel extraction of double-digested DNA bands 
The DNA bands were excised using a scalpel blade and purified (section 2.7.11) 
using the QIAquick Gel Extraction Kit (QIAgen) as per the manufacturer’s 
instructions. The samples were eluted in Elution Buffer, and stored at -20o C. 
 
5.2.6.4 Ligation of inserts into linearised pBluescript vector 
For the ligation reaction, ~50 ng of vector DNA should be mixed with one- to five-
fold molar excess of the target DNA fragment [317]. The required amount was 
calculated from the formula; 
 vectorinsert to of ratiomolar (kb) vector of size
(kb)insert  of size vector x nginsert  DNA  of ng         ×=
 
The ligation reaction was prepared in a PCR tube and incubated overnight in a 14° C 
bath. The ligated products were stored at -20° C. Ligated products were confirmed 
by loading the samples on to gel and separated electrophoretically for 60 min at 100 
V. 
 
5.2.6.5 Electro-transformation of ligated products 
2 µl of the ligated product was mixed with 50 µl of electrocompetent E. coli DH5 
cells (section 2.8.1) and the mixture was transferred to the bottom of an ice-cold 
cuvette (with a 2 mm gap). The Gene Pulser (Bio-Rad) instrument was used to 
perform electroporation at 200 ohms, 25 µF capacitance, and 2.0-2.5 kV, with a 4-5 
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ms pulse. One ml of SOC medium was added to the cuvette to resuspend the cells 
and incubated for 1 h at 37o
 
C. The “transformants” were plated out onto a pre-
warmed LB agar plate containing 100 g/ml ampicillin. The “concentrated 
transformants” were also plated onto a second LB agar plate containing ampicillin, 
by resuspending the pellets in a small volume of S.O.C medium after centrifugation 
for 3 minutes. The plates were incubated overnight at 37° C. 
 
5.2.6.6 Confirmation of successful electro-transformation by PCR and 
restriction enzyme digestion  
 
The colonies were inoculated into LB broth with appropriate antibiotics and 
incubated overnight at 37° C by shaking. The plasmid DNA was extracted using the 
QIA plasmid extraction Kit and analysed by restriction enzyme analysis. PCR was 
performed to confirm the product using the gene specific primers.  
 
5.2.7 Creation of Knock-out mutants 
 
Inverse PCR (IPCR) is a method used for the rapid in vitro amplification of DNA 
sequences that flank a region of known sequence. The primers point away from the 
known sequences and were oriented in the reverse direction of the usual orientation. 
Therefore the entire plasmid is amplified.  
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The plasmid PMW2, kindly provided by Manvendra Saxena, RMIT University was 
grown at 37o C overnight in DH5 alpha in LB broth with kanamycin antibiotic. The 
kanamycin cassette was extracted from the purified plasmid by restriction enzyme 
digestion. The plasmid map of vector PMW2 is given in Appendix III. 
 
Inverse PCR was used to delete part of the gene of interest and to introduce a BamH1 
site. The purified PCR product (purified using Promega Wizard PCR purification 
Kit) and the empty PMW2 vector was digested with BamH1.  The entire digests 
were loaded onto 1.5% gel, and separated by gel electrophoresis for 2 h at 40 V. The 
DNA bands were excised using a scalpel blade and purified using the QIAquick Gel 
Extraction Kit (QIAgen) as per the manufacturer’s instructions. The samples were 
eluted in Elution Buffer, and stored at -20o
 
C. Then the products were ligated with 
the 1.4 Kb Kanamycin cassette of the PMW2 vector. The ligated products were 
electro-transformed into E. coli DH5 alpha cells.  
 
5.2.8 Confirmation of ligation by Restriction enzyme digestion  
 
Colonies were picked from plates and plasmid DNA isolated. The restriction enzyme 
KpnI and SacI was used to digest plasmid DNA samples. The entire digested 
samples were loaded onto 1.5% agarose gels, and separated by agarose gel 
electrophoresis. 
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5.2.9 Confirmation by DNA sequencing  
 
The ABI Prism BigDye Ready Reaction Kit was used to perform DNA sequencing 
as previously described. 
 
5.3 Transformation into C. jejuni  
Transformation was performed by either Natural transformation or Electroporation. 
 
5.3. 1 Natural transformation  
 
C. jejuni 11168 was grown on Horse Blood Agar supplemented with Skirrows in a 
420 C incubator. The cells were inoculated into 1 ml of Heart Infusion Broth (>107 
cells/ml). A 200  volume of cells were transferred onto 800 µl of Heart Infusion 
Agar in a 1.5ml micro-centrifuge tube. The lid of the tube was pierced and closed. 
The tubes were incubated under microaerophilic conditions at 370 C for 3 hrs. 10 µg 
of suicide plasmid DNA was mixed with the bacterial culture. After incubation for 4 
hrs, the cell suspension was cultured on to a Blood Agar plate with Kanamycin 
antibiotic. The plate was incubated under microaerophilic conditions for 3 days at 
420 C. The colonies were confirmed by colony PCR. 
 
 
140 
 
5.3.2 Electroporation of Campylobacter 
C. jejuni cells were grown on Horse Blood Agar plates for 16 hrs at 370 C at 
microaerophilic conditions. Bacteria were harvested using 2 ml Muller Hinton broth 
or wash buffer. Cells were pelleted by centrifugation (>1000g for 5 minutes) and the 
washing steps were repeated. Finally, cells were resuspended in ice cold wash buffer 
and immediately stored in 50  or 100  aliquots at -800 C (section 2.10.1). 
Frozen competent cells and the cuvettes were kept on ice. Five to ten g of DNA 
was mixed with 50  or 100  aliquots of competent cells and electroporation was 
performed at 2.5 kV, 200, 25 F in a 2 mm gap cuvette.  100  of S.O.C medium 
was added and gently spread onto non-selective media. The plates were incubated 
370 C for 5 hrs under microaerophilic conditions. The cells were harvested in 1 ml of 
MH Broth and plated out on the horse blood agar plates with the selective 
antibiotics. Plates were incubated at 420 C for 2 days. The colonies were confirmed 
by colony PCR [131, 318]. 
 
5.4 Results 
 
A total of five knock-outs were created. The results for each gene are 
described below. The scheme for creating each knock-out is shown in Figure 5.1 and 
an example of the full construction for one gene (Cj0391c) is shown in Figures 5.2- 
5.7. The final PCR demonstrating each gene knock-out is shown in Figures 5.8 to 
5.11. 
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Figure 5.1 Flow chart showing the strategy adopted in creating knock-out. 
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5.4.1 Cj 0391c 
 
 
 
 
Figure 5.2 Optimized PCR amplification of gene fragment (Cj 0391c) 636 bp from 
genomic DNA (C. jejuni NCTC11168) using specific primers 
 
 
Lane 1 : Lambda PstI DNA ladder 
Lane 2 : PCR amplification of gene fragment 
   
 
 
 
2 1 
 636bp 
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Figure 5.3 Digestion of pCRII-TOPO/ Cj0391c with EcoRI 
 
 
Lane 1-4 : pCRII-TOPO (3.9 kbp) containing Cj0391c insert (636 bp) 
Lane 5-7 : Empty well 
Lane 8 : Lambda PstI DNA ladder  
 
 
 
 
3.9 kbp 
636  bp 
1 2 3 4 5 6 7 M 
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Figure 5.4 Digestion of pBluescript / Cj0391c and with KpnI and Sac1 
 
 
Lane 1 : Lambda PstI DNA ladder  
Lane 2,3 : pBluescript/ Cj0391c digested with KpnI and Sac1 
Lane 4 : Empty well 
 
 
 
 
M 2 3 4 
2.9 kbp 
636 bp 
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Figure 5.5 Inverse PCR for Cj0391c / pBluescript  
 
 
Lane 1 : Lambda PstI DNA ladder  
Lane 2,3 : Empty well 
Lane 4-9 : Inverse PCR performed on pBluescript containing insert 
Cj0391c 
 
 
 
 
M 2 3 4 5 6 7 8 9 
2.9 kbp 
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Figure 5.6 Confirmation of kanamycin/gene insert in pBluescript by restriction 
enzyme digestion with Kpn1 and Sac1  
 
 
 
Lane 1 
Lane 2 
: 
: 
Lambda PstI DNA ladder  
Confirmation of kanamycin cassette/gene of interest (Cj0391c) 
in pBluescript by restriction enzyme digestion 
   
 
 
 
 
 
2.9 kbp 
2 kbp 
M 2 
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Figure 5.7 PCR showing  the size of the wild type and the predicted size of knock-
out gene Cj0391c  
 
 
 
 
 
Lane 1 
Lane 2-3 
: 
: 
Lambda PstI DNA ladder  
Size of the gene of interest Cj0391c (wild type ) 
Lane 4 : Predicted size of knock-out Cj0391c (knock-out) 
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5.4.2 Cj 1656c  
 
 
 
Figure 5.8 PCR showing the the size of the wild type and predicted size of knock-
out gene Cj1656c 
 
 
Lane 1 : Lambda PstI DNA ladder  
Lane 2-4 : Size of gene of interest Cj1656c 
Lane 5-6 : Predicted size of knock-out Cj1656c 
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5.4.3 Cj1450 
 
 
 
 
Figure 5.9 PCR showing the size of the wild type and the predicted size of knock-
out gene Cj1450 
 
Lane 1 
Lane 2 
: 
: 
Lambda PstI DNA ladder  
:  Siz     Size of the  gene of interest Cj1450 
Lane 3 : Predicted size of knock-out Cj1450 
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5.4.4 Cj0428 
 
 
 
 
 
 
 
 
 
 
Figure 5.10 PCR showing the the size of the wild type and predicted size of knock-
out gene Cj0428 
 
 
Lane 1 : Lambda PstI DNA ladder  
Lane 2-5 : Predicted size of knock-out Cj0428 
Lane 6 : Size of gene of interest Cj0428  
 
 
 
M 2 3 4 5 6   
1.7 kbp 
384 bp 
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5.4.5 Cj 0243c 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11 PCR showing the predicted size of knock-out gene Cj0243c 
 
 
Lane 1 : Lambda PstI DNA ladder  
Lane 2 
Lane 3-5 
: 
: 
Size of gene of interest Cj0243c 
Predicted size of knock-out Cj0243c 
 
 
 
 
4 2 3 M 5 
1.7kbp 
 
 339bp 
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Bioinformatics analyses described in chapter 4 narrowed down the number of genes 
for further investigation. Five genes, Cj1656c, Cj1450, Cj0428, Cj0243c and 
Cj0391c were selected for knock-out analysis. All five genes were predicted to 
encode non-classically secreted hypothetical proteins that were predicted to be 
located extracellularly. Genes were successfully disrupted and gel electrophoretic 
analysis od PCR’s from genomic DNA gave the predicted size. The knock-out 
strains were ready for further analysis. To analyze the in vitro phenotype of the 
knock-out strains, tissue culture studies were carried out.  
 
5.5 In vitro analysis of the phenotypes using the INT 407 intestinal cell line 
 
This study focuses on the analysis of the phenotype of the strains constructed in the 
previous experiments. This analysis was performed on the INT 407 intestinal cell 
line as an experimental model to assess the colonization level of C. jejuni. Although 
this is a mammalian cell line, it is a very well established technique for the 
evaluation of Campylobacter knock-outs [319]. Identification and characterization of 
C. jejuni virulence determinants is possible by evaluating the interactions of C. jejuni 
with the intestinal epithelium.  
 
Tissue culture models have been extensively used to analyse the mechanism of 
bacterial entry into the host cell, survival, and replication in the mammalian cells 
[54, 215, 318, 320]. Studies involve determination of the number of adhered C. 
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jejuni to the intestinal cell line. For example, the tissue culture studies conducted by 
Everest et al. [321] have shown that significant differences in the level of adherence 
occurs between C. jejuni strains isolated from different individuals.  
 
5.5.1 Experimental procedures 
5.5.1.1 Tissue culture growth conditions 
 
The INT 407 cell line was routinely cultured in 25 cm2 or 75 cm2 culture flask, 
(section 2.11.1) or 24 well culture trays containing complete medium supplemented 
with 10% (v/v) NCS (pre-warmed), and antibiotics (50 µg/ml penicillin and 
streptomycin) were added when necessary. The cultures were incubated at 37º C 
with 5% CO2. The medium was replaced every second day or as necessary. The cells 
were washed and cultured in antibiotic free medium overnight before use. 
 
5.5.1.2 Adhesion assay to study the phenotypes with the INT 407 cells  
 
A PBS control group and wild strain C. jejuni NCTC 11168 were used as negative 
and positive control respectively.  
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5.5.1.3 Seeding micro titre plates 
 
INT 407 cells were grown in DMEM medium with 10 % NCS at 37º C with 5% CO2 
and 95% air. Cells were grown to a monolayer of 80% confluency in 75 cm2 flasks 
before they were tripsinised and enumerated in a Neubauer cell counting chamber. 
The percentage of the viability of cells was determined by the tryphan blue exclusion 
method. Cells were suspended in a 0.04% trypan blue solution for 2 min then 
examined. A seed culture of 1 x 105 cells, in 500 µl of DMEM + 10% NCS, was 
placed into each well of a 24 well tray. They were allowed to grow for 16 h to adhere 
before commencing the assay. 
 
5.5.1.4 Preparation of bacterial Inoculums  
Mutant and wild-type strains were grown on Horse blood agar plates supplemented 
with antibiotics and Skirrows selective medium for 24-48 h at 42º C. The colonies 
were then inoculated on to pre-warmed Brucella broth and incubated at 42º C for 18- 
24 hrs. Cells were harvested in 1 ml PBS and adjusted to OD600 = 1. The cell pellet 
was resuspended in 1 ml Brucella broth and incubated at 420 C for 16-18 hrs under 
microaerophilic conditions. Cells were re-suspended in pre-warmed (37º C) DMEM 
with 10% NCS on the day of assay.  
 
Cells were pelleted by centrifugation at 1000 x g for 5 min. The supernatant was 
discarded and the cells were washed and diluted with DMEM.  
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5.5.2 The Adhesion Assay  
 
Bacterial host interactions were studied by an adherence assay. All methods were 
followed with minor modifications as described previously by Wassennar et al [318]. 
INT 407 cells were seeded into wells of a 24 well tissue culture plate at 1 x 105 
cells/well. They were grown for 16-18 hrs. Before commencing each assay INT 407 
cells were washed twice with PBS to remove cell debris. 100 µl of bacterial 
inoculum, containing 2 x 106 bacteria was then used to infect cells by overlaying the 
bacteria on the top of cell lines. The samples included PBS as the negative control, 
wild type C. jejuni NCTC 11168 strain as the positive control and test samples 
included mutant strains of C. jejuni NCTC 11168. All samples were analysed in 
triplicate. Then 400 µl of DMEM with 10 % NCS was added to the wells to give a 
final volume of 500 µl. The 24 well trays were then placed in a 37º C incubator with 
5% CO2 and 95% air at different time intervals ranging from 30 min. to 150 min. 
The cells were then washed with PBS twice to remove cell debris and non-adhered 
bacteria. Then INT 407 cells were lysed with the detergent triton-X114 (200 µl of 
0.25% solution) to release any intracellular bacteria and incubated at 37o C for 15 
min. The lysate was then diluted with 800 µl of PBS. The lysates were then plated 
out on Horse blood agar plates using different dilutions. Plates were incubated for 48 
hours to enumerate the colony formation of adhered or internalized bacteria.  
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5.5.3 Bacterial strains  
 
The strains used in the experiment are given below. 
Control = PBS control  
Positive control= Parent strain Cj 11168 
Test Strains       C. jejuni mutants    Mutant Cj 1656c  
    Mutant Cj 0391c 
                                                           Mutant Cj 1450 
                                                           Mutant Cj 0428 
                                                           Mutant Cj 0243c  
 
5.6  Results 
 
Five knock-out strains were analysed. Among these five knock-outs analysed two 
were shown to have a similar adherence level to the wild-type strain, whereas mutant 
Cj 0243c and mutant Cj 1450 shown decreased adherence, with Cj 1450 showing the 
least adhering capacity. Mutant Cj 0391c exhibited no detectable adhesion. The 
results obtained are shown in the Figure 5.12. 
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Figure 5.12 Comparison of adhesion capability between different knock-out 
strains. Bars and error-bars show the mean ± standard deviation. The 
sign * indicates significant differences in colonization levels at P < 
0.05 as determined by Student’s t-test and # shows P<0.0001. The 
difference in number of colonies of mutants Cj0428 and Cj1656c 
compared to the wild-type strain are not significant (P > 0.05). 
 
 
In addition to adherence, invasion was also studied by including an incubation step 
with gentamycin after the bacteria were incubated with INT 407 cells. This will kill 
adherent bacteria. After lysis of the INT 407 cells, only those bacteria which had 
invaded will be enumerated. The results showed that there were extremely low levels 
of invasion of the wild-type, and no internalized bacteria were observed in any of the 
mutants’ strains. 
 
* 
*
# 
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5.7 Discussion 
  
The work described here was to create knock-out mutants of possible virulence 
genes of C. jejuni. This can provide valuable information on the roles of these genes 
in C. jejuni pathogenesis or colonisation in chickens. To investigate the functions of 
these proteins they were analysed in vitro using human intestinal cells. Genes were 
chosen for mutagenesis studies to determine whether they encoded proteins that had 
a role in adherence to cells. The functions of the proteins encoded by the genes 
selected were not known. Moreover, these non-classically secreted proteins were 
predicted to be secreted extracellularly. In this study, hypothetical non-classically 
secreted proteins from C. jejuni 11168 namely Cj0391c (636bp; 22.7kDa), Cj0428 
(384bp; 14.1kDa), Cj1450 (564bp; 21.3 kDa), Cj1656c (183bp; 6.2 kDa) and 
Cj0243c (45.0 kDa) were selected using Bioinformatics tools and sequence 
homology search tools. 
 
The ability of pathogenic bacteria to bind to host tissues is a prerequisite for host cell 
invasion, where the organisms are protected from the humoral immune responses. 
The ability of C. jejuni to colonize the gastrointestinal tract of humans is proposed to 
be essential for disease [316, 322]. Previous studies have shown that mutants of C. 
jejuni have been created for studies of the genes encoding proteins associated with 
motility and  chemotaxis [323]. Flagellar biogenesis has been extensively studied 
using a flhB mutant [324]. Therefore it is evident that the role of the genes can be 
revealed by the testing of mutants in vivo or in vitro. 
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C. jejuni binds to epithelial cells by several outer-membrane proteins including JlpA, 
PEB1 and CadF [157, 198, 260]. It is difficult to assess the contribution of each 
adhesion molecule in the adherence of C. jejuni to host cells.  Knock-outs have been 
generated in the genes encoding the JlpA, PEB1 and CadF adhesins, and the 
phenotypes examined using suitable cell lines. Previous studies have demonstrated 
that a C. jejuni jlpA knock-out is reduced by  19% in adherence to HEp-2 cells [198], 
C. jejuni peb1 knock-out is reduced by 10–99 % in adherence to HeLa cells [260] 
and C. jejuni cadF knock-out is reduced by 50–90 % in adherence to INT 407 cells 
[282]. CadF is a 37 kDa outer-membrane protein, and promotes the binding of C. 
jejuni to fibronectin. To determine the role of CadF in promoting bacteria–host cell 
interactions, cadF mutants were created. Binding and internalization assays were 
performed using INT 407 cells with C. jejuni wild-type and cadF mutant [282]. 
Studies have revealed that C. jejuni cadF knock-out showed a 59% reduction in 
adherence to INT 407 cells when compared to the C. jejuni wild-type isolate. This 
finding indicated that the reduction in adherence with the knock-out was due to the 
absence of the CadF protein. Conversely, a knock-out study conducted on the 
Cj1477c gene revealed no reduction in the binding of the Cj1477c knock-out to the 
INT 407 cells when compared to the C. jejuni wild-type isolate [282]. Similar to the 
case with cadF, a C. jejuni mutant of Cj1279c (flpA) results in impaired ability to 
bind to chicken LMH hepatocellular carcinoma epithelial cells and to efficiently 
colonize broiler chickens compared to wild strain [103]. Based on the experiments 
conducted creating knock-outs and the in vitro and in vivo assays it was concluded 
that FlpA is a novel C. jejuni adhesion [325]. 
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 Human epithelial cells were used to analyze the bacterial host interactions of the 
phenotypes. Previous work from the literature has demonstrated that C. jejuni is 
capable of entering human epithelial cells [326]. C. jejuni mutants of the selected 
proteins were constructed and utilized to further and more precisely define the role 
of non-classically secreted hypothetical proteins in the interaction of C. jejuni with 
such epithelial cells in vitro. Significant differences in adhesion properties were 
found between different knock-out strains. C. jejuni mutants Cj0428 and  Cj1656c 
adhere to cultured human epithelial cells as readily as the wild type parent strain 
indicating that the proteins encoded by these genes are not a predominant factor in 
the colonization although they might be contributing some factors for internalization. 
Therefore the function of these proteins may be other than adherence to epithelial 
cells. The mutants Cj1450 and Cj0243c showed a reduction in colonization 
compared with the wild-type strain (P < 0.05). This indicates that the protein 
encoded by these genes may be involved in the interaction between bacterial and 
host cells. 
 
One of the knock-out strains (Cj 0391c) showed no adhesion to epithelial cells. The 
gene encoded by this protein does not have an assigned function. As determined by 
Bioinformatics studies, the protein is predicted to be 22.7 kDa, and to be secreted 
from the bacterium. As the mutant strain shows no adherence/invasion into an 
epithelial cell line, it is tempting to hypothesize that the normal role of this protein is 
to facilitate these processes. It is interesting that it is predicted that these proteins are 
actually fully secreted from Campylobacter cells, and therefore would presumably 
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not a simple “linking” molecule that bridges the bacterial and host cells. There may 
be interplay between a number of factors released by host cells or other proteins 
secreted from the bacteria itself that are involved in adherence adhere, or perhaps the 
secreted proteins bind directly to the host cells and facilitate adherence. Further work 
will be required to demonstrate the mechanisms of action. 
 
In future work with the mutants, colonisation studies in chickens should be 
performed. It will be of interest to determine if the mutants have altered colonisation 
levels, and if the immune responses to the mutants are altered in any way. As an 
example, a mutant that is missing a vital immune avoidance molecule might become 
very sensitive to immune responses, which can clear the bacterium. 
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Chapter 6 
 
Investigation of the differences in the proteomes of 
Campylobacter that can or cannot colonize chickens 


6.1 Introduction 
 
Although the Bioinformatics analysis of the genome and proteome of C. jejuni 
reduced the choice of possible antigens as vaccine candidates, a second analysis was 
carried out to strengthen the choice of antigens for future experimental work. This 
study concentrated on the differences in the proteomes of C. jejuni, which is a 
commensal organism in chickens, and C. concisus, which is a non-coloniser in 
chickens. Both however cause gastroenteritis in humans. If further 
differences/similiarities in the secretion of proteins is found, it may be possible to 
find out the actual proteins responsible for the high level of colonization by C. jejuni 
in chickens. 
 
The most common source of gastroenteritis infection is from undercooked or 
improperly cooked poultry products and the current way of preventing disease is an 
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attempt to prevent colonization in poultry. This report investigates a comparative 
study between the proteomes of C. jejuni and C. concisus using various 
Bioinformatics techniques. Predicted secreted proteins of C. jejuni were compared 
using BLAST against the C. concisus proteome and the proteins which showed least 
identity with those of C. concisus genome were selected based on the E value. C. 
concisus does not exist as commensal bacteria in chickens, indicating that this 
particular species lacks the factors responsible for such colonization. Therefore there 
might be differences in the secreted proteins (secretomes) between C. jejuni and C. 
concisus which promote colonization of the former in chickens.   In addition, further 
analysis was carried out on the C. concisus genome to reveal the possible pathogenic 
proteins secreted from the species. As the genomes of C. jejuni NCTC 11168 and C. 
concisus 13826 have been sequenced, these would be the ideal strains for the study. 
This comparative analysis has identified similiarities /differences between the 
secretomes of C. jejuni and C. concisus, which may point to putative virulence 
factors of the bacteria.  
 
A number of non-jejuni Campylobacter species also act as potential pathogens of the 
human intestinal tract. C. jejuni, and its close relative C. coli, are the most common 
cause of human bacterial enteritis, and other members of this genus, including C. 
upsaliensis, C. concisus, C. gracilis, C. rectus and C. showae, also play a role in 
human enteritis. C. concisus is an opportunistic pathogen of the human oral cavity as 
well as a causative agent of gastroenteritis cases in humans.  In C. concisus strains 
isolated from children with gastroenteritis it was shown that the production of 
secreted and cell-associated hemolytic activities makes bacteria more virulent [327]. 
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Analyses using Bioinformatics tools would be a promising approach for predicting 
the secretory virulence factors in C. jejuni and C. concisus. C. concisus does not 
have any known animal host and there are no findings on its isolation as a 
commensal from healthy animals [328]. 
 
The secretome which ultimately contributes to the invasiveness of an organism is an 
essential component of a pathogen’s arsenal. Previous studies have reported that the 
SignalP 3.0 server was used to predict the proteins secreted by C. concisus strain 
13826 [190]. Studies have shown that the secretome of C. concisus is important for 
the general function of the bacterial cell, as well as for virulence. The studies also 
reported that the presence of virulence factors in the secretome of C. concisus come 
into contact with host cells more readily than membrane- bound proteins [190]. 
 
6.2 Methods 
6.2.1 Similarity searching between sequences using BLASTP 
 
Four hundred and seven proteins of C. jejuni were included in the study. These 
proteins were predicted to be secreted using the Bioinformatics analyses described in 
chapter 4. In the first part of the study Basic Local Alignment Search Tool (BlastP) 
was used to identify unique sequences between the two proteomes. Each of the 407 
protein sequences of C. jejuni was aligned against the full protein sequence of C. 
concisus and the percentage of identity was observed. E values greater than 0.01 
were selected as being proteins specific for C. jejuni. Blast results showing E values 
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less than 0.01 (indicating probable homology) were not included in the study. That 
means these proteins show similarity between the two species and might be 
responsible for the gastroenteritis produced in humans. The proteins which show no 
similarity may be the proteins responsible for C. jejuni colonization of chickens.  
 
6.2.2 Bioinformatics analyses performed in the complete proteome sequence of 
C. concisus 
 
In the second part of the study, detailed Bioinformatics analyses were performed 
using SignalP 3.0, SecretomeP, Gneg-PLoc, Gneg-mPLoc and MemType-2L. This 
study was undertaken to reveal the proteome of C. concisus by predicting the 
secretory proteins and their further analyses. This analysis provides information 
regarding the predicted secreted proteins, location of the predicted secreted proteins, 
and proteins with/without transmembrane helices. The complete annotated genome 
sequence of C. concisus reveals C. concisus has 2080 predicted coding sequences. It 
is evident that more proteins are predicted to be present in the C. concisus proteome 
than C. jejuni and yet the bacterium would appear to have a more restricted host 
range. Predicted protein sequences were retrieved from the Sanger website in the 
FASTA format. Two thousand and eighty C. concisus proteins were further 
investigated to narrow down the number of proteins showing possible virulence 
properties. The methods used for analyses in this chapter are the same as the 
methods elaborated in Chapter 4. The selected proteins were tabulated under 
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different groups such as classically secreted, non-classically secreted proteins; 
predicted locations etc and are shown in Appendix V. 
 
6.2.2.1 Prediction of transmembrane regions using the TMHMM Server  
 
An algorithm termed N-best was employed by the TMHMM web server to predict 
the number, position and direction of transmembrane helices and intervening loop 
regions in query sequences. Seven hundred and forty nine predicted secreted proteins 
were included in the study. 
 
6.2.2.2 Beta-barrel outer membrane proteins prediction 
 
MPs (membrane proteins) are categorized into alpha -helical (AMP) and outer 
membrane proteins which mostly include beta barrel folds (OMBBs). Because of 
several long membrane-spanning hydrophobic alpha -helices, alpha -helical 
membranes (AMP) are relatively easy to predict from a protein sequence. OMBBs 
(outer membrane beta barrel proteins) have shorter membrane-spanning regions 
[329]. They are found in the outer membranes of gram-negative bacteria. The shorter 
membrane spanning region of OMBBs assemble into beta barrels, and they lack a 
clear pattern in their membrane spanning strands. They perform diverse functional 
roles, including bacterial adhesion, material transport and they support structural 
integrity of the cell wall. OMBBs play important roles in cell biology; their 
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prediction would be crucial method to predict the virulence mechanism. Two 
thousand and eighty proteins were included in the study. 
 
6.3 Results 
6.3.1 Similarity searching between sequences using BLASTP 
 
A total of 407 predicted secreted proteins of C. jejuni were queried using BlastP. 
Each protein sequence was compared against the complete set of protein sequences 
of C. concisus 13826. The C. jejuni proteins that show similarities to the compared 
genome (C. concisus) were assumed as “common proteins for both C. jejuni and C. 
concisus". The proteins that show no matches (E value cutoff greater than 0.01) 
among the sequences were considered to be C. jejuni specific (although they may be 
found in other Campylobacters). The C. jejuni specific proteins i.e. the proteins that 
show no homologue in C. concisus are shown in Table 6.1. The proteins specific for 
C. jejuni were further investigated by undertaking whole database Blast analysis. 
This was to acquire information regarding the proteins showing similiarity to other 
Campylobacters other than C. concisus and with any other bacterial species.  
 
Classically secreted and non-classically secreted proteins were grouped based on the 
E value obtained from the analysis. The proteins with no homologue in C. concisus 
(and an E value greater than 0.01) are considered more relevant to the present study 
because these may be specific to C. jejuni. It is interesting that two of the proteins 
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selected for knock-outs using the first Bioinformatics analysis were also revealed as 
a significant candidate in the present study. These were Cj 0428 (gi _218562086) 
and Cj 1656c (gi_218563245) as indicated by * and ** in Table 6.1.  
  
Table 6.1 Predicted secreted proteins of C. jejuni  showing  no similarity with C. 
concisus proteins (E value greater than 0.01) 
 
gi Number Homology 
218563245** Various Campylobacter spp & Helicobacter 
218563220 Various Campylobacter spp & Helicobacter 
218562998 Campylobacter & other bacteria 
218562994 Campylobacter & other bacteria 
218562974 Campylobacter & other bacteria 
218562870 Campylobacter & other bacteria 
218562854 Various Campylobacter spp 
218562837 Campylobacter & other bacteria 
218562805 Various Campylobacter spp 
218562776 Campylobacter & other bacteria 
218562590 C. jejuni only  
218562588 C. jejuni only 
218562586 C. jejuni only 
218562487 C. jejuni only 
218562444 Various Campylobacter spp 
218562404 Various Campylobacter spp 
218562382 Various Campylobacter spp 
218562380 C. jejuni only 
218562379 C. jejuni only 
218562378 C. jejuni only 
218562377 C. jejuni only 
218562126 Campylobacter & other bacteria 
218562086* Various Campylobacter spp 
218562076 Campylobacter & other bacteria 
218562073 Campylobacter & other bacteria 
218561914 C. jejuni only 
218561881 Campylobacter & other bacteria 
218561698 Campylobacter & other bacteria 
218563267 Various Campylobacter spp 
218563265 Campylobacter & other bacteria 
218563256 C. jejuni only 
218563214 Campylobacter & other bacteria 
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218563210 Campylobacter & other bacteria 
218563125 Campylobacter & other bacteria 
218563115 Campylobacter & other bacteria 
218563100 Campylobacter & other bacteria 
218563086 Various Campylobacter spp 
218563059 Various Campylobacter spp 
218563048 Campylobacter & other bacteria 
218562965 Various Campylobacter spp & Helicobacter 
218562966 Campylobacter & other bacteria 
218562964 Campylobacter & other bacteria 
218562894 Campylobacter & other bacteria 
218562852 Various Campylobacter spp 
218562782 Campylobacter & other bacteria 
218562781 Various Campylobacter spp & Helicobacter 
218562772 Campylobacter & other bacteria 
218562766 Campylobacter & other bacteria 
218562693 Campylobacter & other bacteria 
218562692 Various Campylobacter spp 
218562676 C. jejuni only 
218562657 Campylobacter & other bacteria 
218562635 Campylobacter & other bacteria  
218562634 Campylobacter & other bacteria 
218562632 Campylobacter & other bacteria 
218562620 Campylobacter & other bacteria 
218562614 Campylobacter & other bacteria 
218562599 Campylobacter & other bacteria 
218562598 Campylobacter & other bacteria 
218562585 Various Campylobacter spp 
218562569 Campylobacter & other bacteria 
218562536 Various Campylobacter spp & Helicobacter 
218562500 Various Campylobacter spp 
218562497 Various Campylobacter spp & Helicobacter 
218562496 Campylobacter & other bacteria 
218562470 Various Campylobacter spp 
218562446 Various Campylobacter spp 
218562406 Campylobacter & other bacteria 
218562376 Various Campylobacter spp & Helicobacter 
218562374 Various Campylobacter spp 
218562367 Campylobacter & other bacteria 
218562354 Campylobacter & other bacteria 
218562279 Campylobacter & other bacteria 
218562264 Campylobacter & other bacteria 
218562261 Campylobacter & other bacteria 
218562260 Campylobacter & other bacteria 
218562245 Campylobacter & other bacteria 
218562243 Campylobacter & other bacteria 
218562242 Campylobacter & other bacteria 
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218562238 Various Campylobacter spp 
218562216 C. jejuni only 
218562205 Campylobacter & other bacteria 
218562175 Campylobacter & other bacteria 
218562149 C. jejuni only 
218562141 Campylobacter & other bacteria 
218562083 C. jejuni only 
218562082 Campylobacter & other bacteria 
218562078 Campylobacter & other bacteria 
218562072 Campylobacter & other bacteria 
218562064 Various Campylobacter spp 
218562037 Campylobacter & other bacteria 
218562034 Various Campylobacter spp 
218561923 Various Campylobacter spp 
218561880 Campylobacter & other bacteria 
218561879 Various Campylobacter spp & Helicobacter 
218561848 C. jejuni only 
218561826 Campylobacter & other bacteria 
218561774 Campylobacter & other bacteria 
218561773 Campylobacter & other bacteria 
218561772 Campylobacter & other bacteria 
218561771 Campylobacter & other bacteria 
218561770 Campylobacter & other bacteria 
218561762 Campylobacter & other bacteria 
218561761 Campylobacter & other bacteria 
218561760 Various Campylobacter spp 
218561729 Campylobacter & other bacteria 
218561726 Campylobacter & other bacteria 
218561711 Campylobacter & other bacteria 
218561697 Campylobacter & other bacteria 
 
 
BlastP analysis was performed on the predicted secreted proteins of C. jejuni. 
Throughout the BlastP searches 28 non-classically secreted proteins of C. jeuni were 
identified with an E value greater than 0.01. Eighty one classically secreted proteins 
of C. jejuni were found to have E value greater than 0.01. Therefore, a total of 109 
proteins were selected as proteins showing an E value greater than 0.01, i.e. present 
in C. jejuni but not C. concisus. These proteins should be further investigated to 
explore the colonization properties of C. jejuni. Out of the 109 selected proteins 15 
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were found to have no homologue in any other species, so these may be truly C. 
jejuni specific. Twenty one of the 109 proteins were shown to have homologues to 
different Campylobacter species other than C. concisus. Out of the 109 selected 
proteins eight proteins were shown to have homologues to various Campylobacter 
species and Helicobacter. Sixty five proteins were shown to have homologues in 
different bacteria. 
 
6.3.2 Bioinformatics analyses performed on the complete proteome of C. 
concisus 
 
The complete annotated genome sequence of C. concisus reveals that it has 2080 
predicted coding sequences. The protein sequences were downloaded in the FASTA 
format for further investigation.  Protein sequences were queried using the SignalP 
3.0 Server and SecretomeP 2.0 severs and therefore predicted classically 
secreted/non-classically secreted proteins. Out of the 2080 proteins analysed 1331 
proteins were predicted to be non-secreted proteins and 749 were predicted to be 
secreted proteins.  The presence and location of signal peptide cleavage sites of each 
protein was queried using the SignalP 3.0 server. Four hundred and twenty four 
proteins were predicted to have signal peptides (classically secreted proteins). The 
SecretomeP 2.0 server was employed to predict non-classically secreted proteins. 
Three hundred and twenty four proteins were predicted to be non-classically 
secreted. The results of queried proteins were recorded. The proteins classified under 
secreted proteins (classically secreted/non-classically secreted) are shown in 
Appendix V. Distributions of the proteins are shown in Figure 6.1. 
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Figure 6.1 424 proteins are predicted to be classically secreted whereas 325 
proteins are predicted as non-classically secreted from the total 2080 
Campylobacter concisus proteins. 
 
The 749 proteins which are categorized under the group “predicted secreted proteins 
(classically secreted/non-classically secreted)” were chosen for further investigation.  
The Gneg-PLoc Server was used to predict the location of the proteins. The proteins 
were then catalogued into various groups depending on the site of location such as 
extracellular, flagellar, fimbrium, outer membrane and periplasm. Out of the 749 
proteins analysed only 99 proteins were predicted to be located outside the cell, and 
61 of the 749 were predicted to be located in the periplasm. Of the 99 predicted 
proteins, fifty proteins were predicted to be completely extracellular, 40 located on 
the outer membrane. Nine proteins were found to be located on the flagellum from 
the category “proteins secreted outside the cell”. None of the proteins were identified 
as fimbrium located. Twelve proteins were predicted to be < 50 aminoacids and 
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these are not included in the study. The majority of proteins were found to be 
predicted to be intracellular. This is similar to the results obtained in Chapter 4, 
where most proteins predicted to be secreted or inserted into the membrane were 
subsequently predicted by Gneg-PLoc to actually be intracellular. Detailed results 
and their accession numbers are shown in Appendix V. The proteins which are 
predicted to be located in various locations are shown in Figure 6.2. 
 
 
 
Figure 6.2 Location of the 749 predicted secreted proteins according to Gneg-
PLoc. 
 
The proteins were queried using the Gneg-PLoc server and the proteins that are 
predicted to be in more than location were recorded. Forty eight proteins were 
predicted to be located in more than one location. This included two locations (41), 
three locations (4), four locations (2), and six locations (1). The proteins which are 
predicted to be located in multiple locations are shown in Figure 6.3. 
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Figure 6.3 48 proteins are predicted to be located in  more than one location  
 
A more advanced version of Gneg-PLoc named as “Gneg-mPLoc” was also used for 
the prediction of the subcellular localisation of gram negative bacterial proteins. 
Multiple location proteins were predicted which is indicated by the character “m” in 
front of “PLoc” of its name. The numbers of the protein locations have been listed in 
Table 6.2.  
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 Table 6.2 The number of the predicted secreted proteins located total or partially 
extracellular according to Gneg-mPLoc. 
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MemType 2 L, a 2 layer predictor was employed for predicting membrane protein 
types. The 749 proteins predicted to be located extracellularly were analysed by 
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Gneg-mPLoc. Out of these 158 extracellular proteins identified by Gneg-mPLoc, 46 
were predicted to be in the membrane. The distribution of the membrane types is 
shown in Table 6.3. 
 
Table 6.3 The proteins predicted as membrane proteins by Memtype  
 
Membrane 
Types 
Number of 
Proteins 
Lipid anchor 9 
Multi-pass 29 
Peripheral 5 
Single-pass type I 2 
Single-pass type 
II 
1 
Total 46 
 
6.3.2.1 Prediction of transmembrane regions using the TMHMM Server  
 
Seven hundred and forty nine proteins predicted to be secreted from the complete 
proteome sequence of C. concisus were included in the study. The results obtained 
are classified as proteins with transmembrane helices and proteins without a 
transmembrane helix. Out of the 749 predicted secreted proteins analysed 354 
secreted proteins were predicted to have a transmembrane helix (TMH) and 395 
were predicted to have no transmembrane helix. Out of these 395 proteins without a 
transmembrane helix analysed, 170 were found to be secreted extracellularly. These 
170 proteins were considered at the top of the list to be investigated further, although 
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some of these are predicted by Gneg-PLoc to be intracellular. Further studies will be 
required to resolve this. The proteins with their accession numbers are given in the 
Appendix V. 
 
6.3.2.2 Beta-barrel outer membrane proteins prediction 
 
Out of 2080 proteins analyzed 469 proteins were grouped under “beta barrel 
proteins”.  As they are present in the outer membrane, further analysis of the 469 
beta barrel proteins would be an ideal step to move forward to understanding 
pathogenesis. 
 
6.4 Summary of Bioinformatics analyses 
Figure 6.4 demonstrates the results of each stage of the Bioinformatics analyses 
carried out in this study. This proposes 170 proteins that are considered to be 
significant candidates for vaccine study. 
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Figure 6.4  Demonstrates the results of each stage of the Bioinformatics analyses carried out 
in the study. 
 
 
 
 
 
Classically secreted (424) Non-Classically secreted (325) 
Predicted Secreted (749) 
Gneg –PLog (99) Gneg –mPLog 
Total/Partial 
Extracellular (158) 
Membrane 
proteins (46) 
Transmembrane 
helix (354) 
No Transmembrane 
helix (395) 
No Transmembrane 
helix & secreted 
extracellular (170) 
Transmembrane prediction 
Total Proteins 2080  C. concisus 
Predicted Non-Secreted (1331) 
 barrel proteins (469) 
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6.5 Discussion 
 
Various bioinformatics tools can be used to explore the properties of a bacterial 
proteome. After the study reported in Chapter 4 of this thesis, a second 
bioinformatics analysis was conducted to predict the possible proteins of C. jejuni 
responsible for Campylobacter colonization in chickens. This analysis was 
performed by comparing the two proteomes of C. jejuni and C. concisus, as C. jejuni 
is a commensal bacteria in chickens, whereas C. concisus is a non-coloniser in 
chickens. Therefore, it may be expected that the former bacterium will contain 
proteins that are not required for the non-chicken colonizing bacterium. Both these 
genomes have been fully sequenced and the predicted protein sequences were 
available to conduct the analysis. It is interesting that although 2080 proteins are 
predicted to be encoded by the C. concisus genome, a smaller host range than C. 
jejuni exists. To date there is no known animal host for C. concisus. If it is possible 
to identify the differences /similiarities in protein secretion between these two 
bacteria, this might be useful for designing an anti-colonization vaccine in chickens. 
Finally, a further analysis of C. concisus genome was conducted to provide 
information regarding the possible virulence proteins of the bacterium. 
 
The first stage of the bioinformatics analysis reduced the number of proteins for 
further investigation by finding out the similarity (using BlastP) between the two 
sequences. This comparative analysis has identified C. jejuni specific proteins with 
no homologue encoded by the C. concisus genome. Out of 407 C. jejuni proteins 
analyzed (i.e. those predicted by SignalP and SecretomeP to be secreted/inserted into 
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membranes), 109 were found to be have no homologue in C. concisus (cutoff E > 
0.01). Some of these have orthologues present in other species of Campylobacter, 
and are not therefore C. jejuni specific. Therefore, there are proteins which were 
shown to be in C. jejuni only, or have homologues to other Campylobacters and 
Helicobacter, or between various Campylobacter species and with different bacteria.  
 
Two proteins previously selected for knock outs were also found in the final analysis 
result obtained from the present study. These were Cj 0428 (gi _218562086) and Cj 
1656c (gi_218563245). Cj 0428 (gi _218562086) showed homology with various 
Campylobacter species, whereas Cj 1656c (gi_218563245) showed homology to 
various Campylobacter spp and Helicobacter. Out of the 109 selected proteins, eight 
proteins were shown to have homologues in various Campylobacter species and also 
Helicobacter. Interestingly these proteins have no homologue encoded by the C. 
concisus genome, which like Helicobacter is a human pathogen.  
 
Fifteen proteins were found to have no homologue outside C. jejuni, so these may be 
truly C. jejuni specific. Therefore future investigation of these 15 C. jejuni specific 
proteins should be considered. The investigation of predicted secreted proteins is 
crucial for understanding the bacterium–host interactions as protein secretion is a 
key virulence mechanism of pathogenic bacteria [315, 330]. It may be prudent to 
investigate such proteins as possible vaccine candidates against chicken colonisation 
by Campylobacter.   
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 In the second stage of analysis, various bioinformatics tools were used to further 
explore the genome of C. concisus. A total of 2080 proteins were analysed, with 749 
proteins predicted to be secreted proteins. Out of the 749 secreted proteins identified, 
424 were found to be classically secreted and 325 were predicted to be non-
classically secreted proteins. This is a relatively higher proportion of non-classically 
secreted proteins present in C. concisus than C. jejuni (112). The C. concisus 
genome encodes 2080 proteins whereas 1654 are predicted to be encoded in C. 
jejuni. Predicted locations of the 749 predicted secreted proteins were analysed. Out 
of these 749 predicted secreted proteins analysed 395 proteins were found to be with 
no transmembrane helix. One hundred and seventy proteins of the 395 were 
predicted to be secreted extracellularly. These 170 proteins of C. concisus are 
considered at the top of the list for investigating the virulence properties of C. 
concisus. Out of these 749 predicted secreted proteins analysed, 469 were found to 
be beta barrel proteins. As OMBBs (outer membrane beta barrel proteins) perform 
diverse functional roles such as bacterial adhesion, material transport and are located 
in the outer membrane, they are also important to identify in genomes [329]. As they 
are present in the outer membrane the further analysis to these 469 proteins also 
might be a useful method to find out the possible virulence factors of C. conscisus. 
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This study was undertaken to identify Campylobacter antigens that may be 
candidates for a vaccine in poultry. As the antibodies present in adult chickens are 
presumably involved in the observed reduction in Campylobacter colonization in 
older birds, and the absence of colonization in young chicks, the targets of these 
antibodies may be potential candidates. If immune responses can be raised against 
these in young chicks, colonization may be slowed. Previous studies have identified 
targets of outer membrane proteins recognized by maternal antibodies [280]. This 
study has selected such antigens and engineered them to be delivered by STM-1 to 
the immune system of chickens. Subsequent challenge of the chicken with 
Campylobacter enables enumeration of the colonization level.  Although there was a 
reduction in the colonization level, the reduction observed was not high enough to 
develop viable vaccines. Anecdotally, industry would need a 5 log reduction in the 
colonization level in order to reduce carcass contamination to a negligible level. 
Therefore, the antigens tested here, although partially inducing a reduction in 
colonization, might not be optimal for delivery by STM1. Although this experiment 
demonstrated that STM 1 is a useful vaccine vector to deliver hetrologous antigens, 
subsequent work was undertaken was identify further potential Campylobacter 
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antigens that may induce a reduction in the colonization of Campylobacter in 
chickens. 
 
To identify Campylobacter antigens responsible for colonization in chickens or that 
can induce a stronger humoral immune response, bioinformatics tools were used to 
analyze the complete sequenced genome of C. jejuni. Out of 1623 proteins analysed, 
407 were predicted to be secreted into the extracellular environment or inserted into 
the membrane. The investigation of secreted proteins is crucial for understanding the 
bacterium–host interactions as protein secretion is a key virulence mechanism of 
pathogenic bacteria [331]. In this study, bioinformatics tools were used to identify 
genes encoding proteins that are fully or partially extracellular in the bacterium, and 
therefore may induce a humoral immune response in the host and/or be responsible 
for the remarkable colonizing capability of Campylobacter in chickens. These 
proteins may be targets of an anti-colonization vaccine. Further characterization of 
the C. jejuni proteome identified 41 proteins as top candidates. These proteins are 
non-classically secreted proteins and were predicted to be secreted extracellularly 
with no transmembrane helix. Some of these are orphan proteins. These are of 
particular interest as these are the macromolecules which interact within the host and 
may be able to induce humoral immune responses. If they are “orphan” proteins that 
are either only identified in C. jejuni or only in Campylobacter species, the proteins 
are presumably undertaking species-specific tasks. Due to the time constraints it was 
not possible to undertake mutagenesis studies on all potential proteins on the list. 
However, the results presented in this study have provided a foundation for the 
future work related to the colonization study. Bioinformatics studies shortlisted 
several proteins of interest and Cj0391c, Cj0428, Cj1450 and Cj1656c were included 
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in the aforementioned list. The proteins Cj1656c and Cj0391c showed similarity with 
Campylobacter and Helicobacter and were also included. Cj0428 is a hypothetical 
non-classically secreted protein and shows similarity with only Campylobacters such 
as C. jejuni and C. coli. Cj0243c and Cj1450 are co-regulated with flagellar genes 
and show similarity with various bacterial species. Bioinformatics analyses and 
information obtained from United States Patent 20080003234 led to the selection of 
these proteins for mutagenesis studies. Previous studies had demonstrated the utility 
of mutants of C. jejuni that were created for studies of the genes encoding proteins 
associated with motility and  chemotaxis [323]. Therefore it is evident that the role 
of the encoded proteins can be revealed by the testing of mutants in vitro. Human 
epithelial cells (INT407) were used to analyze the bacterial host interaction of the 
mutant strains. Significant differences in adhesion properties were found between 
different knock out strains. C. jejuni mutants Cj0428 and Cj1656c adhere to cultured 
human epithelial cells as readily as the wild type parent strain indicating that the 
proteins encoded by these genes are not a predominant factor in the colonization, 
although they might be contributing some factors for internalization. The mutant 
Cj1450 showed a two-fold reduction in colonization compared with the wild-type 
strain (P < 0.05). This indicates that the protein encoded by this gene may be 
involved in the interaction between bacterial and host cells. One of the knock out 
strains (Cj 0391c) showed no adhesion to epithelial cells. The gene encoded by this 
protein is a “hypothetical” non-classically secreted protein and does not have an 
assigned function. As determined by bioinformatics studies, the protein is predicted 
to be 22.7 kDa, and to be secreted from the bacterium. This protein has undefined 
function and shares no sequence similarity with proteins from any organism except 
Campylobacter and Helicobacter. As the mutant strain shows no adherence/invasion 
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into an epithelial cell line, it is tempting to hypothesize that the normal role of this 
protein is to facilitate these processes. It is interesting that it is predicted that these 
proteins are actually fully secreted from Campylobacter cells, and therefore would 
presumably not a simple “linking” molecule that bridges the bacterial and host cells. 
There may be interplay between a numbers of factors released by host cells or other 
proteins secreted from the bacteria itself that are involved in adherence or perhaps 
the secreted proteins bind directly to the host cells and facilitate adherence. Further 
work will be required to demonstrate the mechanisms of action. 
 
This study also investigated a comparative evaluation between the proteomes of C. 
jejuni (a commensal organism in chickens) and C. concisus (which is a non- 
colonizer in chickens) using bioinformatics techniques. This comparative analysis 
identified C. jejuni specific proteins with no homologue identified encoded by the C. 
concisus genome, at an E value cutoff of 0.01. Out of the 407 putative secreted C. 
jejuni proteins analysed 109 such proteins were found. Therefore some of these 
proteins may be involved in facilitating chicken colonization. Interestingly two of the 
proteins selected for knock-outs by the first bioinformatics analyses were also 
shortlisted in the analyses conducted for the proteome comparison between C. jejuni 
and C. concisus. This analysis provides the foundation to choose potential antigens 
for future vaccination studies.  
 
Conversely, the proteome analysis of C. concisus revealed 170 proteins that were 
predicted to be secreted extracellularly, and with no transmembrane helices. 
Therefore these potentially secreted proteins should be considered as top candidates 
to study the virulence mechanisms of C. concisus. 
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Future Directions 
The studies that have been reported here raise many interesting questions and point 
the directions for future research. Some of these are listed below. 
1. What is the level of chicken colonization of each of the mutant strains? For 
these studies, a chicken colonization trial can be performed as described by 
Bachtiar et al [332].  
2. Do any of the five proteins identified have direct effects on chicken cells? 
This can be undertaken by generating recombinant protein. Such a study has 
commenced for one protein, which has been shown in preliminary 
experiments to kill chicken macrophages (Monica Mu, personal 
communication). 
3. Are any of the five proteins potential vaccine candidates? This can be tested 
with a further vaccine trial, as described in Chapter 3.  
4. Finally, the comparison of the proteomes of C. jejuni and C. concisus has 
identified a large number or proteins that potentially can interact with host 
cells, and therefore be targets for immunoprophylaxis. Further study of some 
of these proteins by each of the methods described above may be very 
fruitful.  
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Appendix 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1: Precise molecular weights of the PstI DNA marker 
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Appendix II 
 
 
 
 
Figure A2: Plasmid map of vector pBSII SK 
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Appendix III 
 
 
 
 
 
 
Figure A3: Plasmid map of vector pMW2 
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Appendix IV 
Classically secreted proteins of C. jejuni 
 
 
>gi|218563311 
>gi|218563309 
>gi|218563307 
>gi|218563274 
>gi|218563273 
>gi|218563267  
>gi|218563265  
>gi|218563258  
>gi|218563257  
>gi|218563256  
>gi|218563254  
>gi|218563252  
>gi|218563249  
>gi|218563246  
>gi|218563246  
>gi|218563218  
>gi|218563215  
>gi|218563214  
>gi|218563210  
>gi|218563206  
>gi|218563204  
>gi|218563203  
>gi|218563176  
>gi|218563172  
>gi|218563171  
>gi|218563157  
>gi|218563154  
>gi|218563153 
>gi|218563137 
>gi|218563133 
>gi|218563125 
>gi|218563115 
>gi|218563112 
>gi|218563111 
>gi|218563109 
>gi|218563100 
>gi|218563097 
>gi|218563090 
>gi|218563087 
>gi|218563086 
>gi|218563085 
>gi|218563084 
>gi|218563079 
>gi|218563075 
>gi|218563065 
>gi|218563059 
>gi|218563055 
>gi|218563048 
>gi|218563014 
>gi|218563010 
>gi|218562990 
>gi|218562989 
>gi|218562985 
>gi|218562982 
>gi|218562981 
>gi|218562980 
>gi|218562972 
>gi|218562967 
>gi|218562966 
>gi|218562965 
>gi|218562964 
>gi|218562962 
>gi|218562961 
>gi|218562960 
>gi|218562956 
>gi|218562954 
>gi|218562952 
>gi|218562900 
>gi|218562894 
>gi|218562891 
>gi|218562888 
>gi|218562887 
>gi|218562871 
>gi|218562869 
>gi|218562864 
>gi|218562853 
>gi|218562852 
>gi|218562847 
>gi|218562840 
>gi|218562831 
>gi|218562827 
>gi|218562826 
>gi|218562824 
>gi|218562821 
>gi|218562819 
>gi|218562812 
>gi|218562798 
>gi|218562789 
>gi|218562782 
>gi|218562781 
>gi|218562777 
>gi|218562772 
>gi|218562766 
>gi|218562765 
>gi|218562744 
>gi|218562734 
>gi|218562720 
>gi|218562707 
>gi|218562693 
>gi|218562692 
>gi|218562688 
>gi|218562676 
>gi|218562669 
>gi|218562657 
>gi|218562654 
>gi|218562649 
>gi|218562648 
>gi|218562647 
>gi|218562645 
>gi|218562642 
>gi|218562641 
>gi|218562637 
>gi|218562635 
>gi|218562634 
>gi|218562632 
>gi|218562629 
>gi|218562628 
>gi|218562623 
>gi|218562621 
>gi|218562620 
>gi|218562615 
>gi|218562614 
>gi|218562599 
>gi|218562598 
>gi|218562595 
>gi|218562594 
>gi|218562585 
>gi|218562583 
>gi|218562571 
>gi|218562569 
>gi|218562567 
>gi|218562563 
>gi|218562562 
>gi|218562560 
>gi|218562559 
>gi|218562557 
>gi|218562556 
>gi|218562555 
>gi|218562554 
>gi|218562553 
>gi|218562540 
>gi|218562536 
>gi|218562528 
>gi|218562526 
>gi|218562509 
gi_218562500 
gi_218562497 
gi_218562496 
gi_218562494 
gi_218562492 
gi_218562484 
gi_218562482 
gi_218562478 
gi_218562471 
gi_218562470 
gi_218562462 
gi_218562460 
gi_218562454 
gi_218562453 
gi_218562448 
191 
 
gi_218562446 
gi_218562445 
gi_218562431 
gi_218562412 
gi_218562411 
gi_218562409 
gi_218562408 
gi_218562406 
gi_218562400 
gi_218562399 
gi_218562398 
gi_218562384 
gi_218562383 
gi_218562376 
gi_218562374 
gi_218562373 
gi_218562370 
gi_218562367 
gi_218562366 
gi_218562362 
gi_218562354 
gi_218562326 
gi_218562322 
gi_218562298 
gi_218562296 
gi_218562295 
gi_218562283 
gi_218562279 
gi_218562266 
gi_218562265 
gi_218562264 
gi_218562261 
gi_218562260 
gi_218562259 
gi_218562257 
gi_218562254 
gi_218562252 
gi_218562247 
gi_218562245 
gi_218562243 
gi_218562242 
gi_218562238 
gi_218562216 
gi_218562213 
gi_218562205 
gi_218562192 
gi_218562184 
gi_218562182 
gi_218562175 
gi_218562169 
gi_218562164 
gi_218562161 
gi_218562152 
gi_218562149 
gi_218562141 
gi_218562095 
gi_218562088 
gi_218562083 
gi_218562082 
gi_218562078 
gi_218562072 
gi_218562071 
gi_218562064 
gi_218562054 
gi_218562045 
gi_218562037 
gi_218562034 
gi_218562033 
gi_218562029 
gi_218562025 
gi_218562024 
gi_218562023 
gi_218562017 
gi_218562000 
gi_218561962 
gi_218561951 
gi_218561940 
gi_218561928 
gi_218561927 
gi_218561926 
gi_218561923 
gi_218561902 
gi_218561880 
gi_218561879 
gi_218561861 
gi_218561860 
gi_218561858 
gi_218561857 
gi_218561856 
gi_218561855 
gi_218561854 
gi_218561853 
gi_218561848 
gi_218561847 
gi_218561839 
gi_218561832 
gi_218561826 
gi_218561825 
gi_218561824 
gi_218561812 
gi_218561810 
gi_218561805 
gi_218561795 
gi_218561794 
gi_218561793 
gi_218561784 
gi_218561774 
gi_218561773 
gi_218561772 
gi_218561771 
gi_218561770 
gi_218561762 
gi_218561761 
gi_218561760 
gi_218561758 
gi_218561753 
gi_218561743 
gi_218561742 
gi_218561729 
gi_218561727 
gi_218561726 
gi_218561722 
gi_218561720 
gi_218561713 
gi_218561711 
gi_218561710 
gi_218561707 
gi_218561704 
gi_218561699 
gi_218561697 
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Non-classically secreted proteins of C. jejuni 
 
>gi|218563315  
>gi|218563293  
>gi|218563292  
>gi|218563291  
>gi|218563290 
>gi|218563289 
>gi|218563288 
>gi|218563282 
>gi|218563278 
>gi|218563275 
>gi|218563245 
>gi|218563242 
>gi|218563220 
>gi|218563219 
>gi|218563200 
>gi|218563182 
>gi|218563101 
>gi|218563080 
>gi|218563069 
>gi|218563067 
>gi|218563066 
>gi|218563053 
>gi|218562998 
>gi|218562994 
>gi|218562991 
>gi|218562974 
>gi|218562957 
>gi|218562948 
>gi|218562947 
>gi|218562881 
>gi|218562872 
>gi|218562870 
>gi|218562867 
>gi|218562854 
>gi|218562844 
>gi|218562837 
>gi|218562805 
>gi|218562801 
>gi|218562788 
>gi|218562776 
>gi|218562710 
>gi|218562685 
>gi|218562675 
>gi|218562652 
>gi|218562591 
>gi|218562590 
>gi|218562588 
>gi|218562587 
>gi|218562586 
>gi|218562580 
>gi|218562535 
>gi|218562532 
>gi|218562507 
gi_218562499 
gi_218562495 
gi_218562487 
gi_218562477 
gi_218562476 
gi_218562467 
gi_218562444 
gi_218562443 
gi_218562442 
gi_218562422 
gi_218562404 
gi_218562382 
gi_218562380 
gi_218562379 
gi_218562378 
gi_218562377 
gi_218562375 
gi_218562359 
gi_218562339 
gi_218562337 
gi_218562336 
gi_218562333 
gi_218562326 
gi_218562211 
gi_218562200 
gi_218562180 
gi_218562179 
gi_218562178 
gi_218562146 
gi_218562130 
gi_218562129 
gi_218562126 
gi_218562105 
gi_218562097 
gi_218562093 
gi_218562086 
gi_218562076 
gi_218562073 
gi_218562063 
gi_218562049 
gi_218561992 
gi_218561989 
gi_218561931 
gi_218561914 
gi_218561907 
gi_218561906 
gi_218561899 
gi_218561898 
gi_218561881 
gi_218561849 
gi_218561836 
gi_218561833 
gi_218561792 
gi_218561741 
gi_218561740 
gi_218561735 
gi_218561734 
gi_218561733 
gi_218561698 
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Appendix V 
Predicted secreted proteins of C. concisus
Classically secreted proteins (424) 
gi_158604946_gb_ABW74763.1_ 
gi_158604950_gb_ABW74767.1_ 
gi_158604953_gb_ABW74770.1_ 
gi_158604955_gb_ABW74771.1_ 
gi_158604960_gb_ABW74776.1_ 
gi_158604972_gb_ABW74786.1_ 
gi_158604973_gb_ABW74787.1_ 
gi_158604975_gb_ABW74789.1_ 
gi_158604984_gb_EAT97760.3_ 
gi_158604991_gb_ABW74803.1_ 
gi_158605001_gb_ABW74811.1_ 
gi_158605017_gb_ABW74818.1_ 
gi_158605029_gb_ABW74830.1_ 
gi_158605032_gb_ABW74833.1_ 
gi_158605036_gb_ABW74834.1_ 
gi_158605037_gb_ABW74835.1_ 
gi_158605040_gb_ABW74838.1_ 
gi_157101576_gb_EAT98146.2_ 
gi_157101579_gb_EAT98301.2_ 
gi_157101580_gb_EAT97360.2_ 
gi_157101582_gb_ABV23534.1_ 
gi_158604901_gb_ABW74725.1_ 
gi_158604903_gb_ABW74727.1_ 
gi_158604905_gb_ABW74729.1_ 
gi_158604908_gb_ABW74732.1_ 
gi_158604910_gb_ABW74733.1_ 
gi_158604918_gb_ABW74741.1_ 
gi_158604922_gb_ABW74742.1_ 
gi_158604930_gb_ABW74749.1_ 
gi_158604942_gb_ABW74759.1_ 
gi_158604944_gb_ABW74761.1_ 
gi_157101479_gb_EAT97585.2_ 
gi_157101482_gb_EAT97765.2_ 
gi_157101486_gb_EAT97368.2_ 
gi_157101508_gb_EAT98488.2_ 
gi_157101509_gb_EAT98140.2_ 
gi_157101512_gb_EAT97864.2_ 
gi_157101517_gb_EAT97220.2_ 
gi_157101520_gb_EAT98475.2_ 
gi_157101521_gb_ABV23523.1_ 
gi_157101523_gb_EAT97517.2_ 
gi_157101527_gb_EAT99156.2_ 
gi_157101530_gb_EAT97998.2_ 
gi_157101548_gb_EAT98418.2_ 
gi_157101549_gb_EAT99324.2_ 
gi_157101557_gb_EAT98002.2_ 
gi_157101560_gb_EAT97233.2_ 
gi_157101569_gb_EAT97861.2_ 
gi_157101570_gb_EAT97907.2_ 
gi_157101477_gb_EAT97556.2_ 
gi_157101460_gb_EAT98257.2_ 
gi_157101462_gb_EAT97719.2_ 
gi_157101468_gb_EAT97207.2_ 
gi_112802037_gb_EAT99381.1_ 
gi_112802043_gb_EAT99387.1_ 
gi_157101371_gb_EAT98651.2_ 
gi_157101384_gb_EAT98268.2_ 
gi_157101390_gb_EAT97775.2_ 
gi_157101392_gb_EAT97391.2_ 
gi_157101397_gb_EAT98156.2_ 
gi_157101399_gb_ABV23506.1_ 
gi_157101401_gb_EAT97285.2_ 
gi_157101402_gb_EAT97246.2_ 
gi_157101404_gb_ABV23508.1_ 
gi_157101411_gb_EAT97213.2_ 
gi_157101415_gb_EAT97495.2_ 
gi_157101422_gb_EAT97232.2_ 
gi_157101434_gb_EAT97919.2_ 
gi_157101436_gb_EAT98255.2_ 
gi_157101439_gb_EAT97736.2_ 
gi_157101445_gb_EAT97412.2_ 
gi_157101446_gb_EAT98590.2_ 
gi_157101447_gb_EAT98032.2_ 
gi_157101450_gb_EAT97551.2_ 
gi_112801956_gb_EAT99300.1_ 
gi_112801964_gb_EAT99308.1_ 
gi_112801968_gb_EAT99312.1_ 
gi_112801970_gb_EAT99314.1_ 
gi_112801972_gb_EAT99316.1_ 
gi_112801978_gb_EAT99322.1_ 
gi_112801991_gb_EAT99335.1_ 
gi_112802002_gb_EAT99346.1_ 
gi_112802006_gb_EAT99350.1_ 
     gi_112802014_gb_EAT99358.1_ 
gi_112802024_gb_EAT99368.1_ 
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gi_112802031_gb_EAT99375.1_ 
gi_112802035_gb_EAT99379.1_ 
gi_112801847_gb_EAT99191.1_ 
gi_112801855_gb_EAT99199.1_ 
gi_112801871_gb_EAT99215.1_ 
gi_112801874_gb_EAT99218.1_ 
gi_112801877_gb_EAT99221.1_ 
gi_112801883_gb_EAT99227.1_ 
gi_112801910_gb_EAT99254.1_ 
gi_112801918_gb_EAT99262.1_ 
gi_112801941_gb_EAT99285.1_ 
gi_112801732_gb_EAT99076.1_ 
gi_112801739_gb_EAT99083.1_ 
gi_112801749_gb_EAT99093.1_ 
gi_112801750_gb_EAT99094.1_ 
gi_112801758_gb_EAT99102.1_ 
gi_112801759_gb_EAT99103.1_ 
gi_112801760_gb_EAT99104.1_ 
gi_112801761_gb_EAT99105.1_ 
gi_112801772_gb_EAT99116.1_ 
gi_112801775_gb_EAT99119.1_ 
gi_112801780_gb_EAT99124.1_ 
gi_112801790_gb_EAT99134.1_ 
gi_112801801_gb_EAT99145.1_ 
gi_112801802_gb_EAT99146.1_ 
gi_112801803_gb_EAT99147.1_ 
gi_112801805_gb_EAT99149.1_ 
gi_112801813_gb_EAT99157.1_ 
gi_112801816_gb_EAT99160.1_ 
gi_112801823_gb_EAT99167.1_ 
gi_112801825_gb_EAT99169.1_ 
gi_112801826_gb_EAT99170.1_ 
gi_112801832_gb_EAT99176.1_ 
gi_112801633_gb_EAT98977.1_ 
gi_112801638_gb_EAT98982.1_ 
gi_112801650_gb_EAT98994.1_ 
gi_112801661_gb_EAT99005.1_ 
gi_112801666_gb_EAT99010.1_ 
gi_112801689_gb_EAT99033.1_ 
gi_112801690_gb_EAT99034.1_ 
gi_112801706_gb_EAT99050.1_ 
gi_112801707_gb_EAT99051.1_ 
gi_112801711_gb_EAT99055.1_ 
gi_112801716_gb_EAT99060.1_ 
gi_112801718_gb_EAT99062.1_ 
gi_112801720_gb_EAT99064.1_ 
gi_112801724_gb_EAT99068.1_ 
gi_112801729_gb_EAT99073.1_ 
gi_112801578_gb_EAT98922.1_ 
gi_112801591_gb_EAT98935.1_ 
gi_112801592_gb_EAT98936.1_ 
gi_112801596_gb_EAT98940.1_ 
gi_112801608_gb_EAT98952.1_ 
gi_112801610_gb_EAT98954.1_ 
gi_112801611_gb_EAT98955.1_ 
gi_112801618_gb_EAT98962.1_ 
gi_112801626_gb_EAT98970.1_ 
gi_112801481_gb_EAT98825.1_ 
gi_112801499_gb_EAT98843.1_ 
gi_112801501_gb_EAT98845.1_ 
gi_112801503_gb_EAT98847.1_ 
gi_112801505_gb_EAT98849.1_ 
gi_112801520_gb_EAT98864.1_ 
gi_112801526_gb_EAT98870.1_ 
gi_112801532_gb_EAT98876.1_ 
gi_112801536_gb_EAT98880.1_ 
gi_112801540_gb_EAT98884.1_ 
gi_112801545_gb_EAT98889.1_ 
gi_112801552_gb_EAT98896.1_ 
gi_112801555_gb_EAT98899.1_ 
gi_112801556_gb_EAT98900.1_ 
gi_112801558_gb_EAT98902.1_ 
gi_112801562_gb_EAT98906.1_ 
gi_112801563_gb_EAT98907.1_ 
gi_112801388_gb_EAT98732.1_ 
gi_112801400_gb_EAT98744.1_ 
gi_112801402_gb_EAT98746.1_ 
gi_112801405_gb_EAT98749.1_ 
gi_112801410_gb_EAT98754.1_ 
gi_112801412_gb_EAT98756.1_ 
gi_112801415_gb_EAT98759.1_ 
gi_112801417_gb_EAT98761.1_ 
gi_112801418_gb_EAT98762.1_ 
gi_112801425_gb_EAT98769.1_ 
gi_112801432_gb_EAT98776.1_ 
gi_112801444_gb_EAT98788.1_ 
gi_112801452_gb_EAT98796.1_ 
gi_112801469_gb_EAT98813.1_ 
gi_112801305_gb_EAT98649.1_ 
gi_112801309_gb_EAT98653.1_ 
gi_112801317_gb_EAT98661.1_ 
gi_112801318_gb_EAT98662.1_ 
gi_112801319_gb_EAT98663.1_ 
gi_112801323_gb_EAT98667.1_ 
gi_112801333_gb_EAT98677.1_ 
gi_112801344_gb_EAT98688.1_ 
gi_112801345_gb_EAT98689.1_ 
gi_112801347_gb_EAT98691.1_ 
gi_112801356_gb_EAT98700.1_ 
gi_112801362_gb_EAT98706.1_ 
gi_112801363_gb_EAT98707.1_ 
gi_112801378_gb_EAT98722.1_ 
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gi_112801380_gb_EAT98724.1_ 
gi_112801386_gb_EAT98730.1_ 
gi_112801387_gb_EAT98731.1_ 
gi_112801203_gb_EAT98547.1_ 
gi_112801204_gb_EAT98548.1_ 
gi_112801209_gb_EAT98553.1_ 
gi_112801210_gb_EAT98554.1_ 
gi_112801219_gb_EAT98563.1_ 
gi_112801223_gb_EAT98567.1_ 
gi_112801231_gb_EAT98575.1_ 
gi_112801232_gb_EAT98576.1_ 
gi_112801250_gb_EAT98594.1_ 
gi_112801253_gb_EAT98597.1_ 
gi_112801255_gb_EAT98599.1_ 
gi_112801256_gb_EAT98600.1_ 
gi_112801258_gb_EAT98602.1_ 
gi_112801264_gb_EAT98608.1_ 
gi_112801276_gb_EAT98620.1_ 
gi_112801283_gb_EAT98627.1_ 
gi_112801297_gb_EAT98641.1_ 
gi_112801301_gb_EAT98645.1_ 
gi_112801120_gb_EAT98464.1_ 
gi_112801125_gb_EAT98469.1_ 
gi_112801130_gb_EAT98474.1_ 
gi_112801143_gb_EAT98487.1_ 
gi_112801147_gb_EAT98491.1_ 
gi_112801148_gb_EAT98492.1_ 
gi_112801150_gb_EAT98494.1_ 
gi_112801152_gb_EAT98496.1_ 
gi_112801164_gb_EAT98508.1_ 
gi_112801170_gb_EAT98514.1_ 
gi_112801171_gb_EAT98515.1_ 
gi_112801179_gb_EAT98523.1_ 
gi_112801183_gb_EAT98527.1_ 
gi_112801184_gb_EAT98528.1_ 
gi_112801187_gb_EAT98531.1_ 
gi_112801194_gb_EAT98538.1_ 
gi_112801198_gb_EAT98542.1_ 
gi_112801200_gb_EAT98544.1_ 
gi_112801045_gb_EAT98389.1_ 
gi_112801051_gb_EAT98395.1_ 
gi_112801058_gb_EAT98402.1_ 
gi_112801060_gb_EAT98404.1_ 
gi_112801063_gb_EAT98407.1_ 
gi_112801066_gb_EAT98410.1_ 
gi_112801073_gb_EAT98417.1_ 
gi_112801079_gb_EAT98423.1_ 
gi_112801081_gb_EAT98425.1_ 
gi_112801083_gb_EAT98427.1_ 
gi_112801084_gb_EAT98428.1_ 
gi_112801087_gb_EAT98431.1_ 
gi_112801094_gb_EAT98438.1_ 
gi_112801105_gb_EAT98449.1_ 
gi_112801107_gb_EAT98451.1_ 
gi_112801112_gb_EAT98456.1_ 
gi_112800938_gb_EAT98282.1_ 
gi_112800939_gb_EAT98283.1_ 
gi_112800941_gb_EAT98285.1_ 
gi_112800950_gb_EAT98294.1_ 
gi_112800954_gb_EAT98298.1_ 
gi_112800956_gb_EAT98300.1_ 
gi_112800979_gb_EAT98323.1_ 
gi_112800989_gb_EAT98333.1_ 
gi_112801002_gb_EAT98346.1_ 
gi_112801005_gb_EAT98349.1_ 
gi_112801011_gb_EAT98355.1_ 
gi_112801016_gb_EAT98360.1_ 
gi_112801020_gb_EAT98364.1_ 
gi_112801021_gb_EAT98365.1_ 
gi_112801029_gb_EAT98373.1_ 
gi_112800847_gb_EAT98191.1_ 
gi_112800866_gb_EAT98210.1_ 
gi_112800875_gb_EAT98219.1_ 
gi_112800877_gb_EAT98221.1_ 
gi_112800889_gb_EAT98233.1_ 
gi_112800903_gb_EAT98247.1_ 
gi_112800905_gb_EAT98249.1_ 
gi_112800919_gb_EAT98263.1_ 
gi_112800920_gb_EAT98264.1_ 
gi_112800930_gb_EAT98274.1_ 
gi_112800748_gb_EAT98092.1_ 
gi_112800752_gb_EAT98096.1_ 
gi_112800763_gb_EAT98107.1_ 
gi_112800766_gb_EAT98110.1_ 
gi_112800773_gb_EAT98117.1_ 
gi_112800777_gb_EAT98121.1_ 
gi_112800783_gb_EAT98127.1_ 
gi_112800785_gb_EAT98129.1_ 
gi_112800786_gb_EAT98130.1_ 
gi_112800791_gb_EAT98135.1_ 
gi_112800800_gb_EAT98144.1_ 
gi_112800801_gb_EAT98145.1_ 
gi_112800806_gb_EAT98150.1_ 
gi_112800811_gb_EAT98155.1_ 
gi_112800818_gb_EAT98162.1_ 
gi_112800633_gb_EAT97977.1_ 
gi_112800635_gb_EAT97979.1_ 
gi_112800637_gb_EAT97981.1_ 
gi_112800639_gb_EAT97983.1_ 
gi_112800641_gb_EAT97985.1_ 
gi_112800643_gb_EAT97987.1_ 
gi_112800648_gb_EAT97992.1_ 
196 
 
gi_112800650_gb_EAT97994.1_ 
gi_112800656_gb_EAT98000.1_ 
gi_112800659_gb_EAT98003.1_ 
gi_112800662_gb_EAT98006.1_ 
gi_112800672_gb_EAT98016.1_ 
gi_112800673_gb_EAT98017.1_ 
gi_112800676_gb_EAT98020.1_ 
gi_112800678_gb_EAT98022.1_ 
gi_112800681_gb_EAT98025.1_ 
gi_112800682_gb_EAT98026.1_ 
gi_112800693_gb_EAT98037.1_ 
gi_112800695_gb_EAT98039.1_ 
gi_112800697_gb_EAT98041.1_ 
gi_112800699_gb_EAT98043.1_ 
gi_112800700_gb_EAT98044.1_ 
gi_112800701_gb_EAT98045.1_ 
gi_112800703_gb_EAT98047.1_ 
gi_112800704_gb_EAT98048.1_ 
gi_112800708_gb_EAT98052.1_ 
gi_112800711_gb_EAT98055.1_ 
gi_112800714_gb_EAT98058.1_ 
gi_112800726_gb_EAT98070.1_ 
gi_112800727_gb_EAT98071.1_ 
gi_112800730_gb_EAT98074.1_ 
gi_112800522_gb_EAT97866.1_ 
gi_112800531_gb_EAT97875.1_ 
gi_112800532_gb_EAT97876.1_ 
gi_112800550_gb_EAT97894.1_ 
gi_112800554_gb_EAT97898.1_ 
gi_112800557_gb_EAT97901.1_ 
gi_112800564_gb_EAT97908.1_ 
gi_112800568_gb_EAT97912.1_ 
gi_112800578_gb_EAT97922.1_ 
gi_112800579_gb_EAT97923.1_ 
gi_112800580_gb_EAT97924.1_ 
gi_112800597_gb_EAT97941.1_ 
gi_112800599_gb_EAT97943.1_ 
gi_112800605_gb_EAT97949.1_ 
gi_112800613_gb_EAT97957.1_ 
gi_112800617_gb_EAT97961.1_ 
gi_112800622_gb_EAT97966.1_ 
gi_112800625_gb_EAT97969.1_ 
gi_112800626_gb_EAT97970.1_ 
gi_112800627_gb_EAT97971.1_ 
gi_112800418_gb_EAT97762.1_ 
gi_112800424_gb_EAT97768.1_ 
gi_112800428_gb_EAT97772.1_ 
gi_112800432_gb_EAT97776.1_ 
gi_112800443_gb_EAT97787.1_ 
gi_112800445_gb_EAT97789.1_ 
gi_112800452_gb_EAT97796.1_ 
gi_112800458_gb_EAT97802.1_ 
gi_112800464_gb_EAT97808.1_ 
gi_112800465_gb_EAT97809.1_ 
gi_112800468_gb_EAT97812.1_ 
gi_112800469_gb_EAT97813.1_ 
gi_112800471_gb_EAT97815.1_ 
gi_112800478_gb_EAT97822.1_ 
gi_112800480_gb_EAT97824.1_ 
gi_112800488_gb_EAT97832.1_ 
gi_112800304_gb_EAT97648.1_ 
gi_112800308_gb_EAT97652.1_ 
gi_112800312_gb_EAT97656.1_ 
gi_112800314_gb_EAT97658.1_ 
gi_112800321_gb_EAT97665.1_ 
gi_112800331_gb_EAT97675.1_ 
gi_112800338_gb_EAT97682.1_ 
gi_112800349_gb_EAT97693.1_ 
gi_112800353_gb_EAT97697.1_ 
gi_112800359_gb_EAT97703.1_ 
gi_112800363_gb_EAT97707.1_ 
gi_112800364_gb_EAT97708.1_ 
gi_112800369_gb_EAT97713.1_ 
gi_112800372_gb_EAT97716.1_ 
gi_112800377_gb_EAT97721.1_ 
gi_112800387_gb_EAT97731.1_ 
gi_112800222_gb_EAT97566.1_ 
gi_112800223_gb_EAT97567.1_ 
gi_112800229_gb_EAT97573.1_ 
gi_112800233_gb_EAT97577.1_ 
gi_112800236_gb_EAT97580.1_ 
gi_112800237_gb_EAT97581.1_ 
gi_112800239_gb_EAT97583.1_ 
gi_112800242_gb_EAT97586.1_ 
gi_112800245_gb_EAT97589.1_ 
gi_112800246_gb_EAT97590.1_ 
gi_112800252_gb_EAT97596.1_ 
gi_112800256_gb_EAT97600.1_ 
gi_112800271_gb_EAT97615.1_ 
gi_112800273_gb_EAT97617.1_ 
gi_112800277_gb_EAT97621.1_ 
gi_112800282_gb_EAT97626.1_ 
gi_112800296_gb_EAT97640.1_ 
gi_112800087_gb_EAT97431.1_ 
gi_112800090_gb_EAT97434.1_ 
gi_112800098_gb_EAT97442.1_ 
gi_112800100_gb_EAT97444.1_ 
gi_112800111_gb_EAT97455.1_ 
gi_112800113_gb_EAT97457.1_ 
gi_112800114_gb_EAT97458.1_ 
gi_112800116_gb_EAT97460.1_ 
gi_112800119_gb_EAT97463.1_ 
197 
 
gi_112800132_gb_EAT97476.1_ 
gi_112800159_gb_EAT97503.1_ 
gi_112800161_gb_EAT97505.1_ 
gi_112800169_gb_EAT97513.1_ 
gi_112800172_gb_EAT97516.1_ 
gi_112800174_gb_EAT97518.1_ 
gi_112800179_gb_EAT97523.1_ 
gi_112800193_gb_EAT97537.1_ 
gi_112799989_gb_EAT97333.1_ 
gi_112799998_gb_EAT97342.1_ 
gi_112799999_gb_EAT97343.1_ 
gi_112800001_gb_EAT97345.1_ 
gi_112800012_gb_EAT97356.1_ 
gi_112800013_gb_EAT97357.1_ 
gi_112800015_gb_EAT97359.1_ 
gi_112800042_gb_EAT97386.1_ 
gi_112800060_gb_EAT97404.1_ 
gi_112800064_gb_EAT97408.1_ 
gi_112800071_gb_EAT97415.1_ 
gi_112800073_gb_EAT97417.1_ 
gi_112800081_gb_EAT97425.1_ 
gi_112799900_gb_EAT97244.1_ 
gi_112799916_gb_EAT97260.1_ 
gi_112799928_gb_EAT97272.1_ 
gi_112799936_gb_EAT97280.1_ 
gi_112799946_gb_EAT97290.1_ 
gi_112799958_gb_EAT97302.1_ 
gi_112799962_gb_EAT97306.1_ 
gi_112799967_gb_EAT97311.1_ 
gi_112799979_gb_EAT97323.1_ 
gi_112799983_gb_EAT97327.1_ 
gi_112799985_gb_EAT97329.1_ 
 
Non-classically secreted proteins 
 
 
Non-classically secreted proteins 
(325) 
gi_158604947_gb_ABW74764.1_ 
gi_158604948_gb_ABW74765.1_ 
gi_158604954_gb_EAT98065.3_ 
gi_158604969_gb_ABW74784.1_ 
gi_158604972_gb_ABW74786.1_ 
gi_158604975_gb_ABW74789.1_ 
gi_158604991_gb_ABW74803.1_ 
gi_158605017_gb_ABW74818.1_ 
gi_158605037_gb_ABW74835.1_ 
gi_158605038_gb_ABW74836.1_ 
gi_158605039_gb_ABW74837.1_ 
gi_158605040_gb_ABW74838.1_ 
gi_157101580_gb_EAT97360.2_ 
gi_157101581_gb_EAT97199.2_ 
gi_157101583_gb_EAT97346.2_ 
gi_158604892_gb_ABW74718.1_ 
gi_158604896_gb_ABW74721.1_ 
gi_158604897_gb_ABW74722.1_ 
gi_158604916_gb_ABW74739.1_ 
gi_158604942_gb_ABW74759.1_ 
gi_157101482_gb_EAT97765.2_ 
gi_157101488_gb_EAT97269.2_ 
gi_157101489_gb_EAT97932.2_ 
gi_157101491_gb_ABV23517.1_ 
gi_157101493_gb_EAT97833.2_ 
gi_157101498_gb_EAT98278.2_ 
gi_157101501_gb_ABV23520.1_ 
gi_157101502_gb_EAT97217.2_ 
gi_157101504_gb_EAT98687.2_ 
gi_157101512_gb_EAT97864.2_ 
gi_157101514_gb_EAT97667.2_ 
gi_157101517_gb_EAT97220.2_ 
gi_157101523_gb_EAT97517.2_ 
gi_157101527_gb_EAT99156.2_ 
gi_157101528_gb_EAT97238.2_ 
gi_157101533_gb_EAT97730.2_ 
gi_157101557_gb_EAT98002.2_ 
gi_157101558_gb_EAT98296.2_ 
gi_157101566_gb_EAT97548.2_ 
gi_157101568_gb_EAT97911.2_ 
gi_157101569_gb_EAT97861.2_ 
gi_157101570_gb_EAT97907.2_ 
gi_157101476_gb_EAT97512.2_ 
gi_157101477_gb_EAT97556.2_ 
gi_157101460_gb_EAT98257.2_ 
gi_157101466_gb_EAT98656.2_ 
gi_157101468_gb_EAT97207.2_ 
gi_157101371_gb_EAT98651.2_ 
gi_157101384_gb_EAT98268.2_ 
gi_157101390_gb_EAT97775.2_ 
gi_157101402_gb_EAT97246.2_ 
gi_157101406_gb_ABV23510.1_ 
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gi_157101408_gb_EAT97216.2_ 
gi_157101422_gb_EAT97232.2_ 
gi_157101429_gb_EAT97240.2_ 
gi_157101438_gb_ABV23512.1_ 
gi_157101448_gb_EAT97268.2_ 
gi_157101450_gb_EAT97551.2_ 
gi_112801957_gb_EAT99301.1_ 
gi_112801964_gb_EAT99308.1_ 
gi_112801978_gb_EAT99322.1_ 
gi_112802014_gb_EAT99358.1_ 
gi_112802032_gb_EAT99376.1_ 
gi_112801850_gb_EAT99194.1_ 
gi_112801855_gb_EAT99199.1_ 
gi_112801864_gb_EAT99208.1_ 
gi_112801877_gb_EAT99221.1_ 
gi_112801883_gb_EAT99227.1_ 
gi_112801897_gb_EAT99241.1_ 
gi_112801904_gb_EAT99248.1_ 
gi_112801918_gb_EAT99262.1_ 
gi_112801930_gb_EAT99274.1_ 
gi_112801732_gb_EAT99076.1_ 
gi_112801734_gb_EAT99078.1_ 
gi_112801756_gb_EAT99100.1_ 
gi_112801759_gb_EAT99103.1_ 
gi_112801761_gb_EAT99105.1_ 
gi_112801762_gb_EAT99106.1_ 
gi_112801777_gb_EAT99121.1_ 
gi_112801800_gb_EAT99144.1_ 
gi_112801803_gb_EAT99147.1_ 
gi_112801814_gb_EAT99158.1_ 
gi_112801823_gb_EAT99167.1_ 
gi_112801824_gb_EAT99168.1_ 
gi_112801826_gb_EAT99170.1_ 
gi_112801843_gb_EAT99187.1_ 
gi_112801634_gb_EAT98978.1_ 
gi_112801643_gb_EAT98987.1_ 
gi_112801645_gb_EAT98989.1_ 
gi_112801650_gb_EAT98994.1_ 
gi_112801652_gb_EAT98996.1_ 
gi_112801655_gb_EAT98999.1_ 
gi_112801661_gb_EAT99005.1_ 
gi_112801678_gb_EAT99022.1_ 
gi_112801689_gb_EAT99033.1_ 
gi_112801690_gb_EAT99034.1_ 
gi_112801708_gb_EAT99052.1_ 
gi_112801711_gb_EAT99055.1_ 
gi_112801718_gb_EAT99062.1_ 
gi_112801722_gb_EAT99066.1_ 
gi_112801725_gb_EAT99069.1_ 
gi_112801729_gb_EAT99073.1_ 
gi_112801578_gb_EAT98922.1_ 
gi_112801610_gb_EAT98954.1_ 
gi_112801611_gb_EAT98955.1_ 
gi_112801625_gb_EAT98969.1_ 
gi_112801503_gb_EAT98847.1_ 
gi_112801505_gb_EAT98849.1_ 
gi_112801544_gb_EAT98888.1_ 
gi_112801555_gb_EAT98899.1_ 
gi_112801559_gb_EAT98903.1_ 
gi_112801563_gb_EAT98907.1_ 
gi_112801388_gb_EAT98732.1_ 
gi_112801391_gb_EAT98735.1_ 
gi_112801400_gb_EAT98744.1_ 
gi_112801410_gb_EAT98754.1_ 
gi_112801425_gb_EAT98769.1_ 
gi_112801434_gb_EAT98778.1_ 
gi_112801447_gb_EAT98791.1_ 
gi_112801449_gb_EAT98793.1_ 
gi_112801456_gb_EAT98800.1_ 
gi_112801457_gb_EAT98801.1_ 
gi_112801458_gb_EAT98802.1_ 
gi_112801305_gb_EAT98649.1_ 
gi_112801333_gb_EAT98677.1_ 
gi_112801344_gb_EAT98688.1_ 
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 One hundred and seventy proteins of C. concisus predicted to be secreted extracellularly with no THM 
 
158604946 
158604969 
158604972 
158604991 
158605038 
158605039 
158605040 
157101579 
157101580 
157101581 
157101583 
158604892 
158604896 
157101491 
157101493 
157101512 
157101527 
157101533 
157101566 
157101570 
157101477 
157101466 
157101468 
157101371 
157101406 
157101446 
157101448 
157101450 
112801964 
112802014 
112802032 
112801864 
112801877 
112801739 
112801758 
112801762 
112801777 
112801800 
112801814 
112801826 
112801643 
112801645 
112801652 
112801678 
112801711 
112801722 
112801725 
112801729 
112801611 
112801625 
112801503 
112801563 
112801388 
112801410 
112801412 
112801434 
112801447 
112801305 
112801318 
112801376 
112801386 
112801204 
112801205 
112801209 
112801213 
112801241 
112801248 
112801253 
112801255 
112801256 
112801278 
112801130 
112801139 
112801160 
112801164 
112801176 
112801186 
112801189 
112801194 
112801200 
112801044 
112801084 
112801105 
112801117 
112800975 
112800980 
112800996 
112801001 
112801005 
112801014 
112801016 
112801020 
112801021 
112801036 
112800870 
112800898 
112800744 
112800769 
112800773 
112800820 
112800639 
112800653 
112800659 
112800692 
112800697 
112800717 
112800515 
112800522 
112800525 
112800533 
112800561 
112800579 
112800584 
112800597 
112800617 
112800426 
112800435 
112800440 
112800457 
112800458 
112800469 
112800475 
112800504 
112800510 
112800304 
112800310 
112800312 
112800327 
112800331 
112800339 
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112800373 
112800376 
112800384 
112800211 
112800218 
112800219 
112800226 
112800230 
112800234 
112800242 
112800245 
112800252 
112800260 
112800263 
112800285 
112800300 
112800097 
112800100 
112800103 
112800114 
112800116 
112800117 
112800119 
112800172 
112800197 
112799999 
112800000 
112800012 
112800013 
12800015 
112800018 
112800041 
112800042 
112800071 
112800081 
112799926 
112799944 
112799946 
112799947 
112799948 
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